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SUMMARY 
The thymus provides throughout life the specialized stromal microenvironment required for the 
lifelong generation of naïve T cells. This vital function is dependent on the regular composition and 
organization of its microenvironment, where specialized stromal cells promote thymocytes development 
and selection to functionally mature T cells. The thymic stroma is heterogeneous and mainly composed of 
thymic epithelial cells (TEC) which can be broadly subdivided according to their anatomical location, 
morphology, specific antigenic properties and function into two specialized subsets, i.e. cortical (c) and 
medullary (m) TEC. Although it is well established that appropriate Wnt signalling activity is required for 
normal TEC development and maintenance, the cellular and molecular mechanisms responsible for their 
differentiation and homeostasis remain largely undefined. The canonical Wnt signalling engaging via β–
catenin directly regulates Foxn1 expression in TEC and a precise regulation of intracellular β-catenin 
protein levels is required for normal thymus development and function. Transcription factor Sox9 has 
been reported to physically interact with β-catenin to regulate Wnt/β-catenin transcriptional activity in 
chondrocytes. While the role of Sox9-Wnt interactions in development and maintenance of various organs 
has been acknowledged, no such association has yet been demonstrated in thymic epithelia and Sox9 
target genes in TEC have not yet been identified. 
 In the present study, we demonstrate that Sox9, which is differentially expressed in the thymus by 
non-hematopoietic stromal cells, negatively regulates TEC proliferation and inversely correlates with the 
expression of the transcription factor Foxn1. The TEC-targeted loss of Sox9 disturbs thymus genesis and 
results in a hypoplastic thymus with a phenotypically altered epithelial compartment. Mice with a TEC-
targeted Sox9 deficiency display subset-specific changes in TEC composition and proliferation, a 
phenotype which correlates with an upregulation of Foxn1 expression. Despite these alterations, 
thymopoiesis remains unaffected indicating that Sox9 expression is not required for the TEC`s capacity to 
support T cell development. In vitro studies revealed that Sox9 regulates Foxn1 transcription indirectly by 
binding and regulating the amount of intracellular β-catenin protein. This correlation suggests a crosstalk 
between Sox9 and the canonical Wnt pathway to occur in thymic epithelia. 
 To our best of knowledge, this study provides the first functional evidence that Sox9 controls TEC 
proliferation and differentiation in a dose-sensitive and subset-specific manner and negatively regulates 
Foxn1 expression in TEC. Although, the loss of Sox9 expression in TEC is not sufficient to jeopardize T 
cell development, differential Sox9 expression is critical for the establishment and maintenance of a 
regular thymic microenvironment. 
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1. INTRODUCTION 
The thymus is the primary lymphoid organ responsible for the lifelong generation of new T 
lymphocytes. This process is controlled by a unique stromal microenvironment which enables the 
attraction of hematopoietic precursors from the blood, foster their survival, and promote their expansion, 
maturation and eventual selection to functionally mature T cells (Anderson et al. 1996). A key feature of 
the thymic stroma is a highly organized network of specialized thymic epithelial cells (TEC) which exist as 
phenotypically and functionally different cortical (c) and medullary (m) TEC subsets (Anderson et al. 
2006). In the mouse, approximately one to two millions of newly generated T cells are exported every day 
from the thymus into the peripheral circulation where they contribute to the maintenance of the peripheral 
T cell pool. 
 
1.1. Fetal thymus organogenesis 
The development of a diverse and functionally competent thymic epithelial compartment is a 
prerequisite for regular thymopoiesis. Thymus organogenesis is a highly dynamic process and comprises 
a cascade of developmental events involving coordinated interactions between all three cell types: 
epithelial, mesenchymal and hematopoietic (Manley 2000); reviewed in (Blackburn and Manley 2004; 
Rodewald 2008). There are two main temporal phases in TEC development. The early organogenetic 
stage (i.e. until embryonic day (E) 12.5) is marked by events that result in the positioning, induction, 
outgrowth and initial pattering of the thymic rudiment. This stage is also characterized by epithelial–
mesenchymal interactions in the absence of thymocytes. Late stage organogenesis (i.e. E12.5-E15) 
critically depends on the concurrent presence of thymocytes and results in further epithelial differentiation 
into distinct cortical and medullary subsets. At completion of organogenesis, a fully developed primary 
lymphoid organ has been formed that is competent to generate mature thymocytes. 
 
1.1.1. Formation of the thymic rudiment 
Mouse thymus organogenesis initiates between E9-E11 with the out-budding of endoderm-derived 
epithelium of the third pharyngeal pouch (3
rd
pp) (Figure 1.1) (Manley 2000). The epithelial cells in the 
ventral aspect of 3
rd
pp adopt a thymic cell fate as early as E10.5. This lineage commitment is marked by 
the expression of the transcription factor Foxn1, a key regulator of TEC differentiation (Boehm and Bleul 
2006; Boehm 2008; Rodewald 2008; Corbeaux et al. 2010). During development, thymus-committed 
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epithelia grow into the underlying neural crest mesenchyme of the third and fourth pharyngeal arches. 
This epithelial-mesenchymal interaction creates at E10.5 a first visible, common thymus-parathyroid 
anlage although the signals initiating this formation may occur as early as E9.5 (Cordier and Heremans 
1975; Cordier and Haumont 1980). The molecular and cellular mechanisms responsible for forming the 
epithelial lining of the foregut and how these cells are induced to differentiate and acquire the 
competence to establish a thymus rudiment still remain largely unknown. 
Chick-quail chimera experiments showed that ectopically transplanted prospective pharyngeal 
endoderm of quail isolated prior to the pattering of the 3
rd
pp and the homing of pro-thymocytes to this 
anatomical region was already sufficiently primed to induce the formation of a normal thymic 
microenvironment able to support T cells of host origin (Le Douarin and Jotereau 1975). These findings 
were later confirmed in mice where purified pharyngeal endoderm of E8.5-E9 embryos transplanted 
under the kidney capsule of nude mice generated a functional thymus with a regular cortex/medulla 
organization, independent of physical contribution from the pharyngeal ectoderm (Gordon et al. 2004). 
Together, these experiments concluded that TEC derive solely from endoderm and established the 
"single origin" model of thymus development (Gordon et al. 2004). This contention refuted the “dual-
Figure 1.1 Formation of the thymic rudiment. 
Neural crest cells migrate to the 3
rd 
pharingeal pouch, transform to mesenchymal cells and surround the 
expanding epithelium. At E10.5 the epithelial cells in the ventral aspect of the 3
rd
 pouch commit to the TEC fate. 
The budding and eventual outgrowth of these committed cells forms a thymic rudiment that is morphologically 
detectable by E11.5. Subsequently, lymphoid precursors (shown as round cells with large nucleus) colonize the 
thymic rudiment. Around E12.5, late stage organogenesis begins, with the onset of thymocytes-TEC interactions 
which further pattern the epithelial rudiment. Neural crest-derived mesenchymal cells are shown in gray (taken 
from Manley, 2000). 
E10.5 
10.5 
E11.5 
10.5 
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origin” model that claimed cortical and medullary epithelium are derived from the 3
rd
 pharyngeal cleft 
ectoderm and 3
rd
pp endoderm, respectively (Cordier and Heremans 1975). Importantly, these studies 
also conveyed that at this early stage, cells in the pharyngeal endoderm are already specified to enter the 
TEC lineage well before the formation of the 3
rd
pp and overt signs of thymus organogenesis (Le Douarin 
and Jotereau 1975). However, molecular markers have not yet been identified that distinguish 
endodermal cells specified to give rise to TEC from cells with other fate. 
Budding and outgrowth of the common anlage at about E11.5 is coincident with separation into 
ventral and dorsal domains identified by the expression of transcription factors Foxn1 and Gcm2 (Gordon 
et al. 2001) which are essential for the development of thymus (Nehls et al. 1994; Nehls et al. 1996) and 
the parathyroid tissue (Liu et al. 2007), respectively. At this point in time, the prospective thymus 
epithelium is arranged in a two-dimensional bilayer containing phenotypically and morphologically 
homogenous cell populations that uniformly express cytokeratin (CK) 8, epithelial-cell-adhesion molecule 
1 (EpCam1) and MTS24 (Plet-1) but lack the expression of CK5 and markers used later to differentiate 
cortical and medullary TEC subsets (Klug et al. 2002; Gill et al. 2003). Subsequent to E11.5, the 
organization of TEC changes markedly with the epithelium converting by E12 to a clustered organization 
and by E13.5, TEC form a typical three-dimensional scaffold (Itoi et al. 2001). High level of Foxn1 
expression begins at E11.25 and is essential for subsequent TEC differentiation including the generation 
of distinct cortical and medullary epithelial subsets and the ability to attract T cell precursors (Nehls et al. 
1996). In the absence of functional Foxn1, TEC fail to progress beyond an immature phenotype and to 
attract lymphoid precursors (Nehls et al. 1996; Itoi et al. 2001; Boehm et al. 2003).  
First signs of the heterogeneity within the epithelial compartment are apparent by E12.5 when CK5 is 
upregulated in a discrete subset of TEC resulting in the emergence of a prominent CK5
+
CK8
+
 subset of 
stromal cells that is centrally located and surrounded by cortical CK5
-
CK8
+
 TEC. The CK5
+
CK8
+
 clusters 
contain MTS24
+
 progenitors and subsequently are primarily associated with mature mTEC (Klug et al. 
1998; Klug et al. 2000; Gill et al. 2002). The reciprocal interactions between TEC and thymocytes are 
required to achieve complete maturation of both cell types and are referred to as thymic crosstalk (van 
Ewijk et al. 1994). The formation and initial pattering of the TEC compartment during early stages in 
thymus development however, do not require inductive signals from hematopoietic cells (Klug et al. 2002; 
Jenkinson et al. 2005). This was demonstrated by analysing fetal thymi from Rag2/ɣc-deficient and Ikaros 
mutant mice in which, despite an early block in T cell development, the epithelial compartment organizes 
into a three-dimensional structure containing a predominant cortical CK5
-
CK8
+
 TEC subset and 
centralized CK5
+
CK8
+
 clusters of immature TEC progenitors (Klug et al. 2002). Blood-borne lymphoid 
precursors seed to the avascular thymus anlage at E11.5 (Cordier and Haumont 1980; Fontaine-Perus et 
al. 1981; Suniara et al. 1999) and are indispensable during late fetal stages for continued development 
and maintenance of TEC subsets in the postnatal thymus. 
Introduction 
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Late stage thymus organogenesis begins at around E12.5 with the onset of TEC–thymocyte 
interactions, which further pattern the epithelial rudiment. At E13.5 TEC begin to demonstrate further 
phenotypic heterogeneity, as determined by the expression of markers typically associated with cortical 
and medullary TEC. Binding to the Ulex europaeus agglutinin (UEA-1) lectin (Surh et al. 1992) and the 
expression of MTS10 (Klug et al. 1998), Claudin (Cld)-3 and 4 (Hamazaki et al. 2007) can be used to 
identify medullary, whereas the expression of Delta-like 4 (Dll4) (Tsukamoto et al. 2005), Ly51 (Gray et al. 
2006; Gray et al. 2007a), β5t (Murata et al. 2007) and CD205 (Shakib et al. 2009) to characterize cortical 
TEC subsets present at this stage. Beginning of E12.5 the common thymus/parathyroid primordium 
detaches from the pharyngeal lining and migrates under the influence of neural crest cells towards the 
anterior chest cavity eventually joining at the midline above the heart (Bockman 1997). A day later, the 
parathyroid and thymus domains physically separate and resolve into distinct organs. 
 
1.1.2. The role of mesenchyme in thymus development and function 
Studies have shown that most of the mesenchymal cells surrounding the early thymus anlage are 
derived from neural crest cells (NCC) and not from adjacent pharyngeal arch mesoderm (Jiang et al. 
2000). NCC represent a developmentally plastic population that migrates ventrolaterally from their origin 
in the dorsal lip of the neural tube. During their migration, NCC proliferate and some aggregate to 
produce distinct neural tissues, such as the dorsal root ganglia and sympathetic ganglia, while others 
become mesenchymal cells (Bockman 1997). NCC that migrate to the third pharyngeal arches and there 
transform to mesenchymal cells are referred to as ectomesenchyme because of the ectodermal origin of 
the constituent cells, though they are indistinguishable from mesoderm-derived mesenchymal cells (Le 
Lievre and Le Douarin 1975; Gordon et al. 2004). These cells surround the emerging thymus primordium 
and support growth and development of thymus-committed epithelia (Bockman 1997). 
NCC contribute to the capsule, the septae of the fetal thymus (Jiang et al. 2000) and eventually 
establish the intrathymic network of fibroblasts (Suniara et al. 2000). Although most mesenchymal cells in 
the E12 thymus uniformly express platelet-derived growth factor receptor α (PDGFRα), cells with such a 
phenotype represent a heterogeneous population that changes dynamically during development (Rossi et 
al. 2007b). Their numerical contribution to the thymic stromal composition declines with subsequent 
thymus development, a correlation that mirrors the decrease in TEC proliferation (Yamazaki et al. 2005; 
Rossi et al. 2007b). Therefore, the physical contribution of mesenchymal cells beyond organogenesis had 
been questioned and several studies suggested that once epithelial cells have fully gained the 
competence to support lymphocyte differentiation, and the vasculature of the thymus is complete, the 
contribution of NCC in the thymus is greatly reduced or absent (Jiang et al. 2000; Yamazaki et al. 2005). 
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However, more recent studies using genetic labelling of NCC and their derivatives clearly demonstrate an 
ongoing role for these cells in thymus function (Foster et al. 2008; Muller et al. 2008). NCC that associate 
with the thymic capsule at E12.5, enter the thymus before E13.5 and differentiate into pericytes and 
smooth muscle cells associated with vessels. These cells persist in the adult thymus and provide 
structural support to the thymic blood vessels and possibly regulate endothelial cell function, suggesting a 
switch from their role in supporting TEC proliferation to a role in the vasculature development (Foster et 
al. 2008).  
 Mesenchymal cells of the thymus can be characterized using different markers, including ERTR-7 
(Van Vliet et al. 1986) and MTS15 (Gray et al. 2007a). These provide largely overlapping staining 
patterns in distinct thymus structures such as the capsule, the septae, thymic fibroblasts, and notably 
vessel-associated pericytes (Van Vliet et al. 1986; Gray et al. 2007a). The majority of MTS15
+
 stromal 
cells (75%) also express the cortical TEC marker Ly51 (Gray et al. 2007a), a phenotype proposed to 
represent “cortical mesenchyme” (Muller et al. 2005). Though in the adult thymus, virtually all MTS15
+
 
cells also co-express PDGFR-α, the phenotype of mesenchymal cells is still poorly characterized. 
Moreover, the turnover and the thymus-specific functions of these cells are largely unknown. 
 The functional role for NCC in the formation of the thymus has initially been inferred from the 
different experimental observations. Deficiencies in thymus development are detected in chick embryos 
with the ablation of NCC (Kuratani and Bockman 1990), in spontaneous Pax3-deficient (splotch) mice, 
which display a severe defect in NCC migration (Conway et al. 1997) and in humans with the DiGeorge 
syndrome (Greenberg 1993). Several studies have indicated a role for the mesenchyme in the regulation 
of embryonic TEC proliferation. For example, NCC interact with the epithelial cells of the pharyngeal 
endoderm through the production of fibroblast growth factors (Fgf) 7 and Fgf10 which induce the 
proliferation of FgfR2-IIIb (isoform IIIb of Fgf receptor 2)-expressing TEC (Revest et al. 2001; Jenkinson 
et al. 2003; Jenkinson et al. 2006; Itoi et al. 2007b), an epithelial–mesenchymal interaction that has 
already been observed in the formation of other organs. A typical example is the limb bud, where the 
mesenchymal production of Fgfs stimulates the growth and differentiation of Fgf receptor-bearing 
epithelial cells (Xu et al. 1999). In mice lacking either Fgf10 (Ohuchi et al. 2000) or FgfR2-IIIb (Revest et 
al. 2001), thymus organogenesis proceeds normally until about E12.5, after which the organ fails to 
increase in size. However, cTEC and mTEC development occurs normally and a phenotypically regular 
thymocytes maturation is supported in this hypoplastic thymus. These findings are consistent with 
experimental studies in which the removal of the E12 perithymic mesenchyme prevents normal thymus 
growth, though the initial specification of thymic progenitors into the cTEC and mTEC lineages remains 
undisturbed (Jenkinson et al. 2003). Thus, the mesenchyme regulates the proliferation of developing 
TEC, but does not appear to be required for the commitment to a TEC fate and the subsequent cell`s 
Introduction 
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differentiation. Whether the mesenchyme influences TEC proliferation in the adult thymus (Gray et al. 
2006) is not clear, although it is interesting to note that adult thymic mesenchyme continues to express 
Fgf7 and Fgf10 which influence survival of adult TEC (Rossi et al. 2007a).  
A role for mesenchymal cells in early T cell development has also been demonstrated. Experiments 
involving the generation of reaggregate thymus organ cultures (RTOC) from defined stromal components 
found that mesenchymal fibroblasts are necessary for the maturation of thymocyte precursors beyond the 
CD4
-
CD8
-
CD25
+
CD44
+
 (DN2) immature stage (Anderson et al. 1993; Anderson et al. 1997; Suniara et al. 
2000). Although the precise mechanism by which mesenchymal cells influence thymus development and 
function is unclear, based on the current experimental data a two-stage mechanism for mesenchymal 
involvement has been proposed (Figure 1.2) (Anderson and Jenkinson 2001). In the initial stages of 
thymus formation, mesenchymal cells surround and later enter the thymus anlage, where they provide 
Fgfs and thus, directly stimulate the growth and development of TEC. Mesenchymal fibroblasts present in 
cortical regions of the thymus may directly influence the survival, proliferation or differentiation of 
immature CD4
-
CD8
-
 T cell precursors by providing an extracellular framework to present and concentrate 
essential soluble growth factors and cytokines (Banwell et al. 2000). Collectively, these studies show that 
the signals provided from cells of mesenchyme origin are necessary but not sufficient for the development 
of a regularly structured and normally functioning thymus which also depends on the inductive 
interactions with developing hematopoietic elements. 
Figure 1.2 Model of mesenchymal 
involvement in thymus 
development and function. 
Neural crest-derived mesenchymal 
cells surround and eventually 
invaginate the epithelial rudiment. 
These cells are proposed to have a 
dual role in the thymus. First, they 
produce Fgfs and directly influence 
the growth of early thymic epithelium. 
Second, mesechymal cells in cortex 
form an extracellular scaffold and 
present soluble growth factors 
essential for the development of 
immature thymocytes (ECM, 
extracellular matrix) (taken from 
Anderson, 2001). 
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1.1.3. Molecular control of early organogenesis  
The initiation of thymus organogenesis is dependent on the correct initial formation of the pharyngeal 
region. Therefore, gene mutant mice with defective patterning of the pharyngeal region and defective 
pouch formation will consequently demonstrate a failure in the development of pouch-derived structures, 
including thymus. The analyses of mutant phenotypes and gene expression patterns have identified a 
transcription factor regulatory network that is required for the establishment and early patterning of the 
thymus primordium. At present Tbx1, Hoxa3, Eya1, Six1, Pax1, Pax3 and Pax9 are part of this network. 
Mutations in any of these genes lead to thymus aplasia, hypoplasia, or a complete failure of the thymus 
lobes to migrate caudally and centrally to their regular intrathoracic location (reviewed in (Manley 2000; 
Blackburn and Manley 2004; Hollander et al. 2006)). These genes are expressed in multiple cell lineages 
during development, and hence their loss of function causes also pleiotropic defects in embryonic 
development. It is therefore, often difficult to distinguish a direct role of these genes in thymus 
organogenesis, e.g. in TEC progenitors, from an upstream function, e.g. in formation or patterning of 
pharyngeal apparatus or in NC migration. Hence, experimental systems with TEC-specific and time-
controlled gene deletions may be required to identify precisely the function of individual transcription 
factors in thymus development 
The transcription factor T-box (Tbx1) is related to DiGeorge syndrome (DGS) (Greenberg 1993; 
Packham and Brook 2003; Naiche et al. 2005) which is caused genetically by heterozygous deletions 
within chromosome 22q1. The typical clinical features are cardiac outflow tract and heart pathologies due 
to malformations of pharyngeal arch arteries, parathyroid hypoplasia, and the absence or ectopic location 
of the hypoplastic thymus (Scambler 2000; Naiche et al. 2005). Hallmarks of this phenotype are 
recapitulated in mice homozygously lacking Tbx1, which display agenesis of pharyngeal pouches 2–4 
and a concomitant loss or malformation of pharyngeal pouch-derived organs and tissues (i.e. thymus, 
parathyroid gland, cardiac outflow tract) (Jerome and Papaioannou 2001; Lindsay et al. 2001). Tbx1 is 
expressed in the pharyngeal pouch endoderm but also in the core arch mesoderm and the pharyngeal 
ectoderm but not in NCC-derived mesenchyme (Chapman et al. 1996; Garg et al. 2001). Hence, Tbx1 
expression may play distinct roles in different anatomical sites during development. Pharyngeal pouches 
fail to develop in mice in which a Tbx1 deficiency is restricted to endoderm and they recapitulate the 
defects known from the constitutive null mice, including the absence of the thymus (Arnold et al. 2006). 
Similarly, mice lacking Tbx1 selectively in the pharyngeal mesoderm, have a hypoplastic pharynx with 
impaired pharyngeal endoderm and lack a thymus. A conditional reversion in pharyngeal mesoderm but 
not endoderm, from a defective to a functional Tbx1 allele, is sufficient to rescue the major pathologies 
observed in the Tbx1-deficient mice but fails to restore regular development of the thymus (Zhang et al. 
2006). Therefore, expression of Tbx1 in both pharyngeal core mesoderm and endoderm is a prerequisite 
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for normal thymus development. Tbx1 expression in the pharyngeal region is regulated by sonic 
hedgehog (Shh) signalling (Garg et al. 2001). Analysis of gene expression patterns in wild type and Tbx1-
deficient mice and experiments in vitro have identified several downstream targets of Tbx1 including Fgf8 
and Fgf10 (Vitelli et al. 2002).  
During development, Fgf8 is secreted by the pharyngeal pouch endoderm and provides survival, 
mitogenic and patterning signals to adjacent mesenchyme (Abu-Issa et al. 2002; Frank et al. 2002). 
Reduction of Fgf8 signalling by expressing a hypomorphic Fgf8 allele results either in athymic embryos 
(possibly secondary to severe defects in the formation of the 3
rd
 and 4
th
 pharyngeal arch and pouch) or in 
embryos with a hypoplastic, sometimes ectopic thymus that nevertheless supports a phenotypically 
normal thymopoiesis (Frank et al. 2002).  The hypoplastic phenotype observed in these animals is similar 
to the one reported for mice deficient either for Fgf10 or FgfR2IIIb. The later is a specific Fgf receptor 2 
variant expressed by TEC as early as E13 and transduces signals from its cognate ligands Fgf7 and 
Fgf10, which are secreted by the surrounding mesenchyme (Revest et al. 2001; Jenkinson et al. 2003). It 
is therefore thought that reciprocal Fgf signalling between the endoderm and the mesenchyme may be 
required at an early stage of thymus formation. Such interdependence by reciprocal Fgf signalling is also 
observed during the initial placement and induction of limb bud formation and during early lung 
organogenesis (Hogan and Yingling 1998; Martin 1998).  
Signalling via the bone morphogenetic proteins (Bmp) has been implicated in thymus organogenesis 
(Ohnemus et al. 2002; Bachiller et al. 2003; Bleul and Boehm 2005). Bmps belong to the transforming 
growth factor beta (TGFβ) family of cytokines that encompasses multiple ligands and receptors. Upon 
ligand binding, two transmembrane receptor serine/threonine protein kinases (receptor types I and II) 
activate specific receptor-regulated Smad (R-Smad) proteins. Activated Smads form a multi-subunit 
complex with a common partner, Smad4. These complexes then translocate from the cytoplasm to the 
nucleus where they interact with additional nuclear factors to regulate gene transcription. Several proteins 
have been identified, which physiologically antagonize Bmp signalling by either blocking ligand binding to 
cognate receptor (Noggin or Chordin) or by altering the cytoplasmic signal transduction by competing with 
Smad4 (Smad7). Disruption of the canonical TGFβ/Bmp signalling in TEC by loss of Smad4 expression 
from E12.5 causes a progressive structural disorganization of the thymic microenvironment and a loss of 
TEC competence to attract early T lineage progenitors (ETP) resulting in the extensive thymic and 
peripheral lymphopenia. This findings place Smad4 within the signalling events in TEC that determine 
total thymus cellularity by controlling the number of ETP (Jeker et al. 2008). At E10.5 Bmp4 is expressed 
in the ventral aspect of the 3
rd
pp epithelia and at E12 and beyond also by the surrounding mesenchyme. 
Blocking of Bmp signalling in premigratory NCC by transgenic expression of the decoy receptor Noggin 
leads to a failure in the NCC migration and consequently affects thymus development indirectly 
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(Ohnemus et al. 2002). A TEC-relevant role of BMP-mediated signalling has been demonstrated in 
transgenic mice where Noggin is expressed as early as E11.5 in TEC (Bleul and Boehm 2005). These 
mice display a severely impaired thymus development and a reversion of TEC to a phenotype 
characteristic of foregut epithelium (Bleul and Boehm 2005; Soza-Ried et al. 2008). Together these 
studies demonstrated that in addition to having role in NCC, Bmp signalling also affects TEC biology 
directly (Bleul and Boehm 2005). Mice deficient for Chordin, another Bmp signalling antagonist, display 
an extensive array of malformations that encompass most of the DGS features including the lack of 
thymus, absent parathyroid glands and outflow tract defects (Bachiller et al. 2003). In addition, there is a 
major reduction in Tbx1, Pax9 and Fgf8 expression in the pharyngeal endoderm of Chordin-deficient 
mice. These data suggest that Chordin acts upstream of Tbx1 and Fgf8. In turn, Tbx1 relays the autocrine 
effect of Chordin in the pharyngeal endoderm necessary for a proper development of the thymus, 
parathyroid and thyroid glands. Fetal thymic organ culture (FTOC) experiments have recently provided 
evidence that at least some of the effects conferred by Fgfs may be mediated downstream by Bmp4 
signalling. Indeed, the addition of Bmp4 to FTOC affects T cell differentiation along the αβ-lineage and 
leads to an abnormal accumulation of immature double negative (DN1) thymocytes (Hager-Theodorides 
et al. 2002), an effect that is suppressed Fgfs (Tsai et al. 2003). It was further proposed that Bmp4 
upregulates Foxn1, which in turn increases FgfR2IIIb expression thus, rendering TEC more susceptible to 
Fgf7 and Fgf10 signals provided by different cells including mesenchymal cells as well as double or single 
positive thymocytes (Erickson et al. 2002). In addition, the thymic phenotypes of p63-deficient thymi 
(Candi et al. ; Senoo et al. 2007) and FgfR2IIIb-deficient (Revest et al. 2001; Dooley et al. 2007) are quite 
similar displaying thymic hypoplasia caused by a reduced proliferation. p63 has been implicated in TEC 
differentiation by promoting the survival of progenitor/transit-amplifying cells and, like Foxn1, acts 
upstream of FgfR2IIIb. The expression of p63 expression in the thymus is independent of Foxn1 (Senoo 
et al. 2007) and a possible genetic interaction of Foxn1 with Tbx-p63-FgfR2IIIb pathway is yet to be 
established. 
Hoxa3 (Manley and Capecchi 1998), Pax1 (Wallin et al. 1996), and Pax9 (Hetzer-Egger et al. 2002) 
are expressed by thymic epithelial cells. The exact identity of signal(s) determining the site of the thymic 
anlage is still unknown. Since Hox genes control axial position identity during embryogenesis and since 
the anterior boundary of Hoxa3 expression is along the 3
rd
pp, it has been hypothesized that the 
expression of Hoxa3 determines the positioning and identity of the thymus rudiment (Krumlauf 1994). 
Moreover, the Pax–Eya–Six pathway together with Hoxa3 might also control the separation of the 
thymus/parathyroid primordium from the pharynx and its subsequent migration. Indeed, thymic rudiments 
do not detach from the pharynx of Pax9 mutant mice and the normal separation is delayed In Hoxa3
+/-
Pax1
-/-
-deficient animals (Su et al. 2001; Hetzer-Egger et al. 2002). Pax1 expression is detected in 
virtually all cells in the early endodermal epithelium of the 3
rd
pp and is downstream of Eya1 and Six1 (Zou 
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et al. 2006). The proportion of Pax1-expressing cells declines with age and in the adult mouse only a 
small fraction of cortical thymic cells remains strongly Pax1 positive. Pax1 is necessary for the 
establishment of thymus microenvironment required for normal T cell maturation as naturally occurring 
mutations in Pax1 observed in the so called undulated mice, disturb the maturation of CD4
+
C8
+
 and CD4
+ 
thymocytes (Wallin et al. 1996). Pax9 is expressed in the entire pharyngeal endoderm at E9.0, and its 
function is required for the development of those organs that derive from the pharyngeal pouches. In mice 
deficient for Pax9 expression, a thymus anlage develops ectopically in the larynx. The TEC of this ectopic 
thymus do express Foxn1, a marker of thymic epithelium, but the entire anlage however, fails to migrate 
caudo-ventrally to the upper mediastinum (Hetzer-Egger et al. 2002). 
These studies indicate that at least some molecular mechanisms operational in the patterning of the 
thymus primordium are intrinsic to the endoderm. However, the identity of the regulatory pathways that 
occur concurrently in the adjacent mesenchyme and the molecular nature of the ensuing epithelial–
mesenchymal interactions are less well established. In this context, signals from NC-derived 
mesenchymal cells are essential for normal thymus organogenesis (Anderson et al. 1993; Suniara et al. 
2000; Jenkinson et al. 2003) as the absence or specific defects in NCC formation, migration or survival 
correlate with athymia or thymic hypoplasia (Bockman and Kirby 1984; 1989; Conway et al. 1997; 
Soriano 1997; Ohnemus et al. 2002). Interestingly, Hoxa3, Eya1 and Six1 are also expressed in NCC and 
thus may be required indirectly for a proper development of the thymus. In the absence of Hoxa3 
expression, NCC do densely populate the 3
rd
 pharyngeal arches but the intrinsic capacity of these cells to 
differentiate and/or to induce a correct patterning of 3
rd
pp is impaired (Manley and Capecchi 1995). Eya1, 
a transcriptional co-activator, is expressed early in the pharyngeal endoderm, mesenchyme and 
ectoderm. The importance of Eya1 for thymus organogenesis is revealed by analysing knock out mice as 
these animals have no thymus or parathyroid and fail to express Wnt5b in the endoderm (Xu et al. 2002; 
Zou et al. 2006), which regulates Foxn1 expression in TEC (Balciunaite et al. 2002). Six1 expression is 
markedly reduced in the pharyngeal region of Eya1-deficient embryos, indicating that Six1 expression is 
Eya1 dependent. Six1-deficient mice and mutations in Pax genes display similar phenotypes to mice 
lacking Eya expression and suggests a regulatory network where Eya, Six and Pax control early inductive 
events in the thymus morphogenesis (Laclef et al. 2003). 
To define specific Hoxa3, Eya1 and Six1 function separately for neural crest and endodermal cells 
during thymus organogenesis, the tissue-specific and time-controlled gene ablation studies will be 
required. So far, Pax3 is the only transcription factor known to affect thymus development and to be 
expressed exclusively by NCC. Mutations in Pax3 cause in mice the splotch phenotype (Franz 1989) 
characterized by thymus ectopia, hypoplasia or aplasia (Franz 1989; Conway et al. 1997; Griffith et al. 
2009). However, this phenotype appears to be secondary to NCC death or their failure to migrate. 
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1.1.4. Bipotent thymic epithelial progenitors 
While a single endodermal origin for cTEC and mTEC has been demonstrated in birds (Le Douarin 
and Jotereau 1975) and later confirmed in the mouse (Gordon et al. 2004), it was unclear for a long time 
whether these two morphologically and functionally distinct types of epithelial cells arise from a common, 
i.e. bipotent progenitor population or, alternatively, from separate lineage-committed, i.e. unipotent 
progenitors, and if such progenitors still exist in the postnatal period. A characteristic feature of 
progenitors is that a small number of cells generates a large pool of progeny as a consequence of 
proliferation and differentiation. This developmental process is concurrent with a progressive loss of 
differentiation potential and once completed is believed to be irreversible. Resident tissue-specific 
progenitor cells have been described for several somatic tissues, and their asymmetric self-renewal has 
been linked to homeostatic tissue maintenance (Sharma et al. 2006; Fuchs 2007; Xu et al. 2008). 
An accurate phenotypic identification and assays to reveal functions of progenitor cells at a clonal 
level are major facilitators in elucidating progenitor biology. The existence of bipotent TEC progenitors 
(bTECp) was first suggested by the cytokeratin (CK) staining pattern that uniformly recognizes a large 
CK5
+
CK8
+
 TEC population in the early thymus whereas these cells become progressively restricted in 
either CK5
-
CK8
+
 cTEC or CK5
+
CK8
-
 mTEC during further development (Ritter and Boyd 1993; Ropke et 
al. 1995; Klug et al.). Moreover, the co-expression of cTEC- and mTEC-specific markers by a single cell 
population in the thymus anlage has further contributed to the notion that both TEC lineages may arise 
from a common progenitor pool. MTS24 (Plet-1) is expressed by all TEC at E12 whereas in the adult 
thymus its expression is limited to rare medullary TEC (Depreter et al. 2008). Although initial reports 
suggested that MTS24 could be used to identify and purify TEC progenitors able to generate a functional 
epithelial environment (Bennett et al. 2002; Gill et al. 2002) subsequent studies showed that also MTS24
-
 
embryonic TEC, though at a lower efficiency, can form the epithelial scaffold required for thymopoiesis 
(Swann and Boehm 2007; Rossi et al. 2007b).  
Two groups using different experimental systems demonstrated that single thymus epithelial 
precursors are capable of generating a functional thymic microenvironment with defined cortical and 
medullary areas. Using a cellular approach, Rossi et al. established a clonal assay allowing TEC fate 
mapping (Rossi et al. 2006). Single EpCam
+
 and genetically marked eYFP
+
TEC isolated from an E12 
thymus anlage were microinjected into wild-type 'foster' E12 thymus lobes and then transplanted under 
the kidney capsule of recipient mice. Subsequent immunohistological analysis revealed that single fetal 
TEC contributed to both cTEC and mTEC lineages whereas the contribution to a single TEC lineage was 
absent demonstrating the presence of bTECp in early thymus anlage. Using a genetic approach, Bleul 
and colleagues reported similar findings for postnatal thymus (Bleul et al. 2006). Reversion of conditional 
Foxn1 mutant allele to wild-type function in single epithelial cells led to the development of a structurally 
and functionally normal thymus tissue providing evidence for the continued persistence of bTECp beyond 
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the embryonic period (Bleul et al. 2006). The existence of mTEC-committed progenitors was also 
revealed in lineage tracing experiments demonstrating that the thymus medulla is comprised of individual 
epithelial 'islets' each arising from a single progenitor during TEC ontogeny (Rodewald et al. 2001). 
Recently, separate progenitors for cTEC lineage have also been identified (Shakib et al. 2009). However, 
the identity of the thymus epithelial stem cells remains elusive, and presently bTECp have only been 
identified on the basis of their functional properties. Despite evidence for their persistence after birth, the 
virtual lack of appropriate markers makes it impossible to track and localize these cells in the postnatal 
thymus. Moreover, any capacity for self-renewal of 
thymic epithelial progenitors is currently unknown and 
it is not clear whether the development and 
maintenance of TEC within the adult thymus occurs 
in the same way as in the embryonic thymus. Two 
models of TEC development have been proposed 
both addressing the question whether in the adult 
steady-state thymus cTEC and mTEC are derived 
from a population of bipotent or lineage-committed 
cells (Figure 1.3) (Anderson et al. 2007). In the first 
model a self-renewing pool of bipotent progenitors 
remains existent throughout life and generates 
transient amplifying populations of cTEC- and mTEC-
committed precursors that have lost a self-renewing 
capacity. In a second model, there is a fixed number 
of bipotent progenitors in the thymus that lack the 
capacity for self-renewal and generates separate 
lineage-committed precursors with self-renewing 
capacity which give rise to cTEC and mTEC. Clearly, 
further studies are required to address the self-
renewal capacity of TEC and the stages in TEC 
development at which it may occur. The identification 
of TEC stem cells remains an important goal not least 
in view of possible future prospects to reconstitute 
thymic function by transplanting such tissue-specific 
stem cells (Swann and Boehm 2007). 
 
Figure 1.3 Models of TEC development and 
self-renewal.  
a Bipotent TEC progenitors persist throughout life 
by continued self-renewal and produce lineage-
committed TEC progenitors. b. There is a fixed 
number of bipotent progenitors in the thymus that 
lack the capacity to self-renew. The continued 
production of mature cTEC and mTEC is achieved 
by the generation of lineage-committed TEC 
progenitors with the capacity to self-renew (taken 
from Anderson, 2007). 
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1.2. Generation of a functional thymic epithelial compartment 
Epithelia of the 3
rd
pp endodermal lining acquire a TEC fate and generate a population of progenitors 
that subsequently differentiate into phenotypically diverse cortical and medullary epithelial TEC (Bleul et 
al. 2006; Rossi et al. 2006). For a long time, TEC were considered as postmitotic, end-stage cells that, 
once generated during ontogeny, are maintained in their mature state. It is now clear that TEC can be 
generated from bipotent or committed progenitors in ontogeny (Bennett et al. 2002; Gill et al. 2002; Rossi 
et al. 2006), that stages of immature and mature TEC are phenotypically separable, and that TEC 
undergo a rapid renewal within a few weeks (Gray et al. 2006). These findings suggest that the 
generation and maintenance of steady state TEC compartments is likely to be a result of bTECp activity 
together with subsequent expansion of the cTEC- and mTEC-committed progeny. Identification of 
precursor-product relationships within the cTEC and mTEC lineage represents the first step in elucidating 
the stages and checkpoints in the formation of mature thymic microenvironments and is a major focus of 
current studies. 
 
1.2.1. Cortical microenvironment 
Cells of the cTEC lineage are typically identified by flow cytometry based on their CD45
-
EpCam1
+
Ly51
+
 cell surface phenotype (Derbinski et al. 2001). In tissue sections, intracytoplasmic 
markers are used to identify the major cortical subset of CK5
-
CK8
+
 and the minor subset of CK5
+
CK8
+
 
cells located at the corticomedullary junction (Klug et al. 1998). Distinct cTEC subsets can be further 
defined based on the expression of other cell markers including DII-4 (Tsukamoto et al. 2005), CD205 
(Shakib et al. 2009), β5t (Murata et al. 2007), CD40 (Akiyama et al. 2008a) and MHCII (Jenkinson et al. 
1981; Yang et al. 2006). Of functional significance is the expression of both MHC class I and class II 
molecules on cTEC as this restriction elements regulate thymic selection (McDuffie et al. 1987; Kaye et 
al. 1989; Marrack et al. 1989; Bowlus et al. 1999; Takahama 2006; Yang et al. 2006). 
 
Formation of the thymic cortex  
The steps in cTEC differentiation downstream of bipotent progenitors and the molecular clues driving 
their genesis and maintenance are just beginning to be identified. During early embryogenesis, TEC with 
an immature (CK5
+
CK8
+
) or cortical (CK5
-
CK8
+
) phenotype are already present before the colonization of 
the anlage by lymphoid progenitors at E11.5 (Klug et al. 1998; Klug et al. 2002; Hamazaki et al. 2007). 
Indeed, the emergence of these TEC subpopulations is not impaired in Rag2/γc-deficient mice, which 
have a complete block in T, B, and NK cells development suggesting that the generation of cTEC does 
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not require hematopoietic-derived signals (Klug et al. 2002). However, later in ontogeny, the cortical 
microenvironment of these and other mice with an early block in T cell development displays a disturbed 
cortical architecture and an arrest in TEC differentiation at immature CK5
+
CK8
+
 stage due to a lack of 
thymocyte-mediated signals (Hollander et al. 1995; Klug et al. 1998; van Ewijk et al. 2000). The defective 
cTEC development can be rescued by regular thymopoiesis following hematopoietic stem cells 
transplantation as well as the generation of all T cell subsets up to the DP stage. However, this rescue is 
successful during a short window of time after birth suggesting that the induction of cTEC differentiation 
by thymocytes can only occur in a developmentally restricted manner (Hollander et al. 1995). Unlike mice 
with a very early block in T cell development, mice deficient for Rag1 or Rag2 expression, where 
thymocyte development is arrested at the DN3 stage, have an almost normal cTEC development (Klug et 
al. 1998; van Ewijk et al. 2000) indicating that cTEC differentiation depends on interactions with 
thymocytes committed to the T lineage. 
Analysis of the precursor–
product relationships for the cTEC 
lineage has been hampered by the 
lack of appropriate markers to stage 
the developmental progression of its 
cells. Only recently, committed cTEC 
progenitors (cTECp) and distinct 
stages in cTEC maturation have 
been identified (Shakib et al. 2009) 
based on the differential expression 
of CD205, CD40 and MHCII 
molecules (Figure 1.4) (Shakib et al. 
2009). cTEC with an 
EpCam1
+
CD205
+
CD40
-
 phenotype 
are proposed to represent a population of progenitor cells that is developmentally positioned between 
bipotent progenitors and mature EpCam1
+
CD205
+
CD40
+
MHCII
+
 cTEC. These intermediate cTEC 
progenitors express, in comparison with mature cTEC, lower levels of cTEC-specific transcripts including 
β5t and cathepsin L and display higher proliferation rate.  
The requirement for Foxn1 expression and thymocyte-epithelial crosstalk in cTEC development has 
been investigated by analysis of nude (Foxn1-deficient) and tgε26 (block at the DN1 stage of T cell 
development) embryonic thymus, respectively. Foxn1 but not thymocyte–derived signals is required for 
the initial generation of CD205
+
 cTEC from a bipotent progenitor as early as E12 and agrees with the 
Figure 1.4 A model of cTEC development 
cTEC develop from cTEC/mTEC bipotent progenitors via cTEC-
commited progenitors to mature MHCII-expressing cTEC. The 
requirements for Foxn1 expression and thymocyte-TEC crosstalk are 
depicted. Circular arrows represent proliferation. Imm denotes 
immature, mat denotes mature (taken from Shakib, 2009). 
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notion that Foxn1-deficient TEC may represent bipotent progenitors that have not yet undergone 
commitment to the cTEC and mTEC lineages (Bleul et al. 2006). Further developmental progression such 
as the acquisition of CD40 and MHCII expression on cTEC is however, critically dependent on the 
presence of early stage (DN1–3) thymocytes. Thus, a stage-specific requirement for thymocyte crosstalk 
exists for development of cTEC lineage. How exactly DN thymocytes influence cTEC development 
remains unresolved, though they have been proposed to, in addition to providing signals for 
differentiation, also play a role in remodelling developing cTEC and in the formation of the typical three-
dimensional reticular cortical network (van Ewijk et al. 2000). The present work is focusing on studying 
the molecular mediators regulating the cTEC development and maintenance. A possible role in these 
processes has been assigned to Stat3 signalling as its loss in TEC causes severe postnatal thymic 
hypoplasia including alterations of the cortical architecture (Sano et al. 2001). Similarly, the loss of 
Kremen1, a negative regulator of Wnt signalling leads to a severe defect in cTEC architecture (though 
positive selection still occurs) (Osada et al. 2006) indicating the importance of an appropriate Wnt activity 
for cTEC development. To further investigate specific signalling pathways acting in a cTEC-lineage 
specific fashion, target gene deletion models will be needed. 
 
Function of cortical thymic epithelial cells 
The regular development of cortical TEC is a prerequisite for the generation of a functionally normal 
thymic microenvironment as cTEC provide essential signals and restriction elements during early stages 
of T cell development and positive selection of T cell antigen receptor, respectively. cTEC have unique 
antigen processing and presenting capacities that are distinct from other thymic stromal cells including 
mTEC and dendritic cells (DC) (Bowlus et al. 1999). For example, cTEC specifically express the thymus-
restricted proteasome catalytic subunit β5t, which is a molecule linked to cTEC ability to generate low 
affinity peptides for MHC class I presentation (Murata et al. 2007). Consequently, mice lacking this 
subunit exhibit the selective reduction of CD8
+
 T cells. However, the absence of β5t does not affect 
cortical or medullary architecture or overall thymus size, indicating that β5t may not be essential for the 
overt development and architectural organization of TEC (Murata et al. 2007). Positive selection of CD4
+
 
T cells requires the expression of the lysosomal protease cathepsin L in cTEC (Nakagawa et al. 1998; 
Honey et al. 2002). This enzyme mediates the invariant-chain degradation in cTEC, a key step in MHC 
class II restricted antigen presentation (Nakagawa et al. 1998; Honey et al. 2002). Similarly, the putative 
thymus-specific serine protease (TSSP) (Bowlus et al. 1999) which is exclusively expressed in the 
endosomal compartment of cTEC plays an important role in MHC class II restricted positive selection of 
CD4
+ 
T cells (Gommeaux et al. 2009). Together, these studies established that the unique protein 
degradation and self-peptide presentation by cTEC is pivotal for the positive selection of MHC class I and 
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II restricted thymocytes (Murata et al. 2008; Takahama et al. 2008). How possible heterogeneity among 
cTEC may reflect on their functional specialization remains unknown. The identification of cell surface and 
cytoplasmic markers together with the use of genetic models for in vivo cell tracing studies should help to 
uncover key regulators in the generation of cTEC and will be useful tools to study cTEC heterogenity. 
 
1.2.2. Medullary microenvironment 
Cells of the mTEC lineage can be identified by flow cytometry on the basis of their CD45
-
EpCam1
+
Ly51
-
 phenotype and the concurrent expression of MHC class I and class II molecules 
(Derbinski et al. 2001). Immunohistochemistry identifies major stellate CK5
+
/14
+
CK8
-
 population and a 
minor subset of CK5
-
/14
-
CK8
+
 cells that is distinguished from the cortical subset by globular morphology 
(Klug et al. 1998). The minor subset can be further separated in two subpopulations defined by their 
reactivity with UEA-1, i.e. CK5/14
-
CK8
+
UEA-1
+
 mTEC and CK5/14
-
CK8
+
UEA-1
-
 mTEC. In contrast, the 
stellate mTEC do not bind UEA-1 lectin, but are marked by MTS10 expression (Klug et al. 1998). The 
population of mTEC displays further heterogeneity not least with respect to differential cell surface 
expression of MHCII, CD80, CD86 and CD40, the presence of Aire and consequently tissue-specific 
antigens (Kyewski and Klein 2006). 
 
Function of medullary thymic epithelial cells 
The thymic medulla serves two main functions, i.e. the completion of T cell maturation and the 
establishment of self-tolerance by promoting the elimination of autoreactive SP thymocytes carrying 
TCRs with high affinity for self-antigen–MHC complexes.  A unique property of mTEC is their ability to 
express tissue-restricted self-antigens (TRAs) representing almost all peripheral tissues, irrespective of 
developmental or spatio-temporal expression patterns (Kyewski and Klein 2006). This promiscuous gene 
expression (PGE) program generates a large repertoire of TRAs that are either directly presented to SP 
thymocytes by mTEC or are shed and taken up by medullary DC for antigen presentation. This latter 
mechanism is referred to as cross-presentation (Gallegos and Bevan 2004; Koble and Kyewski 2009). 
Thymic mTEC and DC have also been implicated in the development of Foxp3
+
CD4
+
CD25
+
 regulatory T 
cells, which are involved in the maintenance of self-tolerance in the periphery (Aschenbrenner et al. 2007; 
Proietto et al. 2008; Spence and Green 2008). 
Of key importance to understanding PGE and its relevance for central tolerance was the identification 
of a mTEC subset that expresses the autoimmune regulator Aire, a transcription factor that is defective in 
the human autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome 
(Anderson et al. 2005). Aire protein is localized in the nucleus and regulates, at least in part, PGE aiding 
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to the establishment of central T cell tolerance to peripheral antigens. Aire deficiency in mice results in a 
reduction of specific TRAs available for negative selection and consequently leads to defective tolerance 
induction and organ-specific autoimmunity (Anderson et al. 2002; Liston et al. ; Derbinski et al. 2005). In 
addition, Aire also regulates mTEC differentiation (Gillard et al. 2007; Dooley et al. 2008; Yano et al. 
2008). Aire-deficient thymus displays changes in mTEC composition and organization, including an 
absence of UEA-1
hi
 mTEC (Dooley et al. 2008). Moreover, the contracted CK14
+
 medullary compartment 
lacks the confluent stellate mTEC and has an increased representation of globular mTEC. As in the 
normal thymus, globular CK5
-
/14
-
CK8
+
 mTEC constitute only a minor subset (Klug et al. 1998; Klug et al. 
2002; Gillard and Farr 2006) these cells are suggested to represent the cellular target of Aire-mediated 
apoptosis accounting for the accumulation of these terminally differentiated mTEC in the Aire-deficient 
thymus (Gillard et al. 2007). 
 
Formation of the thymic medulla 
The differentiation of bipotent progenitors into mTEC has been proposed to occur via committed 
mTEC progenitors (mTECp) (Rodewald et al. 2001). While we know little about the developmental 
pathway(s) linking bTECp to the earliest committed mTEC, a more detailed picture emerged on 
differentiation events within the mTEC lineage. The availability of well-defined markers to identify and 
isolate cells within this lineage together with the observation that dissociated fetal thymus stroma is  able 
to form a functional thymus in RTOC settings allowed examination of lineage potential and function of 
different mTEC subsets (Rossi et al. 2007b).  
Along this line, TEC progenitor population that give rise specifically to mature Aire
+
 mTEC was 
identified based on the expression of the tight junction components Claudin (Cld)-3 and 4 (Hamazaki et 
al. 2007). In early ontogeny, Cld-3,4
+
 TEC are found in the most apical layer of the bilayered TEC 
rudiment. By E13.5, the heterogeneity of TEC populations becomes evident as Cld-3,4
+
 cells begin to 
express UEA-1 ligand and MTS10 indicating the commitment to a medullary epithelial fate (Hamazaki et 
al. 2007). A developmental step in the mTEC lineage that involves maturation of Aire
-
MHCII
-
CD80
-
 mTEC 
progenitors into Aire
+
CD80
+
MHCII
+
 mTEC (Rossi et al. 2007c) and culminates in the appearance of 
Involucrin
+
 mTEC (Yano et al. 2008) has also been identified in the embryonic thymus. The 
developmental potential of E13.5 Cld-3,4
+
 TEC has been examined in grafting RTOC studies. While Cld-
3,4
lo
 cells gave rise to both mTEC and cTEC, Cld-3,4
hi
 cells gave only rise to mTEC thus, inferring that 
these cells represent committed mTEC progenitors. This conclusion is in keeping with earlier studies 
demonstrating the thymus medulla to be composed of aggregates of clonally derived islets (Rodewald et 
al. 2001) and further suggests that commitment to the mTEC lineage may occur as early as E13.5 
(Hamazaki et al. 2007). Whether the heterogeneity of mTEC reflects distinct mTEC lineages or various 
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stages of differentiation within a single lineage (Gillard and Farr 2005; Kyewski and Klein 2006) still 
remains to be determined. 
 
Two opposite models of mTEC differentiation 
Two models have been proposed to explain the heterogeneity and lineage relationships between 
mTEC subsets (Derbinski et al. 2005; Gillard and Farr 2005). The terminal differentiation model (Figure 
1.5) postulates that mTEC development proceeds along distinct successive maturational stages and 
culminates in the generation of most mature Aire
+
 mTEC that are characterized by high levels of MHCII, 
CD80, CD86, CD40 expression (Derbinski et al. 2005). As these terminally differentiated mTEC are non-
proliferating and also short lived they are continuously replenished via one or more rapidly cycling Aire
-
 
intermediates that may express either low or high levels of MHCII, CD80, CD86 and CD40 expression 
Figure 1.5 Terminal differentiation model of mTEC development. 
cTEC and mTEC compartments of the thymus are derived from common bipotent progenitors (bTECp), possibly 
via committed cTEC (cTECp) and mTEC (mTECp) progenitors. Cells within the mTEC lineage can be divided into 
distinct subsets – believed to correspond to different maturation stages – based on various levels of MHCII, 
CD40, CD80, CD86 and Aire expression. mTEC also express RANK, and are bound differentially by the UEA-1 
lectin. Mature mTEC (MHCII
hi
Aire
+
) are thought to be terminally differentiated, post-mitotic, short-lived and 
destined to die by apoptosis. The rapidly turning-over mature mTEC population is replenished continuously by 
cells differentiating from proliferating (circular arrow) immature precursors (MHCII
lo
 or MHCII
hi
Aire
- 
cells). mTEC 
maturation is accompanied by a progressive increase in PGE leading to the ectopic synthesis of numerous TRAs 
(taken from Irla, 2010). 
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(Gabler et al. 2007; Gray et al. 2007b). The transition from immature to mature mTEC is in this model 
accompanied by a progressive expansion in the repertoire of promiscuously expressed TRAs. Apoptosis 
of the terminally differentiated mTEC has been postulated to be induced by Aire itself or to be a nefarious 
consequence of PGE (Gray et al. 2007b).  
The developmental (also known as progressive restriction) model (Figure 1.6) suggests as an 
alternative, that high level of mitotic activity detected in the MHCII
hi
CD80
hi
 mTEC (Gray et al. 2007b) is 
indicative of a transit-amplifying population that is less mature then the MHCII
lo
CD80
lo
 population to which 
it gives rise, but express the 
highest levels of Aire and the 
most diverse TRAs repertoire 
(Gillard and Farr 2005). 
Supporting this model is the 
developmental sequence where 
MHCII
hi
 emerge before MHCII
lo
 
mTEC inferring precursor-product 
relationship. Identification of 
lineage relationships between 
mTEC subsets paves the way to 
study molecular mediators and 
cell types regulating mTEC 
development and homeostasis. 
Control of mTEC development by NF-κB activation 
The heteromeric nuclear factor (NF)-κB is activated by two signal transduction pathway (Figure 1.7) 
(Bonizzi and Karin 2004; Hoffmann et al. 2006). The canonical pathway activates the p50/RelA 
heterodimer and the noncanonical pathway results in the formation of the p52/RelB heterodimer that 
translocate into the nucleus to activate gene expression. The importance of the canonical pathway for 
mTEC development was demonstrated by the phenotype of mice lacking TRAF6, a key mediator in the 
upstream signalling events leading to NF-κB activation. The medulla of these mice exhibit an altered 
composition of mTEC subsets and an absence of UEA-1
+
 and mature Aire
+ 
mTEC (Akiyama et al. 2005a). 
However, the exact contribution of the canonical NF-κB pathway to the medulla formation is not clear as 
TRAF6 has also been implicated in the signal transduction of other pathways (Darnay et al. 2007) 
including the NF-κB noncanonical pathway. Hence, the thymic phenotype of TRAF6 mice is likely caused 
by a combined abrogation of several signalling cascades. On the other hand, mice lacking individual 
components of the noncanonical pathway- such as NIK, IKKα and RelB – display disturbed medullary 
Figure 1.6 Developmental model of TEC differentiation. 
The MHCII
hi
CD80
hi 
mTEC
 
have high mitotic activity and thus represent 
the immature mTEC that differentiate into more mature MHCII
lo
CD80
lo 
mTEC. According to this scenario Aire and TRAs expression are 
properties of the immature mTEC compartment (taken from Gillard, 
2006). 
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architecture and a marked reduction in UEA-1
+
 and Aire
+
 mTEC (Burkly et al. 1995; Weih et al. 1995; 
Kajiura et al. 2004; Kinoshita et al. 2006; Zhang et al. ; Lomada et al. 2007). As a consequence of 
structural impairments to the medulla and its function in inducing central tolerance, mice deficient in 
regular NF-κB activation display also various signs of autoimmunity. 
Receptors and ligands of the TNF superfamily govern mTEC development 
Tumor necrosis factor (TNF) signalling to mTEC is essential for the generation and maintenance of a 
correctly organized and functioning medulla. mTEC express lymphotoxin β receptor (LTβR), receptor 
activator of NF-κB (RANK) and CD40 receptor. Though RANK and CD40 engagement is linked to the 
canonical pathway via TRAF6 activation, and LTβR stimulates the noncanonical pathway (Basak and 
Hoffmann 2008), each of these three receptors may also activate the alternative NF-κB pathway but 
induces different biological effects in mTEC.  
The heterotrimer LTα1β2 and the homotrimer LIGHT3 (Tumanov et al. 2003; Irla et al. 2008; Irla et 
al. 2009) are expressed by SP thymocytes and bind to LTβR. Activation of signalling via LTβR regulates 
Figure 1.7 NF-kB signalling 
pathways governing mTEC 
development.  
Members of the NF-kB family of 
transcription factors can be 
activated by the canonical (TRAF6) 
and noncanonical (NIK and RelB) 
pathways. The canonical and 
noncanonical pathways are coupled 
to TNF family of receptors which 
are implicated in mTEC 
development and include LTβR, 
RANK and CD40. In the postnatal 
thymus, the ligands of RANK 
(RANKL) and CD40 (CD40L) are 
provided by SP CD4
+
 thymocytes. 
In the fetal thymus, RANKL is 
provided by LTi cells. LTbR ligands 
(LTa1b2 and LIGHT3) are 
expressed by both CD4
+
 and CD8
+ 
SP thymocytes (taken from Irla, 
2009). 
 Generation of a functional thymic epithelial compartment 
 29 
the mature mTEC in terms of size and organization, but does not affects the expression of Aire and its 
target genes or the differentiation and maintenance of Aire
+
 mTEC as revealed in mice that lack LTβR 
signalling (Venanzi et al. 2007; Gray et al. 2008; Martins et al. 2008). Importantly, signalling through LTβR 
does not involve TRAF6 (Ishida et al. 1996). In contrast, signalling via RANK (Rossi et al. 2007c) 
engages TRAF6 (Akiyama et al. 2005a) and is directly responsible for Aire
+
 mTEC differentiation and the 
transcriptional regulation of Aire and Aire-dependent TRAs. This signalling axis is essential for the initial 
emergence of mature mTEC as RANK-deficient embryos lack Aire
+
 mTEC. However, Aire
+
 mTEC are 
detected, albeit in reduced numbers, in adult RANKL- or RANK-deficient mice. This change in phenotype 
inferred that additional signal(s) may be relevant for the terminal development of mature mTEC in the 
postnatal thymus (Akiyama et al. 2008a). Indeed, subsequent analysis identified the CD40L/CD40 
signalling axes as an additional pathway controlling postnatal mTEC development. Mice deficient for 
CD40 have a marked reduction in Aire
+
 mTEC (Hikosaka et al. 2008; Irla et al. 2008; Akiyama et al. 
2008a), while double deficiency of CD40 and RANKL results in the absence of Aire
+
 mTEC altogether 
and exacerbated symptoms of autoimmunity demonstrating a cooperative role for RANK and CD40 in 
development of mTEC to establish self-tolerance (Akiyama et al. 2008a). 
Furthermore, FTOC confirmed that the development of mature Aire
+
 mTEC and PGE are, in addition 
to stimulation by CD40 or RANK, also dependent on signalling via TRAF6, NIK and RelB and verified that  
each receptor activates both the canonical and noncanonical NF-kB pathways in mTEC (Akiyama et al. 
2008a). Given the heterogeneity and dynamic nature of the thymic microenvironment it remains to be 
determined whether the signals transmitted via LTβR, RANK and CD40 act concomitantly or sequentially 
during specific stages of embryonic and postnatal mTEC development. 
 
Cellular interactions driving mTEC development 
mTEC are not only promiscuous in their choice of genes they express but also in their predilection for 
cellular partners they interact with, reflecting a degree of complexity in the control of their differentiation 
that was not anticipated by the original concept of thymic crosstalk. During fetal thymus organogenesis, 
Aire
+
 mTEC emerge before SP thymocytes are formed (White et al. 2008). In keeping with this 
observation, small numbers of Aire
+
 mTEC are also detected in Rag2-deficient mice that lack SP 
thymocytes (Derbinski et al. 2001; Rossi et al. 2007c; Hikosaka et al. 2008). Aire
+
 mTEC can thus, be 
generated also independent of mature SP thymocytes. On the other hand, the appearance of Aire+ 
mTEC in ontogeny coincides with the presence of lymphoid tissue inducer (LTi) cells. These cells 
represent a population of fetal liver derived hematopoietic cells and are characterized by the expression 
of CD4, the retinoic acid receptor related orphan receptor γt (RORγt) and the transcriptional repressor Id2 
but lack CD3. LTi cells also express RANKL on their cell surface allowing for direct cell–cell interactions 
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with mTEC (Anderson et al. 2007; Rossi et al. 2007c; White et al. 2008). However, these developmental 
signals most likely do not contribute to the development of Aire
+
 mTEC in the postnatal thymus (Hikosaka 
et al. 2008; White et al. 2008) since Aire
+
 mTEC are not reduced in adult mice that lack LTi cells due to a 
deficiency in the expression of Id2 or RORγt (Hikosaka et al. 2008). Furthermore, LTi cells are 
exceedingly rare in the postnatal thymus and are hence unlikely to deliver signals that are sufficiently 
abundant to control mTEC maturation in a view of their high turnover rate. 
Several studies have established the role of positively selected thymocytes for the expansion and 
organization of the medulla in the postnatal thymus. Given their relative late appearance during ontogeny, 
these cells are thought to take over the role of LTi in the adult thymus and contribute to the postnatal 
mTEC homeostasis. This is evident in mice that lack positive selection (TCRα
-/-
, Zap70
-/-
 and Rag2
-/-
) or in 
mice that have deficiencies in CCR7 or CCR7 ligands and hence defective thymocytes migration and 
consequently display severely defective or reduced numbers of mTEC (Ueno et al. 2004; Hikosaka et al. 
2008; Irla et al. 2008). Reconstitution of T cell-deficient severe combined immunodeficient (SCID) mice 
with mature T cells or TCR bearing thymocytes was sufficient to restore mTEC development and hence 
the formation of a correctly organized medulla (Shores et al. 1991; Surh et al. 1992). Similarly, the 
numbers of mature CD80
hi
, CD40
hi
, Aire
+
 mTEC are strongly reduced in mice that lack MHCII (IAα) 
expression and thus, lack positively selected CD4
+
 thymocytes (Nasreen et al. 2003; Irla et al. 2008). 
Conversely, aborted positive selection of CD8
+
 thymocytes in mice that lack MHCI (b2m) expression does 
not lead to a significant reduction in mature mTEC (Nasreen et al. 2003; Irla et al. 2008). Thus, these 
studies establish a specific role of positively selected CD4
+
 thymocytes in controlling mature mTEC 
cellularity in the postnatal thymus.  
The specificity for positively selected CD4
+
 thymocytes is conferred by their selective upregulation of 
CD40L and RANKL and their capacity to induce the development of Aire
+
 mTEC and TRA in RTOC 
(Hikosaka et al. 2008; Irla et al. 2008; White et al. 2008). The relative contribution of LTi and CD4
+
 
thymocytes to the development of medulla has now been reconciled in a model where RANKL signals 
provided by LTi cells promote the initial emergence of mature mTEC during embryogenesis and RANKL 
and CD40L signals delivered by CD4
+
 thymocytes contribute to the maintenance of these cells in the 
postnatal thymus (White et al. 2008; Anderson et al. 2009). This model emphasizes the fact that the 
molecular and cellular mechanisms governing the genesis and function of the thymus are dynamic, and 
that the processes operating in the fetal and postnatal thymus are not necessarily identical.  
The cellularity of mature mTEC is also controlled by the TCR specificity of positively selected CD4
+ 
thymocytes as negative selection of these cells provides to mTEC the signals required for their maturation 
and Aire expression (Irla et al. 2008). Experiments using OT-II transgenic mice which express an MHCII-
restricted TCR specific for ovalbumin (OVA) show that positively selected CD4
+
 thymocytes can drive 
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mature mTEC development only if they can recognize their cognate antigen (i.e. transgene Rip-mOVA) 
on mTEC (Irla et al. 2008). Similarly, CD4
+
 thymocytes in Marilyn mice, which express an MHCII-
restricted TCR specific for the male-specific H-Y antigen, can stimulate CD80
hi
 and Aire
+
 mTEC 
development in male, but not female, mice (Irla et al. 2008). Thus, mature mTEC development is 
controlled by antigen specific, TCR–MHCII mediated contacts between autoreactive CD4
+
 thymocytes 
and mTEC. These contacts presumably stabilize the cellular interactions permitting efficient transmission 
of signals via the RANKL/RANK and CD40L/CD40 signalling axes. Future work will concentrate on 
defining what is the nature of the biological processes (proliferation, survival and differentiation) that are 
regulated in thymic medulla by the canonical and noncanonical NF-kB pathways and by interactions with 
CD4
+
 thymocytes and LTi cells. 
 
1.3. T cell development in thymus 
The thymus carries out two functions essential for a properly functioning adaptive immune response. 
These are the generation of new T cells from hematopoietic stem cells (HSC) and the selection of T cells 
expressing a functional and self-tolerant T cell receptor (TCR) repertoire (Figure 1.8). These critical 
processes are guided by the thymic stroma where different TEC subsets house distinct stages of T cell 
development. cTEC foster the development of CD4
–
CD8
– 
cells into CD4
+
CD8
+
 thymocytes and their 
subsequent positive thymic selection. The cells that carry TCRs capable of interacting with self-peptides 
bound to MHCI or MHCII molecules expressed by cTEC survive and differentiate into CD4
–
CD8
+
 or CD8
–
CD4
+
 thymocytes, respectively. Positively selected thymocytes relocate via chemokine receptor 7 
(CCR7)-mediated chemotaxis to the medulla, where the cognate CCR7 ligands (CCL19 and CCL21) are 
produced by mTEC (Kwan and Killeen 2004; Ueno et al. 2004). In the medulla, mTEC together with DC, 
mediate negative selection of thymocytes bearing high affinity self-reactive TCRs (Hayday and 
Pennington 2007) establishing central tolerance before thymus emigration (Kyewski and Klein 2006).  
A continual supply of blood borne hematopoietic stem cells is crucial for thymopoesis as the thymus 
lacks self-renewing lymphoid precursors. At E11.5 intrathymic vessel formation has not yet occurred and 
hematopoietic precursors must enter the thymus anlage through the capsule (Itoi et al. 2001).The 
chemokine receptors CCR7 and CCR9 are important for this migration, as CCR7- and CCR9- deficient 
mouse embryos exhibit an impaired thymopoesis (Uehara et al. 2002; Benz et al. 2004; Liu et al. 2005). 
After establishment of the blood circulation, high endothelial venules (HEV) at the cortico-medullary 
junction (CMJ) provide the site of entry for these precursors (Lind et al. 2001). Whether the thymus 
emigration in adult mice relies upon the same chemokines that control this process in the embryo remains 
to be determined. 
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Figure 1.8 T cell development in the thymus. 
Lymphoid progenitors arise in the bone marrow and enter the thymus through blood vessels at the CMJ junction. 
They migrate through the cortex to the subcapsular zone as DN (CD4
-
CD8
-
) thymocytes which can be subdivided 
into four developmental stages DN1-DN4. As cells progress through the DN2 to DN4 stages, they express the 
pre-TCR. Signalling through pre-TCR leads to substantial cell proliferation during the transition of DN4 to DP and 
replacement of the pre-TCR α-chain with a newly rearranged TCR α-chain forming a complete αβTCR. The 
αβTCR-expressing DP thymocytes interact with cTEC that express a high density of MHCI and MHCII molecules 
associated with self-peptides. The fate of the DP thymocytes depends on signalling mediated by interaction of the 
TCR with these self-peptide–MHC ligands. Too little signalling results in delayed apoptosis (death by neglect). 
Too much signalling can promote acute apoptosis (negative selection); this is most common in the medulla on 
encounter with strongly activating self-ligands on mTEC and DC. The appropriate, intermediate level of TCR 
signalling initiates effective maturation (positive selection). Thymocytes that express TCRs that bind self-peptide–
MHCI complexes become CD8
+
 T cells, whereas those that express TCRs that bind self-peptide–MHCII ligands 
become CD4
+
 T cells. These cells eventually emigrate from the medulla to peripheral lymphoid sites (taken from 
Germain, 2002). 
Once within the thymic environment, CCR7-, CCR9- and CXCR4-mediated signals separately 
influence the directional movement of developing thymocytes through the distinct regions of the thymus 
(Plotkin et al. 2003; Benz et al. 2004; Misslitz et al. 2004). The commitment to the T cell lineage occurs as 
a consequence of Notch 1 activation via engagement of Delta 1 that is expressed by TEC at the CMJ 
(Jaleco et al. 2001; Lind et al. 2001; Allman et al. 2002). The earliest intrathymic precursors committed to 
the lymphoid lineage express neither CD4 nor CD8 and are thus designated double negative (DN) 
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thymocytes. Using the expression profile of additional cell surface markers, CD44 (Lesley et al. 1985) and 
CD25 (Ceredig et al. 1985), DN murine thymocytes can be further separated into four developmental 
stages called DN1–DN4, where expression of CD117 (c-kit, tyrosine kinase receptor for stem cell factor) 
is used to exclude committed cells from non-T lineages (Balciunaite et al. 2005). The most immature 
population of thymocytes, known as DN1, is defined by the concomitant expression of CD44 (Pgp-1, 
phagocyte glycoprotein-1) and CD117 in the absence of CD25 (IL-2 receptor α chain) (Wu et al. 1991; 
Boyd et al. 1993). The expression of CD25 marks the progression from a DN1 to a DN2 (CD44
+
CD25
+
) 
stage (Godfrey et al. 1994) and the start of TCRβ locus rearrangement (von Boehmer and Fehling 1997). 
DN2 cells also begin to express the surrogate α-chain of the pre-TCR (pTα, also known as gp33). The 
subsequent loss of CD44 and CD117 expression defines the DN3 (CD44
-
CD25
+
) stage of early T cell 
development. DN3 cells have completed their rearrangement of the β-chain locus and if successfully 
express on their cell surface the complete pre-TCR consisting of a β-chain and a surrogate and invariant 
TCRα-chain. This immature form of the TCR allows cells to receive survival signals, a process referred to 
as β-selection, and to progress to the DN4 (CD44
-
CD25
-
) stage of thymocytes development, 
phenotypically characterized by the downregulation of the CD25 expression. This stage is short and 
followed within hours by the acquisition of CD4 and CD8 cell surface expression (reviewed in (Rodewald 
and Fehling 1998; Ceredig and Rolink 2002), a phenotype referred to as double positive (DP). During 
mouse embryonic development, DN1 cells first appear at E12 (Douagi et al. 2000). By E13, DN2 cells 
evolve and by E15.5 both DN3 and DN4 thymocytes can be detected. At E15.5 the first DP appear in 
small numbers. 
The stage of DP thymocytes which holds ~80% of all thymocytes is reached via a transitional 
intermediary phenotype referred to as immature single positive (ISP) cells. These ISP express either CD4 
or CD8 but not both co-receptors at the same time, and can be distinguished from more mature SP 
thymocytes by a lower cell surface expression of their TCRβ and a lack of TCRα-chain expression 
(Paterson and Williams 1987; Yu et al. 2004). The transition of ISP to DP is an actively regulated 
differentiation step that leads to the generation of a large pool of DP thymocytes (Yu et al. 2004). At the 
ISP stage of maturation, the rearrangement of the TCRα locus is initiated which still coincides with cell’s 
active phase of proliferation. Hence, no rearrangement of the α loci occurs until the proliferative phase 
has ended. This sequence of events ensures that each successful rearrangement of the TCRβ-chain 
gives rise to many DP thymocytes. Each of these can independently rearrange their α-chain genes once 
the cells stop dividing, so that a single functional β-chain can be associated in the progeny of these cells 
with many different α-chains maximizing the chance of forming a useful TCR. 
Following the period of α-chain gene rearrangement, a complete and functional α/β TCR is formed on 
the cell surface of DP (Lucas and Germain 1996; Sant'Angelo et al. 1998). Cells at this developmental 
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stage are now susceptible to be positively selected according to the specificity of their TCR. Positive 
selection occurs when the TCR of the thymocytes engages a self-peptide-MHC complex on cortical cTEC 
with a sufficient affinity, resulting in the transduction of a survival and differentiation signal (von Boehmer 
1994; Bevan 1997; Palmer 2003). In addition to selection signals delivered via the TCR/MHCII 
interactions, TEC also provide survival, proliferation and differentiation signals in form of soluble factors 
such as Interleukin-7 (IL-7), stem cell factor (SCF). (Rodewald et al. 1997; Boursalian and Bottomly 1999) 
and Wnts (Raff 1992; Sprent and Kishimoto 2001; Pongracz et al. 2003). Thymocytes that fail to express 
a TCR or express TCR with an insufficient affinity for self MHC molecules complexed to self-antigens 
undergo death by neglect. Thus, developing T cells are destined to die by default unless they are rescued 
by life-sustaining signals.  
Following positive selection and the migration to the medulla, thymocytes that express a TCR with a 
high affinity for self-peptide-MHC complex will be negatively selected by mTEC and DC and die by 
apoptosis resulting in the removal of thymocytes with a self-reactive TCR specificity (Smith et al. 1989; 
Nossal 1994; Sprent and Kishimoto 2002; Palmer 2003; Starr et al. 2003). Fewer than 5% of the 
developing thymocytes are positively selected and survive negative selection leaving the thymus as 
mature T cells bearing now a correctly selected TCR able to recognize foreign antigens in the context of 
self MHC molecules, i.e. they are functional and self-tolerant. Thymic selection occurs during a relatively 
short window of time as the life span of DP cells is limited to approximately 3-4 days. For autoreactive T 
cells that escape negative selection there are additional regulatory mechanisms in place in the periphery 
that control the functionality of these “forbidden” cells and prevent autoimmunity to occur (Sakaguchi et al. 
2001). 
The maturational transition from DP to single positive (SP) thymocytes is gradual and consists of 
various intermediate stages, and is paralleled by the physical translocation from the cortex to the medulla. 
Positively selected DP thymocytes transiently downmodulate both CD4 and CD8 (i.e., CD4
low
CD8
low
 
TCR
intermediate
) only to re-express CD4 attaining a CD4
high
CD8
low
 TCR
intermediate
 phenotype. This expression 
pattern does not yet infer the TCR`s restriction to either MHC class I or II molecules. Subsequently, a 
lineage specific program is activated that results in the suppression of either CD4 or CD8 synthesis 
dependent on the MHC restriction of the selected TCR. CD4
high
CD8
low
TCR
intermediate
 thymocytes that bear 
a TCR specific for antigens presented by MHC class II molecules stop the expression of CD8, upregulate 
the cell surface expression of their antigen receptor and gain the CD4
high
CD8
-
TCR
high
 phenotype of 
mature thymocytes. In contrast, thymocytes which have successfully engaged the antigen in the context 
of MHC class I, maintain and eventually increase their CD8 expression while turning off CD4 synthesis 
and gain the cell surface phenotype of CD4
-
CD8
high
TCR
high 
mature thymocytes. Further interactions of SP 
thymocytes with a diverse set of self-peptides, including TRAs displayed by mTEC and DC, is essential 
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for establishing central self-tolerance (Kyewski and Klein 2006; McCaughtry et al. 2007; Weinreich and 
Hogquist 2008). Completely selected, medullary SP thymocytes undergo a series of maturational stages 
including the upregulation of homing receptors (CD62L) and the downregulation of the heat-stable 
antigen (HSA) CD24 and the early activation marker CD69 (Lucas et al. 1994; Ernst et al. 1995; Gabor et 
al. 1997; Hare et al. 1998; Anderson and Jenkinson 2001). The release of naive T lymphocytes with a 
diverse yet self-tolerant TCR repertoire from the thymus to the circulation is regulated via chemotaxis 
driven by activation of the sphingosine-1-phosphate receptor 1 (S1P1) (Schwab and Cyster 2007). 
 
1.4. Role of Wnt signalling and Foxn1 in thymus development and function 
Wnt (Wingless) signalling is involved in virtually every aspect of embryonic development as it controls 
cell fate specifications, proliferation, migration, polarity and death of cells (Clevers 2006; Scheller et al. 
2006). Wnts constitute a highly conserved family of 19 secreted glycoproteins in humans and 18 in mice. 
Within the thymus, both TEC and thymocytes of all developmental stages express various Wnt proteins 
and their receptors and established TEC lines are able to respond in autocrine and paracrine fashion to 
Wnt-mediated signals (Balciunaite et al. 2002; Pongracz et al. 2003; Osada et al. 2006; Weerkamp et al. 
2006). Appropriate regulation of Wnt signalling activity is required for both normal TEC development and 
function (Kuraguchi et al. 2006; Osada et al. 2006; Zuklys et al. 2009; Osada et al. 2010) and early 
thymocyte development (Mulroy et al. 2003; Weerkamp et al. 2006). Wnt signalling engaging via β-
catenin also regulates expression of Foxn1 (Balciunaite et al. 2002), which is a transcription factor critical 
for thymic epithelial development and responsible for the athymic nude phenotype when mutated in mice 
and humans (Blackburn et al. 1996; Nehls et al. 1996). 
 
1.4.1. The canonical Wnt/β-catenin signalling pathway 
Wnt proteins can stimulate distinct intracellular transduction pathways. Non-canonical Wnt signalling 
refers to a collection of pathways that either activate small GTPases of the Rho family to regulate the 
actin cytoskeleton (i.e. the planar cell polarity pathway) or stimulate the calcium flux and activate protein 
kinase C (PKC) modulating cell adhesion and motility during gastrulation (i.e. the Wnt/Ca
2+
 pathway) 
(reviewed in (Habas and Dawid 2005; Kohn and Moon 2005)). The most well characterized canonical Wnt 
pathway is mediated by β-catenin (Figure 1.9) (Cadigan and Liu 2006; Semenov et al. 2007). Most of the 
β-catenin in cells constitutes a structural component of the cytoskeleton, and is bound to the cytoplasmic 
domain of type 1 cadherins linking them via α-catenin to the actin cytoskeleton (Nelson and Nusse 2004). 
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However, a small dynamic pool of β-catenin shuttles between the cytoplasm and the nucleus to transduce 
canonical Wnt signals (Kimelman and Xu 2006). 
In the absence of 
Wnt signalling, 
cytosolic β-catenin is 
captured by a large 
group of proteins 
known as the 
destruction complex. 
This complex is 
composed of the 
scaffold proteins, Axin 
and adenomatous 
polyposis coli (Apc), 
and the serine/threonin 
kinases, glycogen 
synthase kinase 3β 
(GSK3β) and casein 
kinase 1α (CK1α) 
which phosphorylate 
serine residues in the N-terminus of β-catenin. Phosphorylated β-catenin is recognized by the E3 
ubiquitin ligase, the β-transducin repeat containing protein (β-TrCP) and targeted for proteasome 
degradation. Thus in the absence of Wnt signals, intracellular β-catenin levels are kept low (Kimelman 
and Xu 2006). Binding of Wnt ligands to the serpentine receptor Frizzled (Fz) and the single-span 
transmembrane co-receptor, low-density lipoprotein receptor−related proteins 5 and 6 (Lrp5/6) leads to 
the inactivation of the destruction complex through recruitment of its components to the Fz/Lrp/Dvl 
(Dishevelled) complex (Schmidt-Ott and Barasch 2008). As a result, free dephosphorylated cytosolic β-
catenin is stabilized and translocates into the nucleus.  
Nuclear β-catenin controls the transcription of Wnt target genes in concern with the members of T 
cell factor/lymphoid enhancer factor (Tcf/Lef) family of transcription factors (Logan and Nusse 2004; 
Clevers 2006; Xu and Kimelman 2007). In the absence of Wnt signalling, Tcf/Lef are bound to Wnt target 
gene promoters in a complex with transcriptional co-repressors such as Tle/Groucho and histone 
deacetylases (HDAC) and mediate repression of target genes (Roose et al. 1998; Brannon et al. 1999; 
Daniels and Weis 2005; Hoppler and Kavanagh 2007). As a result of Wnt signalling engaging the 
Figure 1.9 The canonical Wnt signalling. 
Wnt-off state: In the absence of a Wnt signal, the destruction complex 
phosphorylates β-catenin. This leads to ubiquitin-mediated proteasomal degradation 
of β-catenin and keeps intracellular levels low. Meanwhile, Tcf/Lef transcription 
factors recruit Tle/Groucho and histone deacetylases (HDAC) to repress Wnt target 
genes. Wnt-on state: Wnt signalling inactivates the destruction complex, as a result 
β-catenin accumulates intracellularly, translocates to the nucleus where it interacts 
with Tcf/Lef factors and co-activators such as CBP/p300. This interaction promotes 
the transcription of Wnt target genes (taken from Schmidt-Ott, 2008). 
CBP/ 
p300 
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Fz/Lrp5/6 complex, β-catenin interacts with Tcf, displaces these co-repressors and mediate the 
recruitment of co-activators such as the histone acetyltransferase CBP/p300, so that the DNA bound 
complex can now stimulate the transcription of Wnt target genes (Arce et al. 2006; Stadeli et al. 2006). 
Thus, the amount of freely available β-catenin and its post-translational modification are key factors that 
determine the outcome of canonical Wnt signalling (Miller 2002).  
The Wnt activity is also regulated at the level of Wnt ligand binding to its cognate receptor. Different 
secreted proteins have been classified that modulate Wnt signalling by blocking access to receptors and 
signalling via Fz. These proteins include Wnt inhibitory factor (Wif)-1, soluble frizzled proteins (sFz), 
Dickkopf proteins (Dkk1-4) (Niehrs 1999) and Kremen proteins (Krm 1 and 2) (Wodarz and Nusse 1998). 
Wif-1 and sFz act as competitive inhibitors of Fz by directly binding available Wnts (Kawano and Kypta 
2003; Logan and Nusse 2004). In contrast, Dkk1 functions as an antagonist of the canonical Wnt pathway 
as it binds to Lrp5/6 and prevents its interaction with Wnt-Fz complex (Bafico et al. 2001), a prerequisite 
for the successful transduction of signal.  Krm1, acts as an additional negative regulator as it binds to Dkk 
and triggers the internalization and clearing of the Dkk/Lrp5/6 complex from the cell surface (Bafico et al. 
2001; Mao et al. 2002; Devoss et al. 2008).  
The interception of Wnt signalling pathway with diverse factors that induce the biochemical changes 
subsequent to Fz/Lrp5/6 engagement constitute another mechanism to alter the outcome of Wnt 
signalling. In this context, members of the Sox transcription factor family have been reported to fine tune 
the spatial and temporal activity of the canonical Wnt signalling pathway. 
 
1.4.2. Modulation of Wnt signalling activity in thymic epithelia 
Several studies have demonstrated that a precise regulation of Wnt pathway activity is required for 
normal TEC architectural organization, differentiation and function. Deletion of the negative Wnt signalling 
regulator, the adenomatous polyposis coli (Apc) in TEC (and other epithelia) results in a hypoplastic non-
functional thymus characterized by loss of proper cortico-medullary organization and an increase in 
CK14
+
CK8
+
 TEC (Kuraguchi et al. 2006). Similarly, increased canonical Wnt signalling in TEC, as a 
consequence of a lack of Kremen1 expression, leads to a loss of defined cortical and medullary 
compartments and an abundance of CK5
+
CK8
+
 TEC progenitor population (Osada et al. 2006). The 
thymus phenotype observed in these mice however, cannot be exclusively attributed to the increased Wnt 
signalling in TEC, as the general loss of Kremen1 expression also affects thymocytes and mesenchymal 
cells. A precise regulation of intracellular β-catenin protein levels in TEC is also essential for regular 
thymus development and function. Constitutive activation of the canonical Wnt signalling in TEC following 
the expression of a stabilized form of β-catenin alters cellular identity of TEC and leads to an impaired 
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thymic microenvironment unable to support T cell development (Zuklys et al. 2009). Although these 
studies demonstrate the importance of appropriate Wnt signalling for normal thymus organogenesis, the 
early block(s) in thymus organogenesis or the premature death of mutant mice, prevented the analysis of 
the impact of Wnt signalling on TEC biology in the adult mice.  
In a study by Osada et al, an inducible model was used to directly (i.e. without affecting the initial 
development of the thymus or other epithelial organs requiring Wnt signals during development) assess 
the contribution of Wnt signalling for the maintenance of adult epithelial microenvironments. Inhibition of 
canonical Wnt signalling in TEC by induced expression of Dkk1 results in a rapid degeneration of the 
thymus microenvironment as characterized by reduced TEC proliferation, loss of CK5
+
CK8
+
 progenitor 
population and disappearance of immature cycling  ΔNp63
+
TEC and mature Aire
+
mTEC subsets (Osada 
et al. 2010). Removal of Dkk1 expression results in a full recovery of the thymus phenotype, including a 
return to normal thymic size, a re-appearance of the CK5
+
CK8
+
 TEC progenitors and a normal frequency 
of both immature and mature TEC subsets. The reversibility of the pathology suggests that inhibition of 
Wnt signalling does not lead to death of the TEC progenitors but rather reduces their ability to cycle 
and/or give rise to progeny. The concomitant loss of immature ΔNp63
+
 TEC and CK5
+
CK8
+
 progenitors 
implies a role for canonical Wnt signalling in the development or expansion of TEC progenitor population 
with the capacity to maintain properly organized adult thymic microenvironment. Identification of the Wnt 
target genes that regulate biological activity of TEC progenitors may provide useful targets for the design 
of therapies aimed at counteracting either age-associated processes that lead to thymic involution or 
mechanisms resulting in premature thymic degeneration secondary to radio/chemo therapy of the 
thymus. 
 
1.4.3. Role of Foxn1 in TEC development and function 
The Foxn1 (Nehls et al. 1994) is the earliest identified transcription factor in the pharyngeal region 
that is specifically associated with, and has an obligate role in TEC development (Blackburn et al. 1996). 
Foxn1 is cell-autonomously required for initial pattering of the epithelial rudiment into thymus-specific 
domain (Gordon et al. 2001), is sufficient to induce both cortical and medullary differentiation (Blackburn 
et al. 1996; Bleul et al. 2006) and has been implicated in mediating crosstalk-dependent differentiation of 
TEC (Su et al.). 
Low levels of Foxn1 expression in the 3
rd
 pharyngeal pouch thymic epithelium can be first detected 
by qRT-PCR at E10.5. High Foxn1 expression is present at E11.25 in the prospective thymus domain of 
the common thymus/parathyroid anlage just before lymphoid progenitor infiltration (Nehls et al. 1996; 
Gordon et al. 2001; Itoi et al.). Since transplantation experiments suggest that the endoderm already at 
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E8.5-E9 commits to a thymus fate, which is well before an obvious anlage or Foxn1 expression can be 
detected, and because Foxn1-deficient (nude) mice only start to display morphological alternation by 
E11.5, it is unlikely that Foxn1 is responsible for specifying the TEC identity during the initial stages of 
thymus organogenesis. Moreover, cells with a CK5
+
CK8
+
 progenitor phenotype are generated despite the 
absence of Foxn1 function. As such, although often referred to as athymic, nude mice do undergo the 
initial thymus development, the rudiment forms, but fails to differentiate beyond an immature CK5
+
CK8
+ 
stage and it is not colonized by lymphocyte progenitors (Nehls et al. 1996). Hence, the timing of Foxn1 
expression divides thymus development into an early Foxn1-independent phase when the endodermal 
cells in 3
rd
 pouch commit to the thymic fate and a subsequent Foxn1-dependent phase marked by the 
expansion and differentiation of TEC into defined cortical and medullary phenotypes. A domain of Foxn1 
necessary for TEC differentiation has been identified in mice expressing a mutant form of Foxn1 that acts 
as a hypomorph (Su et al. 2003). The thymus of these mice displays an abnormal thymic architecture, 
lacking mature cortical and medullary compartments and harbours specific defects at the DN and DP 
stage of T cell development. In contrast to thymi of nude mice, TEC differentiation is blocked later at the 
intermediate CK5
+
CK8
+
MTS10
+
 TEC progenitor stage that is formed independent of the interaction with 
maturing thymocytes. The allele responsible for the phenotype has a large deletion in its N-terminal 
aspect but harbours an intact DNA binding, nuclear localization and C-terminal domain (Brissette et al. 
1996; Schuddekopf et al. 1996). Hence, the N-terminal domain of Foxn1 is required for crosstalk-
dependent TEC differentiation. Importantly, the coat of these animals is not affected indicating a thymus-
specific role for the N-terminal domain. 
Despite well-established role of Foxn1 for TEC differentiation, it is still unknown whether the epithelial 
progenitors express Foxn1. However, circumstantial evidence suggests they do as first, early TEC all 
express Foxn1 (Nehls et al. 1996) and have precursor activity (Bleul et al. 2006; Rossi et al. 2006; 
Corbeaux et al. 2010); second, cells in the nude thymic anlage can be induced to differentiate normally 
upon re-supply of this gene (Bleul et al. 2006); and third, TEC compartment can be completely destroyed 
using Foxn1-directed cell ablation (Corbeaux et al. 2010). Furthermore, fate mapping of TEC using a 
Foxn1-Cre allele showed that most, if not all TEC arise from Foxn1
+
 progenitors, or at least transit 
through a stage of ubiquitous Foxn1 expression (Gordon et al. 2007; Corbeaux et al. 2010).  
Whether Foxn1 remains constitutively expressed in the adult thymus is also controversial. Although a 
Foxn1
lacZ
 allele is expressed in most, if not all embryonic and adult TEC (Nehls et al. 1996), Foxn1 protein 
expression as characterized by immunohistology using a specific antibody suggests however, that Foxn1-
negative TEC are already apparent at E13 and that many as 80% of adult TEC lack Foxn1 expression 
(Itoi et al. 2007a). Based on this finding the possibility was raised that once a functional thymic 
microenvironment is established, Foxn1 might no longer be required for TEC to sustain thymopoiesis in 
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the postnatal period. This issue was resolved in a transgenic model where adult Foxn1-expressing cells 
were specifically ablated to create a thymic microenvironment composed solely of Foxn1-negative TEC 
(Corbeaux et al. 2010). The finding that thymopoiesis ceases prematurely in these mice indicates that 
Foxn1-negative cells do not contribute to thymopoietic function of the adult thymus. Lineage tracing 
studies further established that Foxn1-negative TEC arise postnatally from Foxn1
+
 progenitors and hence 
do not represent a TEC lineage that develops independently of Foxn1 expression. The Foxn1-negative 
TEC may rather correspond to cells at the end of their lifespan. Hence, Foxn1 in addition to regulating 
TEC differentiation, also marks the functionally competent TEC both in embryonic and adult thymic 
tissues (Corbeaux et al. 2010). 
Although known for long time, Foxn1 function has mostly been studied in the fetal thymus. Mutant 
mice with a regular Foxn1 expression during fetal development but a gradually decreased Foxn1 
expression postnatally (i.e. from 50% down to 20% of the normal Foxn1 levels) have however shed light 
on the functional role of Foxn1 for the postnatal thymus. This downregulation of Foxn1 expression causes 
a progressive degeneration of the thymic compartment culminating in a specific loss of mature 
MHCII
hi
UEA-1
hi
 mTEC and reduced T cell production providing evidence that the maturation and 
maintenance of the postnatal thymic epithelium requires continuous Foxn1 expression (Chen et al. 
2008a). As the mature MHCII
hi
UEA-1
+
 mTEC express high Foxn1 levels and are most sensitive to its 
downregulation they are thought to represent a cellular target for Foxn1 function to maintain the postnatal 
thymus microenvironment. The progressive TEC phenotype directly correlates with the reduced Foxn1 
expression and thus, suggests that there may be a threshold of Foxn1 expression levels required to 
maintain thymus. That the Foxn1 dose is critical for thymus development has been recognized long time 
ago as mice with 50% reduction of Foxn1 expression display mildly thymus size reduction, despite normal 
thymic stromal organization (Scheiff et al. 1978; Kojima et al. 1984). Decreasing further Foxn1 expression 
to 40-30% of normal levels affects the maintenance of MHCII
+ 
TEC and reduction to 20% causes more 
rapid degeneration of thymic epithelium. These findings indicate that TEC are extremely sensitive to the 
modulation of Foxn1 expression, with small changes in Foxn1 levels of only 10 -20%, having large effects 
on thymus phenotypes. 
The phenotype of these mutant mice is strikingly similar to that of older wild type mice undergoing 
normal age-related involution and suggests that changes in Foxn1 expression in TEC contribute to 
thymus senescence. This contention is in keeping with the observation that Foxn1 expression is 
progressively decreased in wild type TEC with aging (Ortman et al. 2002). However, it remains to be 
determined whether this change drives involution or is a consequence of the normal mechanisms 
underlying this physiological process. Independent of the sequence of events, this experimental model 
clearly shows that a TEC-intrinsic mechanisms are responsible for the phenotypic features of aging-
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related involution and that a change in the expression level of a single critical transcription factor in TEC 
is sufficient to induce involution (Su et al. 2003; Chen et al. 2008a). Hence, the function of Foxn1 extends 
beyond its role in the initial TEC differentiation, playing a role in functional maintenance of the 
differentiated mature epithelium and perhaps also during thymus involution. Investigation of the 
mechanisms by which Foxn1 expression and activity are regulated in TEC during thymus development 
and aging will help to understand the molecular control of thymus homeostasis. Identification of Foxn1 
target genes involved in crosstalk-dependent TEC and thymocytes differentiation may help to maintain or 
boost postnatal T cell production. 
 
1.4.4. Role of Foxn1 in proliferation 
Current evidence indicates that Foxn1 regulates both TEC differentiation and proliferation (Blackburn 
et al. 1996; Nehls et al. 1996; Itoi et al. 2001). Consequently, TEC that fail to express Foxn1 are arrested 
at an early undifferentiated CK5
+
CK8
+
 developmental stage and display only a limited capacity for 
proliferation (Blackburn et al. 1996; Nehls et al. 1996; Itoi et al. 2001). A role of Foxn1 in differentiation 
and proliferation has also been assigned to the integument, where Foxn1 is believed to promote the 
proliferation of progenitor cells of the hair shaft and the inner root sheath (Lee et al. 1999). Several 
studies further demonstrate a positive impact of Foxn1 expression on thymic growth. The re-introduction 
of Foxn1 transgene into the nude thymus (Cunliffe et al. 2002; Bleul et al. 2006) and/or intrathymic 
administration of exogenous Foxn1 cDNA in aged wild type mice (Sun et al. 2010) restore thymic size 
and function. Conversely, a downregulation of Foxn1 expression in postnatal TEC consequent to 
expression of a mutant Foxn1 allele reduces TEC proliferation and causes changes of the thymic 
compartment marked by specific decrease of MHCII
hi
UEA-1
+
 and concomitant increase of MHCII
lo
UEA-1
+
 
mTEC (Chen et al. 2008a). Interestingly, the proliferation is specifically decreased in the immature 
MHCII
lo
, but not in the mature MHCII
hi
 mTEC, even though MHCII
hi
 cells are decreased in number and 
MHCII
lo
 increased. Similarly, reduced Foxn1 expression levels achieved by a transgenic expression of 
Wnt signalling inhibitor Dkk1 correlates with a specific reduction in proliferation of immature MHCII
lo
 
mTEC subset. Although the mechanism by which Foxn1 controls TEC proliferation remains to be 
determined, these studies provide clear evidence that Foxn1 affects both differentiation and proliferation 
in a subset-specific manner. 
 
1.4.5. Regulation of Foxn1 expression in thymic epithelium 
The identification of Foxn1-specific interaction partners and/or DNA binding sites that mediate its 
function has been hampered by the fact that only few primary TEC can be obtained from the nude thymus 
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and that these cells lose their functionality upon in vitro culture. However, several studies demonstrated a 
role of Bmp, Shh and Wnt signalling in the transcriptional control of Foxn1 expression in TEC (Figure 
1.10) (Bleul and Boehm 2005; Patel et al. 2006).  
In the 3
rd
 pharyngeal pouch, Foxn1 expression marks the prospective thymic cells in the ventral 
region from E11.25, while Gcm2 is expressed in the dorsal parathyroid domain from E9.5 (Patel et al. 
2006). Bmp4 is strongly expressed in the thymus domain of the 3
rd
 pouch at E10.5 (Bleul and Boehm 
2005; Moore-Scott and Manley 2005) and appears to upregulate directly Foxn1 expression (Patel et al. 
2006). In contrast, Sonic Hedgehog (Shh) is expressed in the parathyroid domain, opposes Bmp4 
expression and restricts the size of the thymic field during early thymus development (Moore-Scott and 
Manley 2005). In the absence of Shh, the pattern of Bmp4 and hence that of Foxn1 expression are 
broadened and encompass at E11.5 the entire pouch (Moore-Scott and Manley 2005), while Gcm2 
expression is absent. These findings are consistent with a previous in vitro report suggesting a role for 
Bmp4 in the induction of Foxn1 in TEC (Tsai et al. 2003). In contrast, at E10.5 expression pattern of 
Noggin, a Bmp antagonist overlaps with that of Gcm2 in the parathyroid domain of 3
rd
 pouch (Gordon et 
al. 2001). Given that Noggin expression is initiated after and independently of Gcm2 expression (Liu et al. 
2007) but concurrent with Bmp4, it is conceivable that Noggin acts in a negative feedback loop inhibiting 
Bmp4 activity and thus, allowing the specification of the Gcm2-expressing parathyroid domain (Bleul and 
Boehm 2005). In this scenario, Foxn1 expression is the default pathway for the pouch endoderm and its 
active suppression is required to allow the establishment of an alternative parathyroid fate (Soza-Ried et 
al. 200Soza-Ried et al. 2008). Alternatively, Foxn1 could prevent the activation of a default pathway, 
Figure 1.10 Regulation of the Foxn1 expression domain in the third pharyngeal pouch (3
rd
pp). 
Signalling through Bmp within the ventral region of the 3
rd
pp endoderm at E10.5-11.5 results in expression of 
Foxn1 and downstream products such as FgfR2IIIb. Ligation of FgfR2IIIb by specific mesenchyme-derived 
ligands, Fgf7 or 10 results in TEC proliferation. Expression of the Bmp antagonist Noggin in the dorsal region, 
possibly under regulation of Shh, restricts the BMP signalling domain and allows for the maintenance of Gcm2 
expression which is essential for the parathyroid development. In the mice lacking Shh, loss of Noggin 
expression results in broadened expression of Foxn1. In the Noggin transgenic mouse, decreased Bmp 
signalling results in the loss of Foxn1 expression and impaired thymus development (taken from Gill, 2009). 
Figure 1.10 Regulation of the Foxn1 expression domain in the third pharyngeal pouch (3
rd
pp). 
Signalling through Bmp within the ventral region of the 3
rd
pp endoderm at E10.5-11.5 results in expression of 
Foxn1 and downstream products such as FgfR2IIIb. Ligation of FgfR2IIIb by specific mesenchyme-derived 
ligands, Fgf7 or 10 results in TEC proliferation. Expression of the Bmp antagonist Noggin in the dorsal region, 
possibly under regulation of Shh, restricts the BMP signalling domain and allows for the maintenance of Gcm2 
expression which is essential for the parathyroid development. In the mice lacking Shh, loss of Noggin 
expression results in broadened expression of Foxn1. In the Noggin transgenic mouse, decreased Bmp 
signalling results in the loss of Foxn1 expression and impaired thymus development (taken from Gill, 2009). 
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which imposes a respiratory cell fate on epithelia of the ventral aspect of the 3
rd
 pouch (Dooley et al. 
2005). Here, Foxn1 would also take part in the specification of the 3
rd
 pharyngeal endoderm beyond a 
mere role as a differentiation factor for epithelial cells already committed to a thymus fate. Inhibition of 
Bmp signalling in TEC from E11.5 by a transgenic expression of Noggin results in abnormal TEC 
development characterized by TEC subsets failing to maintain Foxn1 expression, loss of differentiated 
TEC phenotype and reversion of thymic epithelium to a basal state of foregut epithelium (Bleul and 
Boehm 2005; Soza-Ried et al. 2008). Thus, Bmp signalling is also required from E11.5 onward for the 
maintenance of Foxn1 expression. 
Wnt expression relevant for the thymus organogenesis is detected as early as E10.5 in the 
developing 3
rd
 pharyngeal pouch, and Wnt receptors and downstream signalling components can be 
detected in both TEC and developing thymocytes (Balciunaite et al. 2002). Wnt4 and Wnt5b but not other 
Wnts induce Foxn1 expression in cultured TEC lines. Blocking of Wnt-mediated activation- either at the 
level of its specific receptor, Fz, or at distinct intracellular sites within the canonical signalling pathway- 
inhibits Foxn1 expression (Balciunaite et al. 2002; Osada et al. 2010). However, no single or compound 
Wnt mutant mouse has been reported that resembles the nude thymus phenotype and further clarification 
of the role of Wnt family members upstream of Foxn1 is needed. Loss of Wnt negative regulator Apc in 
TEC results in a hypoplastic non-functional thymus with aberrant architecture of TEC which exhibit 
increased β-catenin localization in the nucleus, a hallmark of canonical Wnt signalling (Kuraguchi et al. 
2006). Whether these changes result in an increased Foxn1 expression in TEC was however not 
reported. A direct effect of Wnt signalling on Foxn1 expression has been confirmed in transgenic mice in 
which the inhibition of Wnt signalling by Dkk1 expression results in a reduction of Foxn1 expression in 
both cTEC and mTEC and correlates with thymic degeneration (Osada et al. 2010). Taken together these 
findings indicate that Wnt signalling is important for the correct TEC development and maintenance and, 
at least in part, this effect may be mediated via the regulation of Foxn1 expression. 
 
1.5. The Sox transcription factor family and its interaction with Wnt 
signalling 
The Sox (Sry-Box) transcription factors have emerged as modulators of canonical Wnt/β-catenin 
signalling in different developmental contexts. They are essential for the biological processes as diverse 
as cell fate specification, stem/progenitor cell proliferation and differentiation and tissue homeostasis 
(Wilson and Koopman 2002; Dong et al. 2004; Kiefer 2007). In this capacity, Sox transcription factors 
interact with the canonical Wnt pathway (Akiyama et al. 2004b; Blache et al. 2004; Kan et al. 2004; 
Mansukhani et al. 2005; Yano et al. 2005; Bastide et al. 2007; Iguchi et al. 2007; Sinner et al. 2007; 
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Tamashiro et al. 2008; Topol et al. 2008). Conversely, Wnt signalling also regulates sox gene expression 
establishing a regulatory feedback loop that fine tunes Wnt signals. The interactions between Sox 
members and Wnt signalling are evolutionarily well conserved and are for example, already described in 
fruit fly. Drosophila SoxF restricts Wnt signalling to a narrow stripe of cells in the developing wing imaginal 
disc, and elevated Wnt signalling in SoxF mutants causes an over-proliferation of the wing disc epithelium 
(Dichtel-Danjoy et al. 2009). Though in the thymus, a precise control of canonical Wnt signalling activity is 
critical for normal TEC development, function and maintenance a direct association between Sox family, 
including its member Sox9, and the Wnt/β-catenin pathway has so far not been established in these cells. 
The identification of precise mechanism(s) how Sox proteins regulate β-catenin/TCF activity during tissue 
development and maintenance of different organs constitutes a focus of intense interest. 
 
Sox9, a member of the Sox family of transcription factors 
The vertebrate genome encodes over 20 different members of the Sox transcription factor family. 
These molecules have so called Sry-box, a 79 amino acid motif encoding a high mobility group (HMG) 
DNA binding domain. This sequence was first described for the founding member of this gene family, the 
mouse Sry (sex-determining region on the Y chromosome) (Gubbay et al. 1990; Sinclair et al. 1990) and 
has characterized this family of transcription factors. Based on their sequence homologies, Sox 
molecules are classified into eight separate subfamilies (SoxA-H) (Bowles et al. 2000). Sox9, together 
with Sox8 and Sox10, belongs to the SoxE subfamily, and is composed of N-terminal HMG domain and a 
C-terminal transactivation (TA) domain (Sudbeck et al. 1996; Pevny and Lovell-Badge 1997; Wegner 
1999). All Sox factors recognize a relatively loosely defined sequence, (A/T)(A/T)CAA(A/T)G (Pevny and 
Lovell-Badge 1997), resulting in DNA bending that is critical for bringing distal control elements to the 
proximal transcriptional start sites (Weiss 2001). Most of Sox proteins contain also nuclear import and 
nuclear export sequences and exhibit the shuttling between the two subcellular compartments, an ability 
that is apparently important for their function (Gasca et al. 2002; Rehberg et al. 2002; Smith and 
Koopman 2004). 
Sox9 was first identified as a key regulator of cartilage and male gonad development (Wagner et al. 
1994; Foster et al. 1994a; Kent et al. 1996; Sudbeck et al. 1996). Heterozygous Sox9 mutations are 
responsible for the campomelic dysplasia, a skeletal dysmorphology syndrome characterized by cartilage 
and endochondral bone malformations and by male-to-female sex reversal in humans (Wagner et al. 
1994; Foster et al. 1994a). Sox9 has also been implicated in the development of cranial neural crest 
derivatives (Spokony et al. 2002; Sakai et al. 2006), in switch from neurogenesis to gliogenesis (Stolt et 
al. 2003) and the organogenesis of the intestine (Blache et al. 2004; Moniot et al. 2004; Bastide et al. 
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2007), the pancreas (Seymour et al. 2007), the hair (Vidal et al. 2005), and the heart (Akiyama et al. 
2004a). Not surprisingly, Sox9 regulates distinct sets of target genes in the different tissues. 
Sox9 and several others Sox proteins have two main biological properties that determine their 
function during tissues 
development and maintenance; 
they have the capacity to 
modulate canonical Wnt 
signalling and the ability to 
regulate in a dose-dependent 
manner stem/progenitor cell 
proliferation and differentiation 
(Taranova et al. 2006; Que et al. 
2007; Formeister et al. 2009). 
The precise mechanism(s) by 
which Sox proteins modulate the 
canonical Wnt pathway is still 
unknown, thought several 
models have been proposed 
including: protein–protein 
interactions, the binding of Sox 
factors to Wnt target gene 
promoters, the recruitment of co-
factors, modulation of protein 
stability and nuclear 
translocation (Figure 1.11). 
Several of these mechanisms 
may operate in parallel whereas 
some Sox proteins, including 
Sox9, employ in distinct cellular 
contexts different mechanisms. 
Many Sox proteins physically 
interact with β-catenin to 
regulate transcription of Wnt 
target genes either in an 
Figure 1.11 Models of Sox-Wnt regulation. 
(A) Sox and Tcf may compete for a limited pool of β-catenin. This may 
occur on DNA or independent of DNA binding. (B) Sox and Tcf may 
compete for DNA binding to the same sites in target gene promoters. (C) 
Sox may stabilize Tcf/Tle repressor complexes and/or exclude β-catenin 
and co-activators. This could occur through Sox DNA binding or by a direct 
interaction between Sox and Tcf (not shown). Sox might recruit (D) 
transcriptional co-repressors or (E) co-activators to Wnt target gene 
promoters, either through DNA binding or by an association with β-
catenin/Tcf. (F) Sox proteins may recruit post-translational modifying 
enzymes to β-catenin and/or Tcf. The resulting phosphorylations (P), 
ubiquitination (Ub), or sumoylation (S) impact protein stability, activity, 
and/or subcellular localization. (G) Some Sox proteins promote the 
degradation of β-catenin. (H) Sox and Wnt signalling can functionally 
interact in negative feedback loops (top) or in mutually repressive 
associations (taken from Kormish, 2009). 
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activating or repressive fashion (Zorn et al. 1999; Takash et al. 2001; Akiyama et al. 2004b; Kan et al. 
2004; Mansukhani et al. 2005). 
The central region of β-catenin consists of 12 armadillo (i.e. a 42 amino acid sequence motif) repeats 
which form a helical groove that mediates the interaction with over 20 different β-catenin binding partners 
(Figure 1.12A) (Xu and Kimelman 2007). Sox9, together with Sox17 and Sox6 directly binds in a region of 
the armadillo repeats that also interacts with Tcf (Zorn et al. 1999; Akiyama et al. 2004b; Iguchi et al. 
2007; Sinner et al. 2007). Thus, Sox9 can sterically hinder Tcf binding to β-catenin which is a similar 
mechanism used by Inhibitor of β-catenin and TCF-4 (ICAT) to displace Tcf/Lef from β-catenin (Xu and 
Kimelman 2007). The β-catenin binding regions in various Sox proteins have also been mapped and 
demonstrate that β-catenin contacts several regions depending on the cell type (Figure 1.12B). Sox9, 
Sox7 and Sox17 all bind β-catenin via their C-terminal regions (Zorn et al. 1999; Takash et al. 2001; 
Akiyama et al. 2004b; 
Sinner et al. 2007), Sry 
binds through its N-
terminal domain 
(Bernard et al. 2008) 
and Sox6 interacts via 
a centrally located 
leucine zipper (LZ/Q) 
element (Iguchi et al. 
2007). The formation 
of a Sox9:β-catenin 
complex leads to the 
degradation of β-
catenin by the 
proteasomal pathway 
and determines 
intracellular β-catenin 
protein levels (Akiyama 
et al. 2004b). This 
interaction may 
constitute a common 
mechanism to specify 
a cell’s response to 
Figure 1.12 Schematic 
representation of Sox9, 
Tcf and β-catenin 
interaction domains. 
(A) β-catenin has a central 
domain of 12 armadillo 
repeats, which can bind 
many proteins including 
Sox, Tcf and the inhibitor 
ICAT. The N-terminal 
domain harbors Serine 
residues that are 
phosphorylated by GSK3β, 
whereas the C-terminal 
region binds to CPB/p300. 
(B) The regions of various 
Sox proteins that have 
been shown to bind and/or 
inhibit β-catenin/Tcf. The 
nuclear import signal 
(NLS), nuclear export 
signal (NES) and DNA-
binding HMG domains are 
indicated (taken from 
Kormish, 2009). 
 The Sox transcription factor family and its interaction with Wnt signalling 
 47 
Wnt signals (reviewed in (Kormish et al. 2009)). Alternatively, Sox proteins may associate with promoters 
of Wnt target genes (Zhang et al. 2003; Bastide et al. 2007; Chao et al. 2007; Iguchi et al. 2007; Chen et 
al. 2008b). Indeed, Sox proteins bind similar DNA sequences as Tcf proteins and thus, may suppress 
Wnt-induced transcription by competing with Tcf for the same promoter sites. However, in vitro DNA 
binding studies argue rather against this model as Sox proteins bind very poorly, if at all, to an optimized 
Tcf consensus sequence (Harley et al. 1994; Zorn et al. 1999; Zhang et al. 2003; Akiyama et al. 2004b). 
Whether Sox factors bind other regulatory sequences of Wnt target genes that are independent of TCF 
sites remains to be determined. 
Structure function studies aimed at determining which Sox protein domains are involved in the 
regulation of β-catenin/Tcf transcriptional activity have come to varying conclusions. In some reports, the 
β-catenin interaction domain is the most critical (Kenny et al. 2003; Mansukhani et al. 2005; Iguchi et al. 
2007; Guo et al. 2008), whereas in other the HMG domain appears to be essential (Zhang et al. 2003; 
Tamashiro et al. 2008; Zhang et al. 2009) and in some studies both the HMG domain and β-catenin 
binding motif are required (Kan et al. 2004; Sinner et al. 2007). These apparent contradictions indicate 
that Sox can activate different mechanisms depending on the cellular contexts. For example, in colorectal 
cells Sox9 requires the HMG domain to repress Wnt signalling (Bastide et al. 2007), whereas in 
chondrogenesis it utilizes the β-catenin interaction domain (Akiyama et al. 2004b). Conversely, Wnt 
activity controls sox gene expression (Figure 1.11H) (Blache et al. 2004; Yano et al.2008 ; Bastide et al. 
2007). Thus, a reciprocal Sox–Wnt interaction is in place that fine tunes Wnt activity in cells expressing 
Sox9. An illustrative example is the feedback loop engaging Sox9 and canonical Wnt signalling in the 
mouse intestine as the latter promotes Sox9 expression which in turn represses Wnt gene transcription 
restricting the epithelial proliferation 
(Blache et al. 2004; Bastide et al. 2007; 
Mori-Akiyama et al. 2007). 
Post-translational modifications 
determine also Wnt signalling activity as 
Sox, Tcf and β-catenin can be modified by 
ubiquitin and small ubiquitin-like modifier 
(sumo) moieties (Figure 1.13) (Gillard and 
Farr 2005; Savare et al. 2005; Taylor and 
Labonne 2005; Hattori et al. 2006; Pan et 
al. 2006). These modifications influence 
the molecular stability, activity, and sub-
cellular localization of these transcription 
Figure 1.13 Schematic representation of Sox9 regulation. 
Sox9 molecular domains, the N-terminal HMG and the C-terminal 
transactivation (TA) domain are represented as boxes. Regulators of 
Sox9 activity on specific amino acid residues are represented above the 
box, with blue representing positive regulators and red representing 
negative regulators. Interaction between Sox9 and other factors is 
represented under the boxes (taken from Kawakami, 2006). 
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factors and signal transducer, respectively (Arce et al. 2006; Hoppler and Kavanagh 2007). E3 ligase-
mediated sumoylation of Sox9 at the Lysin (K) residue 398 enhances the stability and, thus transcriptional 
activity of Sox9 (Hattori et al. 2006), whereas ubiquitination of the same residue promotes Sox9 
degradation (Figure 1.13) (Akiyama et al. 2005b). The parathyroid hormone related peptide-protein 
kinase A (PHTRP–PKA) regulates Sox9 activity via phosphorylation of the Serine (S) residues 64 and 
211 (Huang et al. 2000). This post-translational change enhances DNA binding affinity of Sox9 and 
transcriptional activity at least in chondrocytes (Huang et al. 2000). In contrast, phosphorylation of Sox9 
by the cGMP dependent protein kinase type II (cGKII) inhibits the nuclear entry and thus the activity of 
Sox9 (Chikuda et al. 2004). Because Sox9 can act either as a transcriptional activator or as repressor, 
the various cofactors that bind Sox9 via its C-terminal domain also determine its transcriptional activity 
(Zhou et al. 2002; Tsuda et al. 2003; Arnold et al. 2006).  
In addition to their role in modulating Wnt signalling, Sox proteins have a capacity to act in dose-
sensitive fashion during organ development and maintenance (Wagner et al. 1994; Kist et al. 2002; 
Fantes et al. 2003; Taranova et al. 2006; Formeister et al. 2009). Precise Sox9 expression levels are 
critical for cell fate specification and regular cell proliferation and differentiation since subtle changes in 
Sox9 dosage result in severe malformations. For example, an increase in Sox9 levels by 20% causes 
dwarfism (Akiyama et al. 2004b), whereas a 50% decrease in mice heterozygous for Sox9 null allele and 
in patients with campomelic dysplasia results in chondrodysplasia (Bi et al. 2001). Aberrant maintenance 
and differentiation of the progenitor cell compartment are thought to be the cellular cause of these 
pathologies. 
 
1.5.1. Sox9 interacts with the Wnt /β-catenin pathway during development 
The interaction of Sox9 with Wnt signalling plays important role both in the development as well as 
maintenance of the intestinal epithelium (Pinto et al. 2003; Blache et al. 2004; Bastide et al. 2007; Mori-
Akiyama et al. 2007) and in cartilage formation (Akiyama et al. 2004b; Yano et al. 2005; Akiyama 2006; 
Zhou et al. 2006; Akiyama et al. 2008b). Canonical Wnt signalling controls Sox9 expression, as Sox9 
cannot be detected in intestinal epithelia of Tcf4 null mice, but it is strongly identified in the presence of 
constitutive β-catenin expression (Blache et al.). Conversely, Sox9 overexpression strongly decreases β-
catenin transcriptional activity (Akiyama et al. 2004b; Blache et al. 2004; Bastide et al. 2007) highlighting 
the reciprocal influence these two factors have on each other. The mechanism(s) by which this 
interdependence is achieved has not been elucidated thought it is has been hypothesised that Tcf may 
bind to and regulate the Sox9 promoter or, alternatively one or several intermediate Wnt-dependent 
transcription factors may control Sox9 transcription (Blache et al. 2004).  
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Sox9 interacts with and regulates Wnt signalling activity at least at two levels. It specifies the cell`s 
response to Wnt signals, which potentially trigger very diverse cellular behaviours, including proliferation 
and differentiation, and it also fine-tunes the transcriptional output of the canonical Wnt pathway. 
Conditional deletion of Sox9 at E10.5 from the mouse intestine leads to a complete absence of Paneth 
cells but only to a reduction of the goblet cells indicating different Sox9 requirements for the differentiation 
of these two distinct cell lineages (Bastide et al. 2007; Mori-Akiyama et al. 2007). Because the same 
phenotype is observed in mice in which the Wnt pathway is impaired either by deletion of Tcf (Korinek et 
al. 1998) or overexpression of the inhibitor Dickkopf (Pinto et al. 2003; Kuhnert et al. 2004), a role for 
Sox9 in specifying this particular aspect of the Wnt pathway is suggested. Sox9 also mediates the branch 
of Wnt signalling involved in the maintenance cells in an undifferentiated state by repressing the 
transcription of differentiation genes, including the homeobox gene Cdx2 and the Muc2, normally 
expressed in the mature villus cells of the intestinal epithelium (Blache et al. 2004). Hence, although Sox9 
has generally been described as a transcriptional activator (Sudbeck et al. 1996; Bell et al. 1997; 
Lefebvre et al. 1997; Ng et al. 1997; De Santa Barbara et al. 1998; Liu et al. 2000; Sekiya et al. 2000; 
Bafico et al. 2001; Panda et al. 2001) it can also act as repressors depending on the cellular context and 
it associated interacting proteins. Recently, a model how differential Sox9 expression influences 
proliferation and lineage specification has been suggested for intestinal epithelium where two discrete 
steady-state levels exist (Formeister et al. 2009). Low Sox9 levels have been detected in proliferative 
crypt-based columnar (CBC) stem cells, whereas high Sox9 levels are present in non-cycling, mature 
enteroendocrine cells (Formeister et al. 2009). Moreover, overexpression of Sox9 in crypt cells represses 
proliferation and induces neuroendocrine-like morphologies. These data support a dose-dependent model 
for Sox9 activity, where low levels support and high levels of Sox9 suppress proliferation allowing for 
terminal differentiation of enteroendocrine cells.  
A generalized role for Sox9 in regulating cell proliferation through the Wnt/β-catenin pathway has 
become clear (Akiyama et al. 2004b; Blache et al. 2004; Bastide et al. 2007; Mori-Akiyama et al. 2007). 
The molecular mechanisms responsible for the Sox9-mediated control of cell proliferation have been 
established by overexpressing Sox9 in several cell types (Panda et al. 2001; Afonja et al. 2002; Drivdahl 
et al. 2004; Bastide et al. 2007). High Sox9 levels decrease the transcription of Wnt/β-catenin target 
genes that positively regulate proliferation, c-myc, cyclin-D1 and increase inhibitors of β-catenin/Tcf 
proliferative capacity such as ICAT (inhibitor of β-catenin and Tcf) and TLE2–4 (T cell factor transducin-
like enhancer of splits 2–4). In vivo deletion of Sox9 in intestinal epithelium also correlates with an 
upregulation of c-myc and cyclin-D1 causing an increase in crypt proliferation (Bastide et al. 2007). 
Similarly, enhanced Wnt signalling due to the loss of the negative regulator Apc leads to the expansion of 
the crypt (Sansom et al. 2004; Andreu et al. 2005). Thus, Sox9 inhibits Wnt/β-catenin signalling and its 
target genes involved in cell proliferation contributing to intestinal homeostasis (Blache et al. 2004; 
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Bastide et al. 2007; Mori-Akiyama et al. 2007; Formeister et al. 2009). This observation is in keeping with 
a perceived role of Sox9 as a gatekeeper preventing overactivity of Wnt-dependent transcriptional 
programs (Bastide et al. 2007). 
In chondrocytes, Sox9 has been shown to inhibit the canonical Wnt signalling by promoting 
degradation of stabilized β-catenin (Akiyama et al. 2004b; Topol et al. 2008). According to the current 
model, β-catenin degradation occurs in the cytoplasm (Peifer and Polakis 2000) and is regulated by Wnt 
signalling which controls GSK3β- and CKIα- mediated phosphorylation of β-catenin in the destruction 
complex and degradation by proteasomes, keeping the β-catenin cellular levels low (Ikeda et al. 1998; 
Hart et al. 1999). A small increase in the amount of GSK3β results in a significant decrease in β-catenin 
protein levels and signalling activity (Ikeda et al. 1998; Dajani et al. 2003). The exact molecular 
mechanism by which Sox9 promotes β-catenin degradation is however, still poorly understood. The study 
by Akyama et al. demonstrated that the physical interaction of Sox9 with β-catenin via its C-terminal TA 
domain results in β-catenin degradation by the proteasomal pathway. In addition, this interaction may also 
result in Sox9 protein turnover and the relative levels of Sox9 and β-catenin have been suggested to 
govern proliferation and differentiation of chondrocytes (Akiyama et al. 2004b). Recently, a novel 
degradation mechanism taking place in the nucleus was demonstrated in study by Topol et al., (Topol et 
al. 2008). Sox9 was shown to bind, in addition to β-catenin, components of the destruction complex, 
including the GSK3β and the ubiquitin ligase βTrCP and translocates them to the nucleus where more 
efficient phosphorylation and degradation of β-catenin occurs. It was further proposed that this rapid 
elimination of β-catenin in the nucleus may represent a general mechanism by which transcription factors 
effectively antagonize Wnt/β-catenin signalling during cell fate determination and maintenance. It is 
important to point out that these findings are derived from in vitro context which do not always correlate 
with the activity of transcription factors in vivo. Thus, the significance of these findings remains to be 
confirmed in cell-specific contexts. 
Sox9 has also been involved in the sex determination and development of the hair and the pancreas. 
Sox9 is expressed in an initially bipotent gonad and together with Sry regulates mammalian testis 
determination (Foster et al. 1994a). During development cells are sensitive to Sox9 gene dosage and 
threshold levels of Sox9 expression exist to control the entry into male or female pathway (Wegner 1999; 
Chaboissier et al. 2004; Jakob and Lovell-Badge 2011). Sox9 expression is sufficient to initiate testis 
formation in xx individuals whereas mutations in Sox9 cause a sex reversal in xy individuals (Koopman et 
al. 1991; Clarkson and Harley 2002; Polanco and Koopman 2007). Homozygous deletion of Sox9 in xy 
gonads interferes with the sex cord development, the activation of the male-specific markers and leads to 
the expression of the female-specific markers. These effects are at least in part believed to be caused by 
the inhibition of canonical Wnt signalling via Sox9 (Bernard et al. 2008; Tamashiro et al. 2008) which 
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under physiological conditions promotes ovarian fate and blocks testis development (Chassot et al. 2008; 
Maatouk et al. 2008; Tomizuka et al. 2008). 
Sox9 has also been identified as a crucial transcription factor required for the hair development. Its 
expression is first detected in the epithelial component of the hair placode but later becomes restricted to 
the hair stem cell compartment (bulge) and the outer root sheath (ORS) which is functionally implicated in 
the migration of hair stem cells from the stem cell niche toward the hair bulb (Vidal et al. 2005). Tissue-
specific inactivation of Sox9 demonstrates that although dispensable for hair induction, Sox9 directs 
differentiation of the ORS cell lineage and is required for the formation of the bulge. Consequently, Sox9-
deficient skin lacks external hair secondary to the severe proliferative defects of matrix cells in the hair 
bulb and  the stem cell niche never forms (Vidal et al. 2005).  
During pancreogenesis, Sox9 is required for the maintenance of early pancreatic progenitors and 
also governs their commitment to the endocrine cell fate (Seymour et al. 2008).  Mice with 50% reduced 
Sox9 gene dosage display a specific decrease of endocrine cells caused by reduced generation of 
endocrine progenitors whereas formation of the exocrine compartment is unaffected. Thus, Sox9 dosage 
determinates cell fate assignment in multipotential progenitors. Since Sox9 marks progenitors in a variety 
of tissues, it is of great interest to elucidate the molecular mechanisms which control Sox9 expression in 
time and space as this knowledge would help in our understanding of how different developmental 
processes are regulated. 
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2. AIM OF THE THESIS 
The aim of the thesis was to characterize the role of Sox9 in TEC differentiation and function. Our 
previous gene expression analysis by microarray detected Sox9-specific transcripts in epithelia of the 
third pharyngeal pouch at the time mouse thymus organogenesis is typically initiated. Also supporting a 
possible role for Sox9 in thymus formation and function are the findings from studies in zebrafish, Danio 
rerio where Sox9 dysfunction results in the displacement of pharyngeal arches and severely impaired 
thymus and T cell development (communicated by N. Trede). Further interest to investigate a role for 
Sox9 in thymus development was prompted by findings that Sox9 activity influences cell fate 
specification, differentiation and proliferation via control of the canonical Wnt signalling pathway (Akiyama 
et al. 2004b; Blache et al. 2004; Yano et al. 2005; Bastide et al. 2007; Mori-Akiyama et al. 2007; Topol et 
al. 2008; Formeister et al. 2009). Previous studies have demonstrated that a precise regulation of Wnt 
signalling activity is required for normal TEC development and maintenance, including Foxn1 expression 
(Balciunaite et al. 2002; Osada et al. 2006; Zuklys et al. 2009; Osada et al. 2010). Since a role for Sox9 in 
murine thymus organogenesis and function had not yet been examined, we hypothesized that Sox9 may 
impact TEC development and function either independently or, at least in part, via the interaction with Wnt 
signalling and thereby may modulate the expression of Wnt target genes. To explore this possibility, the 
temporal and spatial expression pattern of Sox9 during regular thymus development and tissue 
maintenance was first investigated. Subsequently, the sox9 gene was inactivated specifically in TEC as 
early as E12.5 using Foxn1-Cre activity and the consequences of an absence of Sox9 expression on the 
formation of structurally and functionally normal thymic microenvironment and transcriptional activity of 
Wnt/β-catenin pathway examined. Finally, the mechanism by which Sox9 may intersect with canonical 
Wnt/β-catenin signalling in thymic epithelia was investigated by overexpression of wild type and mutant 
form of Sox9 molecule in established TEC line. With this study, we sought to uncover the role for Sox9 in 
thymus organogenesis and function and to gain further clues in the cellular and molecular mechanisms 
governing the differentiation and life-long homeostatic maintenance of TEC. 
 
1. Sox9 expression profiling in fetal and adult thymus  
2. The effect of the TEC-specific ablation of Sox9 on thymic microenvironment 
3. Defining the role for Sox9 in thymus organogenesis and function 
4. Mechanism of Sox9-mediated regulation of Foxn1 
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3. RESULTS 
3.1. Temporal and spatial expression pattern of Sox9 in thymus 
3.1.1. Sox9 expression is detected at E10.5 in the 3rd pharyngeal pouch, a site of 
prospective thymus development 
The role of Sox9 in thymus development and function has so far not been identified thought its 
importance in the formation and function of other organs has been well documented (Foster and Graves 
1994; Kent et al. 1996; Akiyama et al. 2002; Stolt et al. 2003; Akiyama et al. 2004a; Blache et al. 2004; 
Moniot et al. 2004; Vidal et al. 2005; Bastide et al. 2007; Seymour et al. 2007; Scott et al. 2010; 
Furuyama et al. 2011). To detect Sox9 expression at the earliest time point of murine thymus 
development, both the ventral and dorsal aspects of the third pharyngeal pouch (3
rd
pp) were isolated from 
embryonic day (E) 10.5 wild type mice using laser-capture microscopy (Figure 3.1A). The microdissected 
tissue was subsequently analysed for the expression of Sox9-specific transcripts using qRT-PCR. At this 
stage of development, the endoderm-derived epithelial cells in the ventral aspect of the 3
rd
pp have 
already adopted a thymic 
fate and form a 
population of progenitors 
able to give rise to all 
cortical and medullary 
epithelial cells types. 
Sox9 transcripts were 
differentially expressed at 
E10.5, with lower Sox9 
mRNA levels detected in 
the ventral epithelial 
lining of the 3
rd
pp 
circumference when 
compared to its dorsal 
aspect, known to develop 
into the parathyroid gland 
(Figure 3.1B). 
  
Figure 3.1 Sox9 is detected as early as 
E10.5 in the endodermal epithelia of 
the 3
rd 
pharyngeal pouch. 
(A) Ventral and dorsal areas were isolated 
separately from 3
rd
 pharyngeal pouch of 
C57BL/6 embryos for (B) Sox9 expression 
analysis by qRT-PCR. The data 
represents the mean ± standard deviation 
(SD) of triplicate analyses; the ventral 
Sox9 expression was arbitrary set to a 
value of 1. Size of Sox9-specific 
transcripts was controlled by gel 
electrophoresis and visualized by EthBr. 
The expression of GAPDH was used as 
an internal control. The data is 
representative of two independent 
experiments. P values were calculated 
using the paired t-test; *p < .05. 
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3.1.2. Sox9 is expressed in thymus stromal but not in lymphoid cells 
Whether Sox9 expression by TEC is maintained throughout thymus patterning and the formation of 
functionally competent microenvironment was next investigated. For this purpose, primary fetal TEC 
(CD45
-
EpCam
+
) were isolated from mice of E13.5 to E17.5 and analysed by qRT-PCR for Sox9 
expression. As demonstrated in Figure 3.2, TEC continue to express Sox9 transcripts throughout the 
thymus organogenesis. To define the type of stromal cells that expresses Sox9 during steady-state 
conditions of the postnatal thymus, epithelial and mesenchymal cells were isolated by flow cytometry 
using the differentiation markers EpCam, Ly51 and MTS15. 
Adult primary TEC (CD45
-
EpCam
+
) were subdivided into cells 
with a cortical (Ly51
+
) and a medullary (Ly51
-
) phenotype. Non-
epithelial stroma was defined by a CD45
-
EpCam
-
Ly51
+
 
phenotype and further characterized by the presence or absence 
of MTS15 expression, which marks a subpopulation of 
mesenchymal cells (Figure 3.3A). These cells were also 
analysed for the expression of the Epithelial V-like antigen (EVA) 
to exclude possible contamination by TEC. Sox9-specific 
transcripts were detected in epithelia with either a cortical or a 
medullary phenotype, and also in MTS15
+
 mesenchymal cells 
isolated from adult thymus (Figure 3.3B). In contrast, thymocytes 
at any developmental stage (DN, DP, SP4 and SP8) were 
consistently negative for Sox9 expression (Figure 3.3C). 
To verify Sox9 expression at the protein level, sections of embryonic and adult thymic tissue were 
investigated by immunohistochemistry. At E10.5, Sox9 protein was detected in the nucleus of CK8
+
 
epithelia in the ventral aspect of the 3
rd
pp (Figure 3.4, upper two panels). Strong Sox9 expression was 
also observed in the mesenchyme of the 3
rd
 pharyngeal arch (Figure 3.4, upper left panel) correlating with 
the detection of Sox9 transcripts in adult thymic MTS15
+
 mesenchymal cells (Figure 3.3B). By E13.5, 
Sox9 protein was detected in virtually all TEC. This expression persisted at later developmental stages 
and after birth (Figure 3.4, middle and bottom panels) corresponding with the detection of Sox9 
transcripts in TEC (Figure 3.2 and 3.3B). Altogether, Sox9 expression was detected at the initiation of 
thymus organogenesis, was maintained throughout fetal thymus development and could be easily 
detected in the thymus stromal but not lymphoid compartment of adult mice. 
  
Figure 3.2 Sox9 expression is 
maintained throughout embryonic 
TEC development. 
Primary fetal TEC (CD45
-
EpCam
+
) of 
the indicated developmental ages 
were isolated by cell sorting from 
C57BL/6 embryos and Sox9 
expression analysed by PCR. 
Amplification products were separated 
by gel-electrophoresis and visualized 
by EthBr. 
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Figure 3.3 Stromal cell-specific expression 
of Sox9 in the adult thymus. 
(A) Flow cytometry profiles of TEC and non-
TEC stromal fractions isolated by cell sorting 
from 6 week old C57/BL6 mice. Thymic 
stromal cells were enriched by Percoll density 
gradient centrifugation. (B) Sox9 is expressed 
in adult TEC and MTS15
+
 mesenchymal cells. 
PCR analysis of unseparated thymus tissue, 
cortical TEC (CD45
-
EpCam
+
Ly51
+
), medullary 
TEC (CD45
-
EpCam
+
Ly51
-
) and non-epithelial 
thymic stromal cells (CD45
-
EpCam
-
Ly51
+
) that 
either express or lack MTS15
 
for Sox9 
expression. The expression of GAPDH and 
the TEC marker Epithelial V-like antigen (EVA) 
were used as controls. (C) Thymocytes do not 
express Sox9. B220
-
CD3
-
CD4
-
CD8
- 
(DN), 
CD4
+
CD8
+ 
(DP), CD4
+
CD8
- 
(SP4), CD4
-
CD8
+ 
(SP8) thymocytes from 4 week old C57BL/6 
mice were analysed for Sox9 expression. PCR 
amplification products were separated by gel-
electrophoresis and visualized by EthBr. Data 
are representative of two independent 
experiments. 
Figure 3.4 Sox9 protein is detected throughout thymus organogenesis and in the adults. 
Immunofluorescence analysis of thymic tissue sections from embryonic and adult C57BL/6 mice for the detection 
of Sox9 (red) and cytokeratin CK8 (green) expression. The inset (upper right panel) represents a magnification of 
the CK8
+
 epithelial cell lining in the ventral circumference of the 3
rd
 pharyngeal pouch at E10.5 The data is 
representative of two independent experiments each analysing a minimum of 3 mice. 
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3.1.3. Sox9 is differentially expressed in adult thymic epithelia 
Since Sox9 has been reported to effect intestinal epithelium biological activity in dose-sensitive 
fashion (Formeister et al. 2009), we next investigated whether Sox9 expression differ among the separate 
thymic epithelial subsets. For this purpose, DAPI negative (i.e. alive) TEC (CD45
-
EpCam
+
) were 
separated based on their Ly51 and UEA-1 expression into cortical (c) TEC (UEA-1
-
Ly51
+
) and medullary 
(m) TEC (UEA-1
+
Ly51
-
). The mTEC subset was further differentiated into immature (i.e. MHCII low 
expressing, designated mTEC
lo
) and mature (i.e. MHCII high expressing, designated mTEC
hi
) epithelia 
(Figure 3.5A). TEC purity was routinely assessed by re-analysing the sorted cell fractions using both flow 
cytometry and qRT-PCR. The integrity of isolated RNA was assessed by RNA 6000 Pico assay and the 
Agilent 2100 bioanalyzer (Appendix Figure 8.1). Distinct Sox9 transcript levels were detected among 
adult TEC dependent on the cells’ developmental stage. mTEC
lo
 expressed the highest Sox9 transcript 
levels, whereas cTEC contained significantly lower and mTEC
hi
 the lowest levels of Sox9 transcripts 
(Figure 3.5B). As Sox9 mRNA and protein could also be detected in long-term established TEC lines 
(Figure 3.6 and Appendix Figure 8.3E), Sox9 expression appears to be cell autonomously regulated and 
thus, independent of continuous lymphoid-epithelial or lymphoid-mesenchymal crosstalk. 
Figure 3.5 Immature mTEC
lo
 cells express the highest level of Sox9 
transcripts. 
(A) Gating strategy used to sort distinct TEC subsets from 4 week old 
Sox9-deficient and -proficient mice. TEC for sorting were enriched by 
EpCam positive selection on autoMACS. (B) Adult cTEC (CD45
-
EpCam
+
UEA1
-
Ly51
+
), immature (MHCII
lo
; mTEC
lo
) and mature (MHCII
hi
; 
mTEC
hi
) mTEC (CD45
-
EpCam
+
UEA1
+
Ly51
-
) were analysed by qRT-PCR 
for Sox9 expression. Data represent the mean ± SD of triplicate analyses; 
Sox9 expression in thymus was set to an arbitrary value of 1. The data is 
representative of five independent experiments utilizing a minimum of 8 
mice in each group and experiment. P values were calculated using the 
paired t-test; *p < .05, ***p < .001. 
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Figure 3.7 Generation of mice deficient 
for Sox9 expression in TEC. 
(A) Schematic representation of Sox9 
wild type (Sox9
wt
) and conditional 
(Sox9
flox
) locus and Cre-mediated 
deletion of exons 2 and 3 to obtain TEC-
specific loss of Sox9 expression 
(Sox9
del
). Grey boxes: Sox9 exons 1-3; 
triangles: loxP sites; arrowheads: location 
of genomic PCR primers (F1 and F2: 
forward primers; R: reverse primer). 
Primer combinations and expected 
amplicon sizes are indicated on the right. 
Location of qRT-PCR primers is indicated 
above the exons; adapted from (Kist et al. 
2002). (B) Conditional Sox9 breeding: 
Sox9
flox/flox
 x Foxn1-Cre. 
 
3.2. Generation of mice deficient for Sox9 expression in thymic epithelium 
3.2.1. TEC-targeted ablation of Sox9 expression 
The expression pattern of Sox9 during fetal tymus development and in the adults suggested an 
important role for Sox9 in TEC differentiation and function. To define this role, Sox9 was conditionally 
ablated in the developing TEC, as mice with a general loss of Sox9 expression do not survive beyond 
E11.5 of gestation precluding the study of thymus development (Bi et al. 2001; Kist et al. 2002). Mice 
homozygous for a conditional Sox9 flox allele, designated [Sox9
f/f
] have exon 2 and 3 of the Sox9 locus 
flanked by loxP sites (Kist et al. 2002) (Figure 3.7A). To generate mice with a TEC-restricted loss of Sox9 
Figure 3.6 Sox9 expression in 
established thymic epithelial cell lines. 
(A) Cortical (c) and medullary (m) TEC 
lines were analysed by qRT-PCR for Sox9 
expression. The Sox9 mRNA data are the 
mean value ± SD of triplicate analyses 
where Sox9 expression in thymus was set 
arbitrary to a value of 1. (B) Size of Sox9-
specific transcripts was controlled by gel 
electrophoresis
 
and visualized by EthBr. 
The data is representative of two 
independent experiments. 
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expression, [Sox9
f/f
] mice were crossed to the Foxn1-Cre transgenic line which expresses the Cre 
recombinase under the transcriptional control of the Foxn1 promoter (Zuklys et al. 2009). Recombination 
mediated by Foxn1-Cre results in the deletion of the last two exons, encoding part of the N`-terminal 
HMG DNA binding domain and the entire C-terminal transactivation (TA) domain of Sox9. Because the 
TA domain is essential for Sox9 function (Sudbeck et al. 1996) and because the HMG domain cannot 
bind DNA (Giese et al. 1991) this targeting strategy results in a complete loss of Sox9 function. Although 
it has not been excluded that a peptide might still be produced from the first exon, such a molecule, if at 
all stabile, does not contain any known functional domains.  
As depicted in Figure 3.7B, heterozygous F1 animals [Sox9
wt/f
::Foxn1-Cre] were established first and 
then backcrossed to [Sox9
f/f
] mice to obtain mice homozygously deficient for Sox9 expression, designated 
[Sox9
f/f
::Foxn1-Cre]. F2 males were backcrossed once again to [Sox9
f/f
] to increase the frequency of 
[Sox9
f/f
::Foxn1-Cre]. The (F3) generation showed a Mendelian distribution of genotypes, with 50% of 
animals expressing Cre recombinase. 
 
3.2.2. Efficiency and specificity of Foxn1-Cre mediated deletion of Sox9 
Sort-purified TEC (CD45
-
 EpCam
+
; >95%) derived from individual mice were next analysed by allele-
specific PCR to verify that the targeted Sox9 locus was efficiently and completely recombined. As shown 
in Figure 3.8A, TEC from [Sox9
f/f
::Foxn1-Cre] mice showed a complete recombination of the Sox9 locus, 
Figure 3.8 The floxed Sox9 alleles are efficiently and specifically recombined in Foxn1-Cre expressing 
mice resulting in a complete loss of Sox9 expression in TEC. 
(A) Genomic PCR (middle panel) and qRT-PCR analysis (right panel) of TEC (CD45
-
EpCam
+
) isolated from 4 
week old mice. Rectangles in dot plots (left panel) indicate the used sorting gates. The undeleted (flox) and the 
deleted (del) alleles are 419 and 314 bp, respectively, and the Foxn1-Cre allele is 300 bp. At mRNA level Sox9 
deletion was confirmed by qRT-PCR using primers annealing in exons 2 and 3 on the both side of an intron 
giving 189 bp amplicon in control mice. (B) Sox9 is deleted specifically in thymic epithelia but not in mesenchymal 
stroma by Foxn1-Cre. Immunofluorescence analysis of thymus tissue sections from 4 week old [Sox9
f/f
] and 
[Sox9
f/f
::Foxn1-Cre] mice for the detection of Sox9 expression. Scale bar: 100µm. The data is representative of 
three independent experiments utilizing a minimum of 3 mice in each group and experiment. 
 Generation of mice deficient for Sox9 expression in thymic epithelium 
 59 
indicated by the loss of the targeted “flox” allele and the presence of a smaller recombined allele, 
designated “del”. The efficiency of recombination was further confirmed at the transcriptional level using 
qRT-PCR (Figure 3.8A, right panel) and at the protein level using immunohistology (Figure 3.8A, right 
panel and 3.8B). As expected in mice with a TEC-restricted loss of Sox9 expression, Sox9 protein was 
still present in mesenchymal cells within the thymus stroma (Figure 3.8B), a finding that agrees with 
above described expression of Sox9 in fetal and adult mesenchymal cells (Figure 3.3B and 3.4). Thus, 
Foxn1-Cre mediated deletion of Sox9 results in a complete loss of Sox9 expression in TEC and provides 
an informative experimental system to study the role of Sox9 for thymus organogenesis and function.  
 
3.2.3.  [Sox9f/f::Foxn1-Cre] mice are viable, fertile but show macroscopical 
changes of epidermal appendages 
Given the TEC-restricted loss of Sox9 expression, [Sox9
f/f
::Foxn1-Cre] mice developed regularly and 
were normally fertile (Figure 3.9). Previous studies have demonstrated the role for Sox9 in the formation 
of the hair stem cell compartment and differentiation of the outer root sheet (ORS) cell lineage (Vidal et al. 
2005). Furthermore, Foxn1 expression was reported for the matrix, cortex and ORS of the hair during the 
anagen phase and the nail forming regions with a role in inducing keratin expression (Meier et al. 1999). 
In agreement with the documented activity of Sox9 and Foxn1 in the context of hair development, 
[Sox9
f/f
::Foxn1-Cre] mice displayed an alopecia (Figure 3.9). This macroscopic lack of the hair was 
apparent as early as 12 days of life and 
persisted. Interestingly and contrary to the 
phenotype of nude mice which display a 
complete lack of the body hair, a normal coat 
was observed on the head region and the 
extremities in [Sox9
f/f
::Foxn1-Cre] mice. This 
could be due to an inefficient Cre activity in 
Foxn1-Cre line. Moreover, the nails of the Sox9-
deficient mice were longer correlating with the 
reported activity of Foxn1 in the nail forming 
region (Figure 3.9). 
  
Figure 3.9 Sox9 deficient mice display alopecia and 
have longer nails. 
Representative pictures of 4 week old [Sox9
f/f
::Foxn1-
Cre] and [Sox9
f/f
] mice. 
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3.3. The effect of Sox9 deletion on the architecture and composition of the 
thymic microenvironment 
3.3.1. Sox9 deficiency results in a hypoplastic thymus, with normal cortico-
medullary segregation and regular T cell development 
The gross anatomical appearance of the thymus from [Sox9
f/f
::Foxn1-Cre] mice was normal and a 
regular segregation into separate cortical and medullary compartments was observed by histological 
analysis of the thymic sections using hematoxylin/eosin (HE) staining (Figure 3.10A). Thymus cellularity 
however, was significantly lower at all ages investigated (Figure 3.10B) when compared to control 
[Sox9
f/f
] mice, though Sox9-deficient TEC remained responsive to age-related changes in cellularity 
showing typical increase during young adulthood and a decrease after the onset of sexual maturity.  
The competence of Sox9-deficient TEC to support T cell development was next investigated. Cell 
suspensions of thymi at 
different postnatal stages 
were stained for the cell 
surface markers, CD4 and 
CD8, to characterize different 
maturational stages during T 
cell development. A normal 
progression from immature 
CD4
-
CD8
-
 to mature either 
CD4
+
CD8
-
 or CD4
-
CD8
+
 T 
cells was observed in 
[Sox9
f/f
::Foxn1-Cre] mice of 
all ages (Figure 3.10A). Also, 
early stages of thymocyte 
development as character-
ized by the single or 
combined expression of 
CD44 and CD25 were not 
affected by the TEC-specific 
loss of Sox9 (Figure 3.11C). 
Developing thymocytes at 
later maturational stages 
normally upregulate expres-
Figure 3.10 Mice with Sox9 deficiency in TEC develop hypoplastic 
thymus with regular cortex-medulla segregation and T cell development. 
(A) Gross anatomy, H&E staining of thymic sections (magnification 4x) and 
flow cytometric analysis of CD4 and CD8 expression in pre-pubescent (2wk), 
adolescent (4wk) and adult (12wk) mice either proficient [Sox9
f/f
] or deficient 
[Sox9
f/f
::Foxn1-Cre] for the Sox9 expression in TEC. The mean relative 
frequency ± SD for the different thymocytes subsets is represented in each 
quadrant. (B) Comparative analysis of thymus cellularity in [Sox9
f/f
::Foxn1-
Cre] and [Sox9
f/f
] mice at indicated ages. A minimum of 3 mice per group was 
analysed at each time point in three independent experiments. Data represent 
the mean values ± SD and p values were calculated using the paired t-test; *p 
< .05, **p < .01. 
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sion of CD69 and TCR/CD3 expression upon positive thymic selection and SP thymocytes in the medulla 
downregulate CD69 and CD24 expression as a part of their post-selectional maturation (Lucas et al. 
1994; Ernst et al. 1995; Gabor et al. 1997; Hare et al. 1998; Anderson and Jenkinson 2001). The 
expression pattern of CD69 and CD24 was normal in [Sox9
f/f
::Foxn1-Cre] mice when compared to control 
[Sox9
f/f
] mice suggesting regular thymic selection and post-selectional maturation of developing 
thymocytes in a Sox9-deficient microenvironment (Figure 3.11A and B). Moreover, the relative frequency 
of CD3
+
CD4
+
 and CD3
+
CD8
+
 T cells in the spleen was the same for adult [Sox9
f/f
::Foxn1-Cre] and control 
[Sox9
f/f
] mice (Figure 3.11D). Similar results were obtained by analysing wild type and mutant mice at 2 
Figure 3.11 Sox9-deficient TEC support normal T cell maturation. 
(A) Relative distribution of thymocyte subpopulations (i.e., DN-SP) based on the expression of CD3 and early 
activation marker CD69 in thymi of 4 week old [Sox9
f/f
::Foxn1-Cre] and [Sox9
f/f
] mice. B) Analysis of 
developmental progression from CD4
-
CD8
-
 to CD4
+
CD8
-
 and CD4
-
CD8
+
 T cells in 4 week old mice based on the 
expression of CD3 and cell surface marker CD24. CD24
high
 cells represent immature and CD24
low
 mature single 
positive CD4
+
CD8
-
 and CD4
-
CD8
+
 T cells. (C) Relative frequency of DN1 to DN4 thymocytes defined by the CD44 
and CD25 expression in the Lin
neg 
thymocyte population of adult Sox9-deficient and -proficient mice. (D) Analysis 
of splenic T cells in 4 week old [Sox9
f/f
::Foxn1-Cre] and [Sox9
f/f
] mice. CD4 and CD8 T cells were gated on CD3
+
 
thymocytes. The mean relative frequency ± SD for the different thymocytes subsets is indicated in each quadrant. 
The data is representative of two independent experiments utilizing a minimum of 3 mice per group. 
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and 12 weeks of age (data not shown). Together, these findings demonstrate that a lack of Sox9 
expression in TEC results in a moderately hypoplastic thymus that is able to support qualitatively normal 
T cell development. 
 
3.3.2. Sox9 prevents cytokeratin 5 expression in cortical TEC 
To determine the impact of Sox9 expression on TEC differentiation and organization, thymic tissue 
sections derived from mutant and control mice were analysed by immunofluorescence. Staining for the 
expression of cortical (CK8), medullary (MTS10, UEA-1, CK5, Aire) and mesenchymal (ERTR7) markers 
revealed a normal architectural organisation of the major epithelial and mesenchymal components in the 
thymus of [Sox9
f/f
::Foxn1-Cre] mice (Figure 3.12). However, the proportion of cytokeratin 5 (CK5) positive 
epithelia was considerably increased since CK5
+
 TEC were not only restricted to the medulla marked by 
the MTS10 expression (Boyd et al. 1993), but could also be detected in the cortex (Figure 3.13A). 
Quantitative image analysis confirmed an increase in the frequency of single CK5
+
 and double CK5
+
CK8
+
 
TEC in mutant thymi (20% vs. 8.5% and 8% vs. 4.7%). Conversely, the frequency of single CK8
+
 TEC 
Figure 3.12 Normal stromal architecture of Sox9-deficient thymi. 
Immunofluorescence analysis of thymus tissue sections from 4 week old mice for the expression of (A) CK8 
(blue), MTS10 (red) and UEA-1 ligand (green), (B) CK8 (blue), CK5 (green) and  Aire (red) or (C) CK8 (blue) and 
ERTR7 (red). Scale bar: 100µm. The data is representative of three independent experiments utilizing a minimum 
of 3 mice in each group and experiment. 
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was reduced in mutant when compared to control mice (23.7% vs. 35.2%) (Figure 3.13B). These changes 
in the relative abundance of the different TEC subpopulations were further confirmed by flow cytometric 
quantification of TEC subsets defined by differential levels of CK5 and CK8 expression. As demonstrated 
in Figure 3.13Ci, the frequency of CK5
hi
CK8
lo
 was increased at the expense of TEC with a CK5
lo
CK8
hi 
phenotype. The observed increase of CK5
+
 TEC was however, not due to the change in the proliferation 
as the expression pattern of the cell cycle marker Ki67 was identical for the two mouse groups (Figure 
3.13Cii). In keeping with a higher abundance of CK5
+
 cells, transcripts specific for CK5 were also more 
frequent in TEC (CD45
-
EpCam
+
) isolated from Sox9-deficient mice (Figure 3.13D). 
The CK5
+ 
TEC localized outside of the medulla also expressed other markers characteristic for 
cortical TEC including CK8, β5t, DEC205 and Ly51 (Figure 3.14) as assessed by immunochistochemistry. 
In contrast, these cells failed to display markers typical for mTEC such as Aire, MTS10 and UEA-1 
(Figure 3.12A and B) suggesting that cTEC acquired the expression of CK5 in the absence of Sox9. To 
further characterize the thymic microenvironment in the absence of Sox9 expression, the localization of 
CD25
+
 cells within the thymus was investigated (Figure 3.15). CD25 expression identifies DN2 
(CD44
+
CD25
+
) and DN3 (CD44
-
CD25
+
) population of immature thymocytes. Physiologically, DN2 cells 
are located in the deeper cortex close to the CMJ, while the DN3 cells accumulate in the subcapsular 
region of the cortex (Lind et al. 2001; Petrie and Zuniga-Pflucker 2007). In Sox9-deficient 
microenvironment these immature cells were rather dispersed throughout the cortex implying a possible 
defect in migration of these cells (Figure 3.15). 
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Figure 3.13 Increased proportion of CK5
+ 
TEC located in the cortex of Sox9-deficient mice. 
(A) Immunofluorescence analysis of 4 week old [Sox9
f/f
::Foxn1-Cre] and [Sox9
f/f
] mice for the detection of 
cytokeratin CK8 (blue), MTS10 (red) and CK5 (green) expression. Scale bars: 100µm. (B) Quantification of CK5 
and CK8 expression on thymic sections as measured by the NIH Image-J area analysis software. Data represent 
the proportion of area occupied in the thymus by TEC that express either CK5 (CK5
+
), CK8 (CK8
+
), or both 
(CK5
+
CK8
+
). Co-localization tool was used to determine the percentage of TEC co-expressing CK5 and CK8. The 
mean values ± SD were calculated using 3-4 sections from a minimum of 3 mice analysed in each group. Data in 
(A-B) are representative of three independent experiments. (C) Quantification of (i) TEC subsets defined based 
on the differential expression of CK5 and CK8 and (ii) their proliferative capacity in thymi of 4 week old [Sox9
f/f
] 
and [Sox9
f/f
::Foxn1-Cre] mice as assessed by flow cytometric analysis. The mean frequency ± SD of keratin 
subsets is provided as a percentage in each quadrant. (D) qRT-PCR analysis of CK5 and CK8 expression in TEC 
(CD45
-
EpCam
+
) isolated by cell sorting from 4 week old Sox9-proficient and -deficient mice. The data represents 
the mean ± SD of triplicate qRT-PCR analyses where cytokeratins expression in control [Sox9
f/f
] mice was set to a 
value of 1 for comparison. The data in (C-D) are representative of two independent experiments utilizing a 
minimum of 3 mice per group. Statistical significance was calculated using the paired t-test; *p < .05, **p < .01, 
***p < .001. 
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Figure 3.14 CK5
+ 
cells detected in adult Sox9-deficient thymi display a cortical origin. 
(A) Consecutive sections of adult thymus tissue stained by immunofluorescence for the expression of medullary 
markers MTS10 (red) and CK5 (green) and for cortical markers CK8 (blue) and β5t (blue), respectively and (B) 
for CK5 (green) and the cortical markers DEC205 (red) and Ly51 (blue), respectively. Data are representative of 
two independent experiments each analysing a minimum of 3 mutant and control mice. m: medulla; scale bars: 
100µm. 
Figure 3.15 Altered distribution of 
CD25
+
 cells in Sox9-deficent 
microenvironment. 
Immunohistofluorescence analysis 
of thymic sections from adult 10 
week old [Sox9
f/f
] and 
[Sox9
f/f
::Foxn1-Cre] mice for the 
expression of CK18 (red), CK5 
(green) and CD25 (blue). Scale 
bars: 100µm. 
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3.3.3. Composition, phenotype and proliferation of the thymic epithelia proficient 
and deficient for Sox9 expression 
Differential Sox9 expression has been linked to the control of proliferation and terminal differentiation 
of intestinal epithelia (Formeister et al. 2009). To assess if Sox9 plays a similar role in physiology of 
thymic epithelia and given that distinct Sox9 expression levels exist among TEC, the cellularity, 
phenotype and proliferation of different TEC subsets in the absence and presence of Sox9 expression 
were investigated. 
 
3.3.3.1. Changes in the mTEC composition in [Sox9f/f::Foxn1-Cre] mice 
Whether the thymic hypocellularity observed in [Sox9
f/f
::Foxn1-Cre] mice is consequence of a 
decrease in the number of all TEC, only a specific TEC subpopulation or is independent of a change in 
thymic epithelial cellularity was first investigated. Absolute TEC (CD45
-
EpCam
+
) cellularity was 
consistently diminished in pre-pubescent (2 weeks), adolescent (4 weeks) and adult (12 weeks) 
[Sox9
f/f
::Foxn1-Cre] mice (Figure 3.16Ai). Thus, the epithelial scaffold was reduced in size due to the 
fewer cells. The composition of thymic microenvironment was further analysed using the cortical marker 
Ly51 and differential expression of MHCII molecule (Appendix Figure 8.2). Thymic epithelial subsets 
changed in older (i.e 4 and 12 week old) [Sox9
f/f
::Foxn1-Cre] mice demonstrating an increase in the 
mTEC
lo
 and decrease in the mTEC
hi
 frequency. This gradual change in the mTEC
hi
 to mTEC
lo
 ratio is a 
function of age and was independent of an absence of Sox9 expression as control [Sox9
f/f
] mice showed 
identical changes with aging (Gray et al. 2006). A detailed quantification however, revealed that specific 
TEC subpopulations were differentially affected by the loss of Sox9 expression. mTEC with an immature 
phenotype (i.e. mTEC
lo
) were diminished both in absolute and relative numbers (Figure 3.16Ai+ii) but the 
relative frequency of mTEC with a mature phenotype (i.e. mTEC
hi
) was increased at all time points 
investigated (Figure 3.16Aii). In absolute numbers mTEC
hi
 were however decreased when compared to 
control [Sox9
f/f
] mice of the same age (Figure 3.16Ai). The ratio of TEC to total thymus cellularity was only 
unchanged in 2 week old [Sox9
f/f
::Foxn1-Cre] mice but significantly decreased at any time point thereafter 
(Figure 3.16B). In conclusion, the loss of Sox9 expression in TEC affects the composition of the epithelial 
microenvironment as marked by an altered representation of mTEC with an immature and mature 
phenotype. 
 
3.3.3.2. Sox9 controls specifically proliferation of immature mTEClo cells 
Since the lack of Sox9 expression changed the cellularity and representation of TEC within the 
thymic microenvironment, TEC proliferation in [Sox9
f/f
::Foxn1-Cre] mice was next assessed using Ki67 as 
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a marker of cell division (Gerdes et al. 1984).  Previous studies showed that adult mTEC
hi
 proliferate the 
most among thymic epithelia (Yang et al. 2006; Gray et al. 2007b). In 2 week old Sox9-proficient mice 
10% of mTEC
lo
 and 21% of mTEC
hi
 cells were actively dividing (Figure 3.17). Only 10% of the mTEC
hi 
cells were still dividing at 4 weeks, whereas mTEC
lo
 showed minor decrease in the proliferation rate. By 
12 weeks of age, the proportion of dividing cells further fell and both mTEC
lo
 and mTEC
hi
 displayed a low 
steady state rate of cell division (6% and 7 %, respectively). The TEC-targeted loss of Sox9 expression 
resulted in an increased  proliferation of  mTEC
lo
 (Figure 3.17), which further correlated with an increased 
representation of mature mTEC
hi
 cells at all time points investigated (Figure 3.16Aii). These changes in 
mTEC composition and proliferation inversely correlated with distinct Sox9 expression levels normally 
detected among TEC subsets (Figure 3.5B) suggesting that Sox9 dosage may indeed have an impact on 
Figure 3.16 Specific reduction of mTEC
lo
 and relative expansion of mTEC
hi
 in Sox9-deficient thymus. 
(A) Quantitative analysis of the (i) absolute cellularity and (ii) relative frequency of cortical (MHCII
+
Ly51
-
; 
cTEC), immature medullary (MHCII
lo
Ly51
-
; mTEC
lo
) and mature medullary (MHCII
hi
Ly51
-
; mTEC
hi
) thymic 
epithelia (CD45
-
EpCam
+
). (B) Ratio of TEC to thymus cellularity in [Sox9
f/f
] and [Sox9
f/f
::Foxn1-Cre] mice at 
different ages. The data (mean values ± SD) are representative of three independent experiments utilizing a 
minimum of 3 mice per group and time point. Statistical significance was calculated using the paired t-test; *p 
< .05, **p < .01, ***p < .001.  
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mTEC growth. In contrast, a lack of Sox9 expression in cortical epithelia had no significant impact on 
proliferation and consequently, absolute and relative numbers of cTEC remained unchanged (Figure 3.16 
and 3.17). Together these results revealed that Sox9 acts in a dose-sensitive and subset-specific manner 
in the regulation of TEC proliferation and differentiation. 
 
 
 
3.4. High Sox9 expression levels suppress the proliferation of a thymic 
epithelial cell line 
To directly probe the effect of Sox9 expression on TEC proliferation, wild type Sox9 was 
overexpressed in an established cortical (c) TEC1.2 line using retroviral transduction (Appendix 8.3 A and 
B). An upregulation of Sox9 mRNA and protein levels was verified in transduced cells by qRT-PCR and 
immunochistochemistry analysis (Appendix 8.1 C and D). Subsequently, cell proliferation was assessed 
by BrdU incorporation and detection of Ki67 expression. Seventy and 81 percent of the control cells 
actively proliferated 16 and 24 hours after a BrdU pulse, respectively. Enforced Sox9 expression 
however, significantly reduced spontaneous TEC proliferation (Figure 3.18A+B). In parallel, the absolute 
cellularity of Sox9-transduced TEC had decreased by a third on day three of culture when compared to 
control cells (Figure 3.18C). This decrease was specific as the expression of a Sox9 mutant lacking the 
C-terminal transactivation (TA) domain, designated Sox9 M,  failed to repress TEC proliferation as 
assessed by BrdU incorporation, Ki67 expression and the determination of the absolute cell number 
(Figure 3.18A-C). These results indicated that high Sox9 expression levels are able to suppress cell 
Figure 3.17 Increased proliferation of immature mTEC
lo
 cells in Sox9-
deficient thymus. 
Proliferation of distinct TEC subsets in [Sox9
f/f
] and [Sox9
f/f
::Foxn1-Cre] mice was 
assessed by analysis of Ki67
 
expression at the indicated ages. The data (mean 
values ± SD) are representative of three independent experiments utilizing a 
minimum of 3 mice per group and time point. Statistical significance was 
calculated using the paired t-test; *p < .05, **p < .01, ***p < .001. Note that Ki67 
expression in cTEC at 4 and 12 weeks of age could not be accurately assessed, 
due to the too low frequency of Ly51
+
 cTEC obtained per individual thymus. 
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proliferation, and agree with the in vivo data showing that high Sox9 expression in TEC correlates with an 
increased proliferation consequent to the loss of Sox9. 
 
3.5. Sox9 as a modulator of Wnt/β-catenin signalling in thymic epithelia 
A functional and physical interaction between Sox9 and the Wnt/β-catenin pathway has been 
demonstrated in the context of tissue development and maintenance of different organs. Whether such a 
“cross-talk” exists during thymus organogenesis and maintenance was next investigated. 
 
3.5.1. Sox9 negatively regulates Foxn1 expression in thymic epithelia 
Sox9 has been identified to modulate “Wnt/β-catenin” transcriptional activity by controlling β-catenin 
protein levels (Akiyama et al. 2004b). A precise regulation of β-catenin amounts is essential for regular 
TEC development and function (Zuklys et al. 2009) and Wnt signalling engaging β-catenin regulates 
Foxn1 expression (Balciunaite et al. 2002). Therefore, the abundance of Foxn1 transcripts in adult thymic 
Figure 3.18 High Sox9 expression levels suppress TEC proliferation in vitro. 
(A) BrdU incorporation and (B) Ki67 expression were measured in TEC lines stably transduced with an empty 
retroviral vector (control) or a retroviral vector recombinant for the expression of either Sox9 mutant (Sox9 M) or  
wild type (Sox9 WT). (C) The absolute number of transduced cells after three days culture. The values represent 
the mean ± SD of triplicate analyses. The data is representative of three independent experiments. Statistical 
significance was calculated using the paired t-test; *p < .05, **p < .01, ***p < .001. 
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epithelia was investigated in relation to Sox9 expression. Lower steady-state levels of Foxn1 transcripts 
were typically detected in wild type thymus and sorted TEC (CD45
-
EpCam
+
) when compared to Sox9 
levels (Figure 3.19A i+ii). The TEC-targeted loss of Sox9 expression associated with a significant 
upregulation of Foxn1-specific transcripts in whole thymic tissue and sorted EpCam
+
 TEC (1.5 and 2.9 
fold, respectively) (Figure 3.19A i+ii). Given that a lack of Sox9 expression changed TEC composition and 
proliferation, Foxn1 transcripts were also investigated in separate thymic epithelial subsets. For this 
purpose, TEC (CD45
-
EpCam
+
) with cortical (UEA-1
-
Ly51
+
) and medullary (UEA-1
+
Ly51
-
) immature 
mTEC
lo
 (MHCII
lo
) and mature mTEC
hi
 (MHCII
hi
) phenotype (Appendix 8.1) were isolated from adult wild 
type and mutant mice. Wild type mTEC
lo
 expressed fewer Foxn1 transcripts when compared to mTEC
hi
 
and cTEC (Figure 3.19A iii) revealing an inverse correlation between the steady-state levels of Sox9 and 
Foxn1 transcripts (Figure 3.19B). Similarly, an inverse correlation of Sox9 and Foxn1 expression was also 
noted in analysed TEC lines (Figure 3.20). Consequent to a loss of Sox9 expression, all TEC upregulated 
Foxn1 transcripts. The greatest increase was observed in mTEC
lo
 subset but the differences in Foxn1 
Figure 3.19 Foxn1 transcripts are upregulated in Sox9-deficient thymus. 
(A) qRT-PCR analysis of Foxn1 expression in (i) whole thymic tissue, (ii) TEC (CD45
-
EpCam
+
), (iii) cortical (c: 
UEA1
-
Ly51
+
) and medullary (m: UEA1
+
Ly51
-
) immature (MHCII
lo
) and mature (MHCII
hi
) TEC isolated from 4 week 
old [Sox9
f/f
::Foxn1-Cre] and [Sox9
f/f
] mice. Foxn1 mRNA expression in tissue of control [Sox9
f/f
] mice was set 
arbitrary to a value of 1, respectively. (B) Sox9 and Foxn1 expression in TEC subsets is inversely correlated. 
Ratio of Sox9 and Foxn1 mRNA expression in distinct TEC subsets of Sox9-proficient and -deficient mice. The 
Foxn1 and Sox9 mRNA data represent the mean ± SD of triplicate qRT-PCR analyses. Statistical significance 
was calculated using the paired t-test; *p < .05, **p < .01, ***p < .001. The data are representative of four 
independent experiments utilizing a minimum of 8 mice per group and experiment. Statistical significance was 
calculated using the paired t-test; *p < .05, **p < .01, ***p < .001. 
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expression levels typical observed between the separate subpopulation remained also in the gene 
targeted mice (Figure 3.19A iii).   
The association of Foxn1 expression with Sox9 (Figure 3.19) was further confirmed at the protein 
level by quantitative expression analysis of thymic tissue sections derived from [Sox9
f/f
] and 
[Sox9
f/f
::Foxn1-Cre] mice using Image-J software. Foxn1 protein expression was significantly increased in 
both cortex and medulla of the mutant mice when compared to their wild type controls (Figure 3.21) and 
correlated with above described changes in Foxn1 mRNA expression (Figure 3.19). These results 
identified a specific role of Sox9 as a negative regulator of Foxn1 expression in TEC.  In summary, the 
loss of Sox9 expression in TEC leads to subset-specific and dose-dependent changes in both TEC 
proliferation and composition which correlated with an increase in Foxn1 expression. 
 
3.5.2. Sox9 physically binds and regulates β-catenin protein levels in thymic 
epithelia 
Next, the underlying molecular mechanism by which Sox9 modulates Foxn1 expression in TEC was 
explored. Previous studies in chondrocytes have shown that Sox9 controls β-catenin protein levels 
through the formation of a physical complex with β-catenin. This interaction is mediated via the C- 
terminal domain of Sox9 and leads to the degradation of β-catenin and hence, inhibits Wnt/β-catenin 
controlled transcriptional activity (Akiyama et al. 2004b). To investigate whether in thymic epithelia Sox9 
physically interacts with β-catenin and thus regulates its cellular availability, co-immunoprecipitations 
Figure 3.20 Sox9 and Foxn1 expression levels in established TEC lines. 
(A) qRT-PCR analysis of cortical (c) and medullary (m) TEC lines for Sox9 and Foxn1 expression. (B) Correlation 
of Sox9 and Foxn1 expression in indicated TEC lines. The Sox9 and Foxn1 mRNA data are the mean value ± SD 
of triplicate analyses where Sox9 and Foxn1 expression in thymus was set arbitrary to a value of 1. The data are 
representative of three independent experiments. 
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were carried out with TEC lines stably transduced to express either a  HA-tagged Sox9 wild type (Sox9 
WT) or Sox9 mutant (Sox9 M) molecule that lacked the C-terminal TA domain but contained N-terminal 
HMG domain (Appendix 8.3). Sox9 physically interacted in TEC with β-catenin in a fashion that was 
partially dependent on its C-terminal TA domain as mutant Sox9 could also formed a physical complex 
with β-catenin (Figure 3.22A, upper panel and gel). However, fewer β-catenin molecules were bound by 
mutant Sox9 as quantified by Image-J analysis (Figure 3.22A, lower panel) indicating that wild type Sox9 
associated more efficiently with β-catenin, probably due to the engagement of both the C- and N-terminal 
domains. Moreover, the overexpression of wild type Sox9 markedly reduced the amount of β-catenin that 
could be immunoprecipitated by β-catenin antibody when compared to the mutant Sox9 molecule (Figure 
3.22A, upper panel, lower gel).  
To obtain direct evidence that Sox9 regulates β-catenin protein levels in thymic epithelia, lysates 
from TEC lines stably transduced to express either a control vector or a wild type and mutant Sox9 were 
analysed by Western blotting. The overexpression of wild type Sox9 strongly reduced the nuclear and to 
a lesser extent the cytoplasmic concentrations of β-catenin in TEC whereas the expression of a C-
Figure 3.21 Foxn1 protein expression is increased in the thymus with Sox9-deficient TEC. 
(A) Immunofluorescence analysis for thymic CK8 and Foxn1 expression in adult [Sox9
f/f
::Foxn1-Cre] and [Sox9
f/f
] 
mice. Scale bars: 100µm. (B) Quantitative analysis of Foxn1 protein expression on thymic sections of Sox9-
proficient and -deficient mice as measured by NIH Image-J area analysis software. Cortical and medullary areas 
were defined by staining for CK8 and TEC morphology (i.e., globular versus satellite, respectively). Data 
represent the percentage of cortical and medullary area occupied by Foxn1
+ 
cells. The mean values ± SD were 
calculated using 3-4 sections from a minimum of 3 mutant and control mice. P values were calculated using the 
paired t-test; *p < .05, ***p < .001. The data are representative of two independent experiments. 
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terminal TA-deficient mutant Sox9 did not change the cellular β-catenin amounts (Figure 3.22B). These 
findings suggested that the C-terminal domain is involved in the regulation of β-catenin levels.  
Though the efficiency in expressing wild type Sox9 in TEC was lower when compared to mutant 
Sox9 (Figure 3.22C, middle gel in upper panel and Appendix 8.3C), the ratio of β-catenin bound to Sox9 
in relation to total cellular β-catenin was consistently higher for TEC overexpressing wild type Sox9 
(Figure 3.22C, lower panel) indicating both more efficient binding and degradation of β-catenin in the 
presence of the C-terminal domain. Thus, in TEC both the C- and N-terminus of Sox9 can bind β-catenin, 
but only the interaction mediated via the C-terminal TA domain determines the cellular β-catenin levels 
and nuclear availability, probably by promoting β-catenin degradation. 
 
Figure 3.22 Sox9 binds and regulates β-catenin protein levels in thymic epithelia. 
(A) Wild type Sox9 (Sox9 WT) binds β-catenin more efficiently than its C-terminal deletion mutant (Sox9 M). 
Upper panel: cell lysates of cTEC1.2 transduced to express a HA-tagged mutant (M) or  wild type (WT) form of 
Sox9 were immunoprecipitated using either anti-HA or anti-β-catenin antibodies and bound β-catenin was 
detected by Western blotting (WB). Immunoprecipitation of cell lysates with mouse IgG served as a control. Lower 
panel: quantification of β-catenin bound by mutant and wild type Sox9 molecule as measured by densitometry 
using the NIH Image-J software. Sox9 WT was arbitrary set to a value of 1. (B) Wild type but not mutant Sox9 
reduces β-catenin protein levels in nucleus and cytoplasm. Upper panel: subcellular fractions of cTEC1.2 
transduced with an empty retroviral vector (control) or vectors recombinant to express either mutant or wild type 
Sox9 were analysed by WB for the expression of β-catenin. Histon H1 and α- tubulin expression were used to 
measure lysate purity and to control loading. Lower panel: nuclear and cytoplasmic β-catenin expression in 
indicated lysates was quantified by the NIH Image-J software. Cells transduced with an empty retroviral vector 
(control) were set to a value of 1 for comparison.  (C) β-catenin and HA-Sox9 protein expression in total lysates of 
transduced cTEC1.2 was assessed by WB analysis (upper panel) and the ratio of bound β-catenin to total cellular 
β-catenin expression in indicated lysates calculated  (lower panel). Sox9 WT was arbitrary set to a value of 1. The 
data are representative of two independent experiments. 
Results 
74 
3.5.3. Reduced β-catenin protein levels correlate with downregulation of Foxn1 
expression in wild type Sox9-transduced cells 
 
Finally, whether the reduction of β-catenin protein detected in TEC line overexpressing wild type 
Sox9 associates with changes of Foxn1 expression was investigated. Indeed, a significant decreases of 
Foxn1 transcripts (Figure 3.23A) and consequently protein (Figure 3.23B) were observed as a 
consequence of wild type Sox9 overexpression and thus, correlated with the reduced β-catenin 
availability in TEC (Figure 3.22B). In contrast, the stable expression of a TA-deficient Sox9 mutant did 
neither alter protein concentration of β-catenin nor Foxn1 expression (Figure 3.23 and 3.22B). Thus, Sox9 
regulates Foxn1 expression indirectly via the control of β-catenin levels and an intact C-terminal domain 
is required for this effect. In conclusion, these in vitro findings established that Sox9 expression negatively 
modulates Foxn1 through the physical and functional interaction with β-catenin and suggest crosstalk 
between Sox9 and the Wnt canonical pathway in thymic epithelia (Figure 3.24). 
 
  
Figure 3.23 Wild type but not mutant form of Sox9 downregulates Foxn1 expression. 
(A) Foxn1 mRNA levels in transduced cTEC1.2 were assessed by qRT-PCR. Data represents the mean ± SD of 
triplicate analyses where Foxn1 expression in cTEC1.2 transduced with an empty retroviral vector (control) was 
set to a value of 1. (B) Foxn1 protein expression in indicated lysates of transduced cTEC1.2 was detected by WB 
(left) and quantified by densitometry using Image-J software (right). The data are representative of two 
independent experiments. Sox9 WT was arbitrary set to a value of 1 for comparison. 
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Figure 3.24 Hypothetical model of Sox9-mediated regulation of Foxn1 in thymic epithelia. 
(i) The canonical Wnt signalling engaging via β-catenin directly regulates Foxn1 transcription in TEC (Balciunaite 
et al. 2002) and a precise regulation of intracellular β-catenin levels is required for normal thymus development 
and function (Zuklys et al. 2009). Sox9 determines intracellular β-catenin protein levels by promoting β-catenin 
degradation through formation of Sox9:β catenin complex. (ii) Overexpression of wild type Sox9 leads to β-
catenin degradation inhibiting expression of Wnt/β-catenin target gene Foxn1. (iii) Loss of Sox9 expression in 
TEC results in increased β-catenin amounts and thus upregulation of Foxn1. 
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4. DISCUSSION 
The interest to investigate a role for Sox9 in thymus development was prompted by findings that 
Sox9 activity may influence cell fate specification, differentiation and proliferation via control of the 
canonical Wnt signalling pathway (Akiyama et al. 2004b; Blache et al. 2004; Yano et al. 2005; Bastide et 
al. 2007; Mori-Akiyama et al. 2007; Akiyama et al. 2008b; Topol et al. 2008; Formeister et al. 2009). 
Though a role for Sox9 had not yet been examined, we and others have already demonstrated that an 
appropriate Wnt signalling activity is critically important for thymus organogenesis and tissue 
maintenance (Balciunaite et al. 2002; Kuraguchi et al. 2006; Osada et al. 2006; Pongracz et al. 2006; 
Weerkamp et al. 2006; Zuklys et al. 2009; Osada et al. 2010). As Sox9 has been demonstrated in 
mesenchymal and epithelial cells to inhibit Wnt/β-catenin signalling by promoting β-catenin degradation in 
the cytoplasm and by inhibiting β-catenin transcriptional activity in the nucleus (Akiyama et al. 2004b; 
Blache et al. 2004; Bastide et al. 2007; Topol et al. 2008), we first investigated the expression pattern of 
Sox9 during regular thymus development and subsequently examined the consequences of an absence 
or overexpression of Sox9 in thymic epithelia.  
At the time mouse thymus organogenesis is typically initiated, Sox9 expression could readily be 
detected in both prospective thymic epithelia of the 3
rd
 pharyngeal pouch and also mesenchyme of the 3
rd
 
pharyngeal arch suggesting an early role for Sox9 in the thymus formation and function. However, TEC-
directed Sox9 expression was largely dispensable for the formation of a functional microenvironment 
because the deletion of Sox9 did not impact on the cell’s fitness to support regular thymopoiesis. Since 
the formation of the early thymic primordium involves coordinated actions between cells of ectodermal, 
endodermal and mesodermal origin (Graham 2001), Sox9 may be required in thymus stromal cells other 
than TEC and thus may, via an involvement in the mesenchymal-epithelial crosstalk, indirectly impact on 
TEC development. Indeed, a role of Sox9 in epithelial-mesenchymal transformation (EMT) during 
development of various organs has been reported (Akiyama et al. 2004b; Moniot et al. 2004; Sakai et al. 
2006; Scott et al. 2010). For example during gut development, Sox9 specifies the pyloric sphincter 
epithelium through mesenchymal-epithelial crosstalk (Moniot et al. 2004). Ectopic expression of Sox9 in 
the gizzard mesoderm transdifferentiates the adjacent epithelium into pyloric sphincter-like epithelium and 
contrary, the loss of Sox9 function in the mesoderm of the pyloric sphincter affects the differentiation of 
pyloric sphincter epithelium. In heart development, Sox9 expression is activated in endocardial 
endothelial cells and is required for EMT and subsequent proliferation and differentiation of endocardial 
mesenchymal cells that form endocardial cushions, primordia of valves and septa (Akiyama et al. 2004a). 
Sox9 is also required for NCC formation, differentiation and maintenance (Sakai et al. 2006; Scott et al. 
2010). It is thus conceivable that mesenchymal Sox9 expression in the 3
rd
 pharyngeal arch and adult 
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MTS15
+
Ly51
+
 stromal subset impacts indirectly on TEC development and maintenance though, the 
molecular signature of such a mesenchymal-epithelial crosstalk would still need to be defined. 
Alternatively, the lack of a pronounced phenotype may be explained by a relatively late deletion of Sox9 
should the activity of this transcription factor be required only transiently during early thymus 
organogenesis. In [Sox9
f/f
::Foxn1-Cre] mice, the Cre recombinase is active in TEC from E12.5 (Zuklys et 
al. 2009), resulting in the recombination of the Sox9 locus both after the commitment of endodermal cells 
to a TEC fate (as marked at E10.5 by Foxn1 expression) and after the formation of a separate thymus 
anlage by E12.5 (Gill et al. 2003). Thus, both the relatively late and TEC-restricted deletion of Sox9 may 
account for the absence of a gross phenotype during early thymus organogenesis.  
Sox9 was differentially expressed at E10.5 in the epithelia of 3
rd
 pharyngeal pouch. Low Sox9 
levels were typically observed in the ventral aspect of the pouch correlating with the Foxn1 expression 
normally detected in this region and required for subsequent TEC differentiation. Contrary, high Sox9 
expression levels were detected in the dorsal aspect which lacks Foxn1 and develops into the parathyroid 
gland. This reciprocal expression pattern may suggest a possible interdependence between these two 
transcription factors. 
Sox9 expression persisted throughout the fetal TEC development and in the adult thymus distinct 
Sox9 expression levels were detected among TEC subsets with cortical (Ly51
+
UEA-1
-
) and medullary 
(Ly51
-
UEA-1
+
) immature mTEC
lo
 (MHCII
lo
) or mature mTEC
hi
 (MHCII
hi
) phenotype. The importance of 
discrete Sox9 levels in regulation of epithelial cell proliferation and differentiation has previously been 
demonstrated in the intestinum (Formeister et al. 2009). The low levels of Sox9 support proliferative 
capacity in the stem/progenitor cell compartment whereas high levels of Sox9 suppress proliferation of 
cycling precursors and allow terminal differentiation of enteroendocrine cells. These data suggested that 
Sox9 may also in thymic epithelia act in a dose-dependent fashion. Indeed, substantial numerical and 
compositional defects were detected in Sox9-deficient thymic microenvironment and the mTEC
lo
 subset 
was most severely affected. Interestingly, this latter subset contained the highest steady-state Sox9 
expression levels which correlated with its enhanced proliferation upon the loss of Sox9. This correlation 
indicated that high Sox9 levels present in mTEC
lo
 normally suppress cell proliferation, a finding similar to 
what has been reported for the intestinal epithelium (Formeister et al. 2009). The repressive effect of high 
Sox9 expression levels on TEC proliferation was confirmed by in vitro studies where the enforced 
expression of wild type Sox9 in an established TEC line reduced the cell`s proliferation. Together, these 
results revealed that Sox9 dosage directly impacts on the cell proliferation and thus may influence cell 
differentiation. 
The molecular mechanism responsible for the Sox9-mediated control of cell proliferation has 
been established by overexpressing Sox9 in several cell types (Panda et al. 2001; Afonja et al. 2002; 
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Akiyama et al. 2004b; Drivdahl et al. 2004; Bastide et al. 2007). High Sox9 levels decrease the 
transcription of Wnt/β-catenin target genes associated with cell cycle progression (i.e. c-myc and cyclin-
D1) and increase inhibitors of β-catenin-mediated cell proliferation (i.e. ICAT: inhibitor of β-catenin and 
Tcf and TLE2-4: transducin-like enhancer of splits 2-4). In vivo deletion of Sox9 in the intestinal epithelium 
also correlates with an upregulation of c-myc and cyclin-D1 causing an increase in crypt proliferation 
(Bastide et al. 2007) whereas Sox9 overexpression in chondrocytes downregulates cyclin D1 and inhibits 
proliferation (Akiyama et al. 2004b). In Sox9-deficient TEC, the expression of c-myc and cyclin-D1 was 
only slightly increased however, the results were not reproducible. Nevertheless, the possible mechanism 
by which Sox9 controls TEC proliferation may relay on the same principle, but include other yet not 
identified Sox9 target gene and/or Wnt associated genes. In this regard, high Sox9 expression detected 
in mTEC
lo
 subset may suppress proliferation either indirectly by inhibiting transcription of genes that 
positively regulate proliferation or directly by controlling genes encoding inhibitors of cell proliferation. In 
either case, the lack of Sox9 expression would remove this suppression accounting for the enhanced 
proliferation of mTEC
lo
. To identify Sox9 target genes and molecular mechanism by which Sox9 regulates 
TEC proliferation, a transcriptome analysis of mTEC
lo
 and mTEC
hi
 subsets isolated by cell sorting from 
Sox9-deficient and -proficient mice have been initiated. 
The TEC-targeted loss of Sox9 expression affected the composition of the adult thymic 
compartment as marked by a specific reduction of immature mTEC
lo
 (MHCII
lo
UEA-1
+
) and concomitant 
increase of mature mTEC
hi
 (MHCII
hi
UEA-1
+
) subset indicating that the maturation and maintenance of the 
postnatal thymic epithelium requires Sox9 expression. Moreover, the numerical and proportional 
decrease of mTEC
lo
 and the proportional increase of mTEC
hi 
appeared to derive, at least in part, from the 
enhanced mTEC
lo
 proliferation suggesting that the transition of mTEC from a MHCII low to a MHCII high 
phenotype is Sox9 dependent. This phenotype further implied that Sox9 influences the dynamic process 
of mTEC proliferation and thereby affects their differentiation. Currently, two models of mTEC 
differentiation are proposed both addressing the lineage relationships between mTEC subsets (Derbinski 
et al. 2005; Gillard and Farr 2005). According to the terminal differentiation model (Derbinski et al. 2005), 
increased MHCII expression levels directly correlate with mTEC differentiation dissecting mTEC into 
immature MHCII
lo
 and mature MHCII
hi
 subsets. Alternatively to this view and based on the higher mitotic 
activity of MHCII
hi 
compared to the MHCII
lo
 subset (Gray et al. 2007a), the developmental model suggests 
that mTEC
hi
 may rather represent a transit-amplifying population and hence be less mature than and give 
rise to MHCII
lo
 population  (Gillard and Farr 2005). The later is supported by the sequential developmental 
appearance of first MHCII
hi
 and then MHCII
lo
 mTEC suggesting a precursor-progeny relationship. 
However, there are still large gaps in our understanding of TEC differentiation and thus the maturation 
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state, developmental potential and homogeneity of these subsets is undetermined and open to 
speculation.  
Relevant to the terminal differentiation model (Derbinski et al. 2005) and given the specific 
increase in the proliferation of immature mTEC
lo
 upon the loss of Sox9, the decrease in immature mTEC
lo
 
may be due to their faster transition to mature mTEC
hi 
whose frequency is consequently increased. 
However, though the frequency was increased, the absolute cellularity of mTEC
hi
 was reduced. One 
explanation for the numerical decrease of mTEC
hi
 may be that mTEC
hi
 as terminally differentiated cells 
have a shorter half life resulting in a higher turnover rate of these cells in the absence of Sox9 expression. 
Alternatively, mTEC
lo
 as progenitors of mTEC
hi
 may, in addition to the increased proliferation, also die 
faster due to the lack of Sox9, accounting for the decrease of their numbers and consequently mTEC
hi
 
progeny, two possibilities that were not addressed in this study. The fact that Sox9 deficiency affected 
specifically medullary compartment but had no discernable impact on cTEC biology, indicates different 
requirement for Sox9 in the development of these two cell lineages. These findings here strongly favor a 
terminal differentiation model for Sox9 function in medullary thymic epithelium as distinct Sox9 expression 
levels were associated with both the immature and terminally differentiated cells and affected cell 
proliferation. Moreover, the changes in mTEC composition and proliferation inversely correlated with 
endogenous Sox9 expression levels suggesting that Sox9 dosage plays an important role in the 
regulation of TEC homeostasis. Findings that all mTEC that express high levels of Sox9 are immature 
and their proliferation increases consequent to the loss of Sox9, combined with the in vitro data 
demonstrating that high Sox9 levels are able to suppress the proliferative capacity of a TEC line support a 
dose-sensitive model for Sox9 activity in thymic epithelia. In this model, high levels of Sox9 expression 
act to repress the proliferation of mTEC
lo
 progenitors allowing their maturation to terminally differentiated 
mTEC
hi
. The loss of Sox9 expression, releases this repression leading to the enhanced proliferation and 
accelerated transition of mTEC
lo
 to mTEC
hi
 accounting for the relative increase of the mature mTEC
hi
 
observed in Sox9-deficient hypocellular thymus. Thus, Sox9 expression controls TEC proliferation and 
influence the composition of the epithelial microenvironment in a subset specific and dose-sensitive 
manner.  
Sox9 may, in addition to kinetics of mTEC maturation, also regulate the expansion of mTEC
lo
 
compartment. A central role of CD40/CD40L signalling in the induction of mTEC
lo
 expansion and medulla 
maintenance has been established (Gray et al. 2006; Hinterberger et al. 2010; Metzger and Anderson 
2011). This contention is supported by the finding that CD40L overexpression on thymocytes causes 
massive expansion of mTEC at the expense of cTEC (Dunn et al. 1997). An accelerated transition of 
mTEC
lo
 to mTEC
hi
 in the absence of Sox9, may reduce the permissive period for CD40 signalling and 
thus result in an inefficient expansion of mTEC
lo
 compartment. Indeed, the TEC subset distribution in 
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Sox9-deficient thymus is similar to that of mice lacking CD40L by exhibiting the numerical and 
proportional decrease in mTEC
lo
 and proportional increase in mTEC
hi
 subset (Gray et al. 2006). 
Alternatively, Sox9 may directly regulate the cell surface expression of CD40 on TEC. Consequently, its 
loss would result in a reduced CD40 expression and thus, a suboptimal mTEC
lo
 expansion accounting for 
the contraction of mTEC
lo
 compartment in the absence of Sox9 expression. 
The inability of Sox9-deficient mTEC
lo
 to expand efficiently may further account for the reduced 
size of the EpCam
+
 TEC scaffold observed in mice at 2, 4 and 12 weeks of age. During TEC 
development, the population of mTEC
lo
 expands significally after the second week of age becoming the 
predominant subset in the adult thymus and leading to a gradual decrease in the ratio of mTEC
hi
 to 
mTEC
lo
 with age (Gray et al. 2006). In 2 week old Sox9-deficient mice, though TEC cellularity was 
reduced, the ratio of TEC to thymus cellularity was not changed. This may be explained by the fact that at 
this age mTEC
lo
 represent a minor population of TEC and thus, any changes in their number may not be 
sufficient to be reflected in the ratio. In contrast, at the age of 4 and 12 weeks, mTEC
lo
 represent the 
major TEC subset, and consequently any decrease in their number due to the lack of Sox9 is directly 
reflected in the TEC to thymus cellularity ratio. It is likely that a smaller mTEC compartment would be less 
efficient in supporting negative selection of thymocytes, due to the relative rare expression of antigens. 
However, a regular thymic selection and post-selectional maturation of developing thymocytes was 
observed in the thymus with Sox9-deficient TEC indicating that Sox9 expression is not required for TEC 
capacity to support thymopoiesis. Furthermore, the fact that the epithelial scaffold, despite the size 
reduction, was able to support all stages in T cell development argues for its high efficiency in the 
absence of Sox9. 
The high turnover rate of postnatal TEC with a replacement time of 10 to 14 days (Gray et al. 
2006) indicates that the composition and organization of the thymic epithelial compartment changes 
dynamically and includes interplay between progenitor cells, transit-amplifying cells and loss of cells from 
the terminally differentiated compartment. The early and sustained Sox9 expression in TEC precursors 
and their committed progeny may suggest a possible role of Sox9 for both the generation of new TEC 
from a stem/progenitor pool or rather mTEC-committed progenitors, and for the maintenance of medullary 
TEC. Both of these events, if defective, cause a failure in TEC replacement after turnover and may 
account for the numerical and compositional changes of medullary compartment observed in the thymus 
lacking Sox9 expression. Supporting the possible role of Sox9 in the regulation of TEC progenitors 
biology are findings that Sox9 marks progenitors in a variety of tissues, and influences cell fate 
assignment, proliferation and differentiation. For example, Sox9 specifies an initially bipotent gonad to 
testis fate and triggers the differentiation of Sertolli cells (Chaboissier et al. 2004; Kim and Capel 2006; 
Jakob and Lovell-Badge 2011). During pancreogenesis, Sox9 maintains early pancreatic progenitors and 
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governs their commitment to the endocrine cell fate (Seymour et al. 2007; Seymour et al. 2008). Sox9 is 
also required for the formation of hair stem cells and their migration as well as for the formation of 
multipotent NCC, their differentiation and maintenance (Sakai et al. 2006; Scott et al. 2010). In the 
intestinum, Sox9 regulates proliferation of crypt stem/progenitor cell compartment and affects cell lineage 
specification (Akiyama et al. 2004b; Blache et al. 2004; Bastide et al. 2007; Formeister et al. 2009). 
However, defining the role of Sox9 in TEC progenitors is rather a difficult task as relatively little is known 
about developmental pathway(s) and lineage relationships of TEC stem/progenitor populations and 
presently, they are neither clearly defined nor technically assessable for isolation. Altered mTEC 
proliferation and composition observed in Sox9-deficient thymus further argue for a role of Sox9 in the 
maintenance of the medullary compartment, in particular the immature mTEC
lo 
subset. Finding that this 
subset expresses the highest Sox9 levels and is most sensitive to the loss of Sox9 implays that it may 
represent a cellular target for Sox9 function to maintain the postnatal thymus microenvironment. 
Though, a lack of Sox9 expression in TEC led to the development of a hypocellular thymus, 
regular cortico-medullary organization was observed and the major cortical (CK8), medullary (MTS10, 
UEA-1, CK5, Aire) and mesenchymal (ERTR7) populations were present and properly located. However, 
the frequency of CK5
+
 TEC localized outside of the medulla was significantly increased. This increase of 
CK5
+
 TEC was not due to the change in the proliferation as the TEC subsets defined by distinct CK5 and 
CK8 expression levels displayed normal proliferation activity in the absence of Sox9. They also do not 
represent a population of CK5
+
CK8
+
 TEC progenitors or CK8
-
CK5
+
 mTEC (Klug et al. 1998; Klug et al. 
2000; Klug et al. 2002) that expanded in the cortex as detailed phenotypic analysis showed that they co-
express several markers typically associated with differentiated cTEC, such as CK8, β5t, DEC205 and 
Ly51, but not mTEC-specific markers Aire, MTS10 and UEA-1. The altered thymic CK5 expression 
pattern rather suggests that cortical epithelia in the absence of Sox9 acquired CK5 expression. An in silco 
analysis of CK5 promoter region situated 10kb downstream of the CK5 transcriptional start site revealed 
11 putative Sox9 binding sites suggesting that Sox9 may indeed directly regulate CK5 transcription in 
thymic epithelia. This contention was further supported by the upregulation of CK5-specific transcripts in 
Sox9-deficent TEC which also correlated with an increased CK5 protein expression as demonstrated by 
quantitative flow cytometric and image analysis. Thus, Sox9 deficiency results in a hypocellular thymus 
marked by the altered representation of immature and mature mTEC and the abundance of CK5
+
 cells in 
the cortex. 
For normal TEC differentiation, maintenance and function, a precise regulation of Wnt activity is 
essential (Kuraguchi et al. 2006; Osada et al. 2006; Pongracz et al. 2006; Weerkamp et al. 2006; Zuklys 
et al. 2009; Osada et al. 2010). A functional and physical interaction between Sox9 and the Wnt/β-catenin 
pathway has been demonstrated in the development and maintenance of various tissues but has yet not 
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been demonstrated in thymus. The canonical Wnt signalling engaging via β-catenin directly regulates 
Foxn1 expression in TEC as blocking of Wnt signalling at the cell surface or at distinct intracellular sites 
within the canonical pathway inhibits Foxn1 (Balciunaite et al. 2002). However, a precise mechanism by 
which Wnt signals control the transcription of Foxn1 in vivo is not yet fully established. Following the 
deletion of Sox9 in TEC, Foxn1 was increased in both cortex and medulla identifying Sox9 as a negative 
regulator of Foxn1 in TEC. This increase of Foxn1 expression may be due to a preferential expansion of a 
TEC subset with the high Foxn1 expression (i.e cTEC and/or mTEC
hi
) or alternatively, due a single cell 
upregulation of Foxn1 in the absence of Sox9. Which of these contentions is true depends greatly on the 
sensitivity of Foxn1 antibody. If for example low Foxn1 levels are not detected, the Foxn1 increase could 
be easily misinterpreted as there are new and/or more cells expressing (high) Foxn1 (i.e increased 
number of Foxn1
+
 cells) although, it may as well be, that an individual cell upregulated Foxn1 from non-
detectable to detectable (and high) Foxn1 levels. Given the general contraction of mTEC compartment in 
Sox9-deficient thymus combined with the Sox9 ability to modulate Wnt/β-catenin transcriptional activity 
suggest that enhanced Foxn1 expression is rather caused by a single cell upregulation of Foxn1 and 
affects all three major TEC subsets (i.e. cTEC, mTEC
lo 
and mTEC
hi
) deficient for Sox9. Further intriguing 
observation from this study is that the strongest increase of Foxn1 expression was observed in the 
mTEC
lo
 subset which normally expresses the highest Sox9 and the lowest Foxn1 levels and displays an 
increased proliferation upon the loss of Sox9. Though, a direct correlation between Foxn1 and 
proliferation has yet not been clearly demonstrated in the postnatal thymus, the reintroduction of Foxn1 
transgene into the nude thymus (Cunliffe et al. 2002; Bleul et al. 2006). and administration of exogenous 
Foxn1 cDNA in aged wild type mice (Sun et al. 2010) restore thymic size It is tempting to speculate that 
the increased Foxn1 expression in immature mTEC
lo
 contributed, at least in part, to their enhanced 
proliferation in the absence of Sox9. In turn, the possibility that the alternations of mTEC composition and 
proliferation observed in Sox9-deficient microenvironment also contributed to the changes in Foxn1 
expression cannot be formally excluded. 
The underlying molecular mechanism by which Sox9 modulates Foxn1 expression in thymic epithelia 
was explored in TEC lines stably transduced to express either wild type or mutant Sox9 molecule that 
lacks the C-terminal TA domain but contains N-terminal DNA binding domain. Sox9 has been 
demonstrated in mesenchymal and epithelial cells to inhibit Wnt/β-catenin signalling by promoting β-
catenin degradation and/or by inhibiting β-catenin transcriptional activity in the nucleus (Akiyama et al. 
2004b; Blache et al. 2004; Bastide et al. 2007; Topol et al. 2008). In TEC, the amount of β-catenin protein 
needs to be precisely regulated for regular thymus development and function (Zuklys et al. 2009). Studies 
aimed to determine which domains of Sox9 protein are required to inhibit Wnt/β-catenin activity have 
come to various conclusions, and it seems that Sox9 activates different mechanisms in distinct cell types 
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and several of these may also operate in parallel. The study by Akyama et al. demonstrated that the C-
terminal TA domain of Sox9 is required for binding and subsequent β-catenin degradation. This 
interaction determines intracellular β-catenin protein levels and affects the transcription of Wnt/β-catenin 
target genes (Akiyama et al. 2004b). Contrary, Topol et al. showed that Sox9 promotes β-catenin 
degradation and inhibits β-catenin dependent transcription by two parallel and independent mechanisms 
that employ different domains of Sox9. In their study, the N-terminus of Sox9 binds and degrades β-
catenin whereas the C-terminus is required to repress β-catenin mediated transcription (Topol et al. 
2008). Results here demonstrate that in thymic epithelia Sox9 physically associate with β-catenin using 
both N- and C-terminal domains. However, the interaction mediated via N-terminus of Sox9 mutant 
molecule did not reduce β-catenin amount. Instead, the binding via the C-terminal TA domain was 
required for Sox9 to induce a decrease of β-catenin protein. These results agree with Akiyama et al. by 
showing that the C- and not N-terminal domain of Sox9 regulates the cellular β-catenin protein levels and 
its nuclear availability, probably by promoting β-catenin degradation. Whether in TEC, Sox9 uses the C-
terminal domain also to repress directly β-catenin mediated transcription, as suggested by Topol et al., 
cannot be excluded. 
The Sox9-mediated degradation of β-catenin can take place in both the nucleus and/or cytoplasm 
(Akiyama et al. 2004b; Topol et al. 2008). While Akyiama et al. demonstrated efficient β-catenin 
degradation in the cytoplasm by the ubiqitination/26S proteasome pathway (Akiyama et al. 2004b), Topol 
et al. reported a novel degradation mechanism in the nucleus (Topol et al. 2008). Sox9 was shown to 
bind, in addition to β-catenin, components of the destruction complex, the GSK3β and the ubiquitin ligase 
βTrCP and translocates them to the nucleus where more efficient phosphorylation and degradation of β-
catenin occurs. The latter mechanism could also be activated by Sox9 in thymic epithelia, given that the 
strongest reduction of β-catenin protein was detected in nucleus when compared to the cytoplasm of TEC 
stably overexpressing wild type form of Sox9, though both mechanisms may also act in parallel and at 
different efficiency. These in vitro findings also predict increased β-catenin protein levels in primary TEC 
after Sox9 removal as there is no Sox9 to interact with and degrade β-catenin. Assessment of β-catenin 
protein levels in total cell fraction of primary TEC lacking Sox9 expression by flow cytometry revealed only 
slight increase of β-catenin protein. This may be explained by the fact that most of β-catenin in the cell is 
associated with cytoskeleton and thus generates the high background hindering the detection of free, non 
bound β-catenin and changes in its amount. Therefore, and given the most pronounced reduction of β-
catenin protein in the nuclear fraction of wild type Sox9-transduced TEC, β-catenin levels should be 
quantified separately in nucleus and cytoplasm of primary TEC. This however requires sorting of TEC and 
subsequent separation of cellular subfractions which is at the moment technically not feasible. 
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The finding that Sox9 to regulates β-catenin protein levels in TEC represents one possible 
mechanism by which Sox9 may control transcription of Wnt/β-catenin target gene, including Foxn1 in 
thymic epithelia. Indeed, the reduction of β-catenin protein detected in a TEC line overexpressing wild 
type Sox9 associated with a significant downregulation of Foxn1 expression whereas, the stable 
expression of a TA-deficient mutant Sox9 did neither alter β-catenin nor Foxn1 expression. These in vitro 
studies demonstrated that Sox9 regulates Foxn1 expression indirectly through the physical and functional 
interaction with β-catenin mediated via the C-terminal TA domain of Sox9. In keeping with Topol et al. it is 
also conceivable that the C-terminus of Sox9 directly inhibits Foxn1 transcription. The N-terminus of Sox9 
however, does not take part in direct regulation as the TA-deficient Sox9 mutant did not modulate Foxn1 
expression levels. The capacity of Sox9 to bind and control β-catenin levels in thymic epithelia may 
constitute a mechanism to fine tune the activity of Wnt signalling and thus the expression of Wnt target 
genes during thymus development and maintenance. Further, this interaction may also serve to control 
the extent of Wnt activity and prevent overactivity of Wnt/β-catenin dependent transcriptional program 
during normal TEC homeostasis. 
Collectively, the present study demonstrated that the differential expression of Sox9 is important in 
the regulation of TEC proliferation and differentiation. Moreover, Sox9 via its association with β-catenin 
modulates Wnt signalling activity and acts as a negative regulator of Foxn1 expression in thymic epithelia. 
We propose that Sox9 plays a role in the establishment and maintenance of the normal adult thymic 
microenvironment, at least in part, by regulating β-catenin protein and thus level of Wnt activity through 
the physical and functional interaction with β-catenin (Figure 3.24). Sox9 may also influence TEC 
development and function independently of the association with β-catenin and identification of 
downstream targets of Sox9 during thymus development and maintenance is next important step. 
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5. CONCLUSIONS 
The work described in this thesis leads to the following findings: 
1.) Sox9 is expressed as early as E10.5 in the prospective thymic epithelial cells and also in 
mesenchymal but not in lymphoid cells, and persists into adulthood. 
2.) Loss of Sox9 expression in TEC leads to the specific changes in TEC composition and proliferation 
which inversely correlate with the differential Sox9 expression levels normally present among TEC 
subsets. The immature MHCII
lo
 UEA-1
+
 mTEC express high Sox9 levels and are most sensitive to 
the loss of Sox9 and thus, may represent a cellular target for Sox9 function to maintain the postnatal 
thymus microenvironment.  
3.) The high Sox9 expression in immature mTEC
lo
 cells correlates with their enhanced proliferation upon 
loss of Sox9 and indicates that high steady-state Sox9 levels act to suppress TEC proliferation. This 
conclusion is confirmed by the overexpression of Sox9 in an established TEC line which reduces the 
cell`s proliferation. 
4.) In Sox9-deficient thymus, the contraction of mTEC
lo
 and the relative expansion of mTEC
hi
 
compartment appear to derive, at least in part, from enhanced mTEC
lo
 proliferation suggesting that 
Sox9 expression controls TEC proliferation and thereby influences the composition of the thymic 
microenvironment. 
5.) Despite the alterations in mTEC composition, thymopoiesis remains unaffected in the thymus with 
Sox9-deficient TEC indicating that Sox9 expression is not required for TEC capacity to support T cell 
development.  
6.) The TEC-targeted loss of Sox9 expression correlates with a significant upregulation of Foxn1 in all 
TEC subsets and identifies Sox9 as a negative regulator of Foxn1 expression in thymic epithelia. 
7.) In vitro studies established that Sox9 controls Foxn1 transcription indirectly through the formation of 
a physical complex with β-Catenin. Binding mediated via the C-terminal TA domain of Sox9 induces 
a decrease in β-catenin protein levels and consequently inhibits Wnt/β-catenin transcriptional activity 
on Foxn1. Hence, Sox9 negatively regulates Foxn1 by controlling amount of β-catenin.  
Collectively, this study provides evidence that transcription factor Sox9 acts in dose-sensitive and subset-
specific manner in the regulation of TEC proliferation and differentiation and negatively regulates Foxn1 
expression in TEC. Thus, differential Sox9 expression is critical for the establishment and maintenance of 
a regular thymic microenvironment. 
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6. FUTURE PERSPECTIVES 
Several issues still need to be addressed to understand the detailed function of Sox9 in thymus 
development. 
1.)  To achieve Cre-mediated recombination and Sox9 deletion both at an earlier time point during 
thymic organogenesis and in mesenchymal cells, Sox9
flox/flox 
mice should be next crossed to Hoxa3-
Cre line in which Cre expression occurs before E10.25 (Macatee et al. 2003) and is active not only in 
TEC but also in cells of mesenchymal and ectodermal origin. This is purposeful given that Sox9 
expression was detected already at E10.5 in both prospective thymic epithelia as well as in the 
mesenchyme, and Foxn1-Cre used here acts only from E12.5 and solely in TEC.  
2.)  To further address the fate of immature mTEC
lo
 and mature mTEC
hi 
cells lacking Sox9 expression, 
the survival and turnover of these cells should be assessed. This may help to clarify the decrease of 
their absolute numbers in Sox9-deficient thymus. 
3.)  To explore the molecular mechanism and identify Sox9 target genes involved in the regulation of 
TEC proliferation and differentiation a transcriptome analysis of mTEC
lo
 and mTEC
hi
 subsets isolated 
by cell sorting from Sox9-deficient and -proficient mice have been initiated. In particular, it would be 
interesting to know whether CD40 is one of Sox9 downstream genes considering its role in the 
expansion of mTEC
lo 
compartment and given the specific contraction of mTEC
lo
 observed in Sox9-
deficient thymus. 
4.)  Since Sox9 can act as a transcriptional activator or repressor, the identification of thymus-specific 
cofactors that interact with Sox9 and regulate its function in spatio-temporal fashion would contribute 
to our knowledge of how Sox9 transcriptional activity and thus developmental processes in which 
Sox9 participates are controlled. 
5.)  Also an important step in understanding TEC development is the identification of signalling pathways 
and mediators involved in the epithelial-mesenchymal crosstalk during thymus organogenesis and 
maintenance. Given Sox9 detection in the mesenchyme of the 3
rd
 pharyngeal arch at the onset of 
thymus organogenesis and in the adult MTS15
+
 Ly51
+
 mesenchymal cells, defining the role of Sox9 
in epithelial-mesenchymal communication represents an avenue worth further investigation.  
Together, the ablation of Sox9 expression in both thymic epithelia and mesenchyme combined with gene 
expression profiling should help to dissect complex genetic network controlling TEC differentiation and 
normal thymus homeostasis. 
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7. MATERIAL AND METHODS 
7.1. Materials 
7.1.1. Mice 
Conditional Sox9
flox/flox 
mice, (Sox9
f/f
) with loxP-sequences flanking Sox9 exons 2 and 3 (Kist et al. 
2002) were a kind gift of Andreas Kispert and Gerd Scherer (Institute of Human Genetics, University of 
Freiburg, Germany). They were originally on a 129 x C57BL/6 x NMRI mixed genetic background.  
Foxn1-Cre mice were produced as P1 artificial chromosome (PAC) transgenic animals (Zuklys et al. 
2009). Briefly, the CDS for iCre (i.e for eukaryotes codon usage optimized version of the bacteriophage 
p1 cre recombinase) was inserted into Foxn1 PAC clone RPCI21-436p24 and injected into pronuclei of 
fertilized B6D2F1 oocytes. Two independent transgenic lines were generated each displaying identical 
pattern of Cre activity. The line B6;D2-Tg (Foxn1-Cre)8Ghr, designated Foxn1-Cre was used for the 
present study and was maintained as a heterozygous colony. Foxn1-Cre mice were bred to [Sox9
f/f
] mice 
to generate mice deficient for Sox9 expression specifically in TEC [Sox9
f/f
::Foxn1-Cre] as described in 
section 3.2 and depicted in Figure 3.7. C57BL/6 mice were purchased from RCC Ltd, Füllingsdorf. For 
developmental staging, the day of the vaginal plug appearance was designated as embryonic day (E) 0.5. 
Mice were housed at the Center for Biomedicine`s animal facility in accordance with Institutional and 
Cantonal Review Board. 
7.1.2. Standard buffers 
Cell culture 
Cell culture media 
500ml Iscove's Modified Dulbecco's Medium (IMDM) (Invitrogen)  
50ml Fetal Bovine Serum (FBS) (10%) (Perbio)  
0.5ml 50mM 2-Mercaptoethanol (50µM) (Invitrogen)  
Antibiotics: used only for PlatE cultures  
Penicillin-Streptomycin solution (10 000U penicillin and 10mg streptomycin/ml; Sigma): used at final 
concentration of 100U/ml Penicillin and 100μg/ml Streptomycin 
Puromycin (1mg/ml): used at final concentration of 1µg/ml 
Blasticidin (10mg/ml): used at final concentration of 10µg/ml  
Puromycin and/or Blasticidin were added from time to time for three to four days to re-select PlatE 
cells containing retroviral packaging construct. 
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Freeze medium 
90% FBS and 10% Dimethylsulfoxid (DMSO) 
Flow cytometry 
FACS buffer: for staining of thymic stromal cells  
Hank's Balanced Salt Solution (HBSS) containing 2% or 5% FBS (Perbio) 
FACS buffer: for staining of lymphocytes  
Phosphate buffered saline (PBS) pH7.4 containing 2% FBS (Perbio) 
0.5M Ethylenediamine-tetraacetic acid (EDTA) (Ambion): for stromal cell preparation, used at final 
concentration of 2.5mM or 10mM  
Collagenase/Dispase (Roche): stock (10mg/ml) used at final concentration of 1mg/ml  
Dnase (Roche): stock (10mg/ml) used at final concentration of 50µg/ml 
DAPI: stock (0.5mg/ml) used 1: 5000 
Fixation/Permaebilization: 
Fixation/Permaebilization kit (eBioscience): Diluent and Concentrate mixed at ratio 3:1  
Immunohistochemistry 
1% cresyl violet acetate: 0.5g per 50ml 100% EtOH 
0.1% Dethylpyrocarbonate (DEPC): 1ml per 1L milliQ H2O, autoclaved 
0.5% Toluidine Blue: 0.25g per 50ml milliQ H2O 
Fixation:  
4% PFA/PBS: 4g per 100ml PBS; dissolved at 55°C for 1 hour 
4%PFA/4% sucrose/PBS: 4g sucrose per 100ml 4%PFA/PBS 
Aceton  
Permeabilization:  
0.25% Triton X-100/PBS 
Blocking:  
5% normal goat serum (NGS)/PBS 
10% bovine serum albumin (BSA)/PBS 
Western blotting 
Separating gel (80%, 10ml, separation range between 36-94kDa):  
4.6ml milliQ H2O 
2.7ml 30% Acyrlamide/Bis Solution (Biorad)  
2.5ml 1.5M Tris-HCl pH8.8 (Sigma) 
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100μl 10% Sodium Dodecyl Sulfate (SDS) (Eurobio) 
100μl 10% Ammonium Persulfate (APS) (Sigma)  
6μl Tetramethylethylendiamin (TEMED) (Eurobio) 
Stacking gel (5%, 4ml): 
2.7ml milliQ H2O 
0.67ml 30% Acrylamide/Bis Solution (Biorad)  
0.5ml 1M Tris HCl pH6.8 (Sigma) 
40μl 10% SDS (Eurobio) 
40μl 10% APS (Sigma) 
4μl TEMED (Eurobio) 
RIPA buffer 
5ml 1M Tris-HCl pH8 (50mM) (Sigma) 
3ml 5M NaCl (150mM) 
10ml 10% NP-40 (1%) 
5ml 10% Deoxycholic Acid (0.5%) 
Fill up to 100ml with milliQ H2O  
Complete Protease Inhibitor Cocktail Tablets (Roche): 1 tablet in 2ml H2O; 40µl per 1ml Ripa buffer 
SDS Loading buffer (2x): 
1ml 1M Tris-HCl pH6.8 (100mM)  
2ml 20% SDS (4%) (Eurobio) 
0.02g Bromophenol blue (0.2%) (Sigma) 
2ml Glycerol (20%) (Sigma) 
142.85µl β-Mercaptoethanol (200nM) (Sigma) 
Fill up to 10ml with miliQ H2O 
SDS Running buffer (5x) 
15.1g Tris base (125mM) (Sigma) 
94g Glycine (1.25M) (Biorad)  
25ml 20% SDS (0.5%)  
Fill up to 1L with milliQ H2O  
Transfer buffer (10x) 
30.3g Tris Base (Sigma) 
144.1g Glycine (Biorad)  
Fill up to 1L with milliQ H2O 
Transfer buffer (1x) 
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100ml Transfer buffer (10x) 
200ml Methanol (Fluka) 
Fill up to 1L with milliQ H2O 
Washing:  
TPBS: 1%Tween 20 (1ml) (Sigma) in PBS (1L) 
Blocking:  
Blotto: 5% skim milk (2.5g) in TPBS (50ml) 
Antibody dilutions: 2.5% skim milk (1.25g) in TPBS (50ml) 
Stock solution 
PBS (10x) 
80g NaCl 
2g KCl 
14.4g Na2HPO4 
2.4g KH2PO4 
Fill up to 1L with milliQ H2O 
1.5M Tris-HCl pH8.8 
90.75g Tris-HCl per 500ml milliQ H2O, adjust pH with HCl 
1M Tris-HCl pH6.8 
60.5g per 500ml milliQ H2O, adjust pH with HCl 
1M MgCl2 
20.3g MgCl2•6 H2O per 100ml milliQ H2O 
5M NaCl 
29.3g NaCl per 100ml milliQ H2O 
Tail lysis buffer 
10ml 1M Tris pH 8.5 (100mM) 
1ml 0.5M Na-EDTA (5mM) 
1ml 20% SDS (0.2%) 
4ml 5M NaCl (200mM) 
Fill up to 1L with H2O 
Proteinase K added freshly at final concentration of 100μg/ml 
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Molecular cloning 
Luria-Bertani medium (LB) 
10g Bactotryptone (Difco) 
5g Bacto-yeast extract (Difco) 
10g NaCl 
Fill up to 1L with deionized water, autoclave 
SOB Medium 
20g Tryptone 
5g Yeast extract 
0.5g NaCl 
Fill up to 950ml with deionized water and shake it until dissolved 
Add 10ml 250mM KCl and adjust pH to 7.0 with 5N NaOH (~ 0.2ml) 
Fill up to 1L with deionized water, autoclave 
Add 5ml of sterile 2M MgCl2 just before use 
250mM KCl 
1.86g in 100ml deionized water 
2M MgCl2: 
19g in 100mL deionized water 
CCMB80 buffer: for preparation of competent cells 
10mM KOAc pH7.0 (10ml of a 1M stock/l) 
80mM CaCl2xH20 (11.8g/l) 
20mM MnCl2x4H20 (4g/l) 
10mM MgCl2x6H20 (2g/l) 
10% Glycerol (100ml/l) 
Adjust pH down to 6.4 with 0.1N if necessary 
Filter sterile and store at 4°C 
7.1.3. Primers 
All primer sequences are indicated in 5`3` direction 
Table 7.1 Primers 
Number Gene Forward primer Reverse primer 
Genotyping 
3514 wt/flox Sox9_F2 CCGGCTGCTGGGAAAGTATATG  
3516 del Sox9_F1 CTCCGGTAGCAAAGGCGTTTAG  
3515 Sox9_R  CGCTGGTATTCAGGGAGGTACA 
1621/1626 Foxn1-Cre CTCTCCTCCGAGTATCCAATCTG CCCTCACATCCTCAG GTTCAG 
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qRT-PCR analysis 
3459/3460 Sox9 ACGGAACAGACTCACATCTC CCTCTCGCTTCAGATCAACT 
465/466 Foxn1 TCTACAATTTCATGACGGAGCACT TCCACCTTCTCAAAGCACTTGTT 
3971/3972 CK5 TCAACAAGCGTACCACGGC GGCATCGACCCTGGCC 
1268/1269 CK8 GCCACTGAAGTCCTTGCCAG- GGTTGGCCAGAGGATTAGGG 
490/491  Aire TGTGCCACGACGGAGGTGAG GGTTCTGTTGGACTCTGCCCTG 
2156/2157 CCL21 AGCTATGTGCAAACCCTGAGGA TTCCAGACTTAGAGGTTCCCCG 
3476/3477 β5t   
3157/3158 CD45 AATTTCAGAGCATTCCACGG GAAGTCATCAACTGTCTC ATCC 
605/606 GAPDH GGTGAAGGTCGGTGTGAACG ACCATGTAGTTGAGGTCAATGAAGG 
1108/1109 EVA GTAAACTGTGCCGCCTGCTC TCCCGTTGACTGCCTCCA 
4134/4135 EpCam TGAGGACCTACTGGATCATC TATCGAGATGTGAACGCCTC 
571/572 CyclinD1 GGAGACCATTCCCTTGACTG GTTGTGCGGTAGCAGGAGAG 
670/671 c-myc CACAGCAAACCTCCGCACAG TGTGTGTCCGCCTCTTGTCGT 
Cloning of Sox9 wild type and mutant 
3914 
BamHI 
Sox9WT/M 
*cgcGGATCCatgtcggaggactcggctggttcgc    
3916 NotI Sox9 WT   *ataagaatGCGGCCGCtcagggtctggtgagctgtgt 
3915 NotI Sox9 M  ataagaatGCGGCCGCTCAtgggtggccgttgggtggcaa 
Sequencing of Sox9 plasmids (5`HA pPRIG) 
440 T7 (G)TAATACGACTCACTATAGGG  
3800 Sox9 WT/M TCCAGCAAGAACAAGCCACA  
3801 Sox9 WT/M CATGAGTGAGGTGCACTC  
3802 Sox9 WT ACGTGTGGATGTCGA AGCA  
3803 Sox9 WT TACAGCGAGCAGCAGCAGCA  
3918 Sox9 N`HA  TGTGGCTTGTTCTTGCTGGA 
*linker RESTRICTION SITE Sox9 mRNA 
TGA stop codon introduced in Sox9 M reverse primer 
7.1.4. Antibodies 
Table 7.2 Antibodies 
Antibody Clone Manufacturer 
TEC analysis 
CD45 PECy7 30-F11 BioLegend 
EpCam Cy5 G8.8 Our laboratory 
EpCam bio G8.8 Our laboratory 
pan MHC class II (I-A/I-E) Fluos M5/114.15.2 BD Pharmingen 
Ly51 PE 6C3/BP1 BD Pharmingen 
Ly51 A647 6C3/BP1 BioLegend 
Ly51 FITC 6C3/BP1 eBioscience 
UEA-1 Cy5.  Our laboratory 
MTS15 Cy5  Our laboratory 
BrdU PE MOPC-21 BD Pharmingen 
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Ki67 PE B56 BD Pharmingen 
CD16/CD32 2.4G2 BD Pharmingen 
Lymphocytes  analysis 
CD3 Cy5 KT3 Biolegend 
CD4 PE GK1.5 Biolegend 
CD8 PECy7 53-6.7 Biolegend 
CD24 FITC M1/69 Biolegend 
CD69 FITC H1.2F3 eBioscience 
B220 FITC RA3-6B2 eBioscience 
ckit APC 2B8 eBioscience 
CD44 PE IM7 eBioscience 
CD25 FITC PC61 eBioscience 
CD3 bio KT3 BD Pharmingen 
CD4bio GK1.5 BD Pharmingen 
CD8 bio 53-6.7 BD Pharmingen 
TCRβ bio H57-597 Biolegend 
TCRγδ bio GL3 eBioscience 
NK1.1 bio PK136 eBioscience 
CD11b bio M1/170 eBioscience 
CD11c bio N418, p150/90 eBioscience 
CD19 bio ID3 eBioscience 
Immunohistochemistry 
Rabbit anti-CK5 pAb  Covance 
Mouse anti-CK8 mAb  Progene 
Mouse anti-CK18 bio mAb  Progene 
Rat anti-CD25 Cy5  BD Biosciences 
Rat anti-ERTR7 mAb  Our laboratory 
Rat anti-MTS10 mAb  Our laboratory 
Rat anti-CD25 Cy5  BD Biosciences 
UEA-1 bio lectin  Vector Laboratories 
Rabbit anti-β5t   
Rat anti-Ly51 A647  Biolegend 
Rat anti-CD205 bio  Abcam 
Rabbit anti-Foxn1 pAb  Kindly provided by T. Amagai 
Rabbit anti-Sox9 pAb  Kindly provided by M. Wegner 
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Mouse anti-HA mAb  Covance 
Goat anti- Rabbit A488  Invitrogen 
Goat anti-Rabbit  A555  Invitrogen 
Goat anti-Rat A488  Invitrogen 
Goat anti-Rat A555  Invitrogen 
Goat anti-Rat A647  Invitrogen 
Goat anti-Mouse A555  Invitrogen 
Goat anti-Mouse A647  Invitrogen 
IP and Western blotting 
Mouse anti-β-catenin mAb  BP Transduction Laboratories 
Rabbit anti-Foxn1 pAb  Kindly provided by T. Amagai 
Mouse anti-HA mAb  Covance 
Rabbit anti-Sox9 pAb  Kindly provided by M. Wegner 
Rabbit anti-GAPDH pAb  Abcam 
Mouse anti-Histon H1 mAb  Santa Cruz 
Mouse anti-Tubulin mAb  Sigma 
Goat anti-Mouse Ab, HPR-conjugated  GE Healthcare 
Goat anti-Rabbit Ab, HPR-conjugated  Southern Biotechnology 
7.2. Methods 
7.2.1. Genotyping of [Sox9f/f] and [Sox9f/f::Foxn1-Cre] mice 
Isolation of genomic DNA from mouse tissue 
Small tissue piece (tip of tail, embryonic limb) was digested in 700μl lysis buffer containing 
Proteinase K overnight at 55°C in a Thermomixer shaker (Eppendorf). Undigested tissue was pelleted for 
5 min at maximum speed and the supernatant poured into a new tube containing an equal volume of 
isopropanol. DNA was precipitated by inverting the tubes, thereafter pelleted by centrifugation at full 
speed, washed in 70% ethanol and pelleted again. The supernatant was then discarded and the DNA 
pellet air dried. TE buffer was added (200-400μl) and after incubation at 55°C for 30 min the pellet 
resuspended. DNA was stored at +4°C. 
 
PCR reaction mix: 
100ng genomic DNA (or 10ng cDNA)  
0.5µl Forward primer (10µM) 
0.5µl Reward primer (10µM) 
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0.5μl dNTPs (10mM) 
2.5µl Buffer 10x (Sigma) 
0.2µl Taq Polymerase (Sigma) 
µl H2O up to 25µl  
PCR conditions: 
94°C 2 min (initial denaturation) 
32 cycles: 94°C 30 sec; 56°C 45 sec; 72°C 30 sec (denaturation; annealing; elongation) 
72°C 5 min (final elongation)  
Same reaction mix and conditions were used for PCR analysis of Sox9 expression in thymic stroma. 
 
7.2.2. RNA isolation, cDNA synthesis and quantitative real time RT-PCR (qRT-
PCR) analysis 
Total RNA isolation  
RNA isolation was carried out in an RNase free environment wearing disposable gloves to avoid 
contamination of the samples. Total RNA from whole thymic tissue and TEC lines was isolated according 
to the standard TRI-reagent protocol (Molecular Research Center Inc). Snap-frozen (using liquid nitrogen) 
tissue was suspended in 1ml of TRI-reagent homogenized with a Polytron homogenizer (Kinematica PT 
1200) for 30-60 sec with increasing speed and incubated for 10 min at RT. To extract the aqueous phase, 
100μl (1:10) Bromochloropropanol (Molecular Research Center Inc.) were added, the samples vortexed 
for 10 sec and incubated for another 10 min at RT. After centrifugation at 14`000 rpm for 10 min at 4°C 
the aqueous phase was transferred to a new Eppendorf tube into an equal volume of isopropanol 
(Sigma), mixed and incubated for 1 h at RT in order to precipitate the RNA. The samples were then 
centrifuged at 14000 rpm for 30 min at 4°C, the supernatant discard and the pellet washed with 1ml 75% 
ethanol (Fluka), vortexed and centrifuged at full speed for 10 min at 4°C. The supernatant was completely 
removed and the RNA pellet air dried for 5-10 min at RT, thereafter dissolved in 10-30μl of RNAase free 
water. The concentration of the total RNA was measured by optical density (OD) using a Gene-Quant 
machine II (Pharmacia) and the following formula: concentration (μg/ml) = 40 x OD260 x dilution. The 
OD260/OD280 ratio of the samples was always equal or above 1.8. RNA integrity was analysed by gel 
electrophoresis on a 1% agarose/ethidium bromide (0.25μg/ml) gel. To extract RNA from sorted TEC and 
microdissected tissue the RNeasy Micro kit (Qiagen) (max. 500`000 cells) was used following the 
manufacturer’s instructions. Here, the yield and integrity of RNA was routinely assessed by RNA 6000 
Pico assay and the Agilent 2100 bioanalyzer. The samples were then stored at -80°C until further 
processed. 
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cDNA synthesis 
For the generation of cDNA, 3-5μg of total RNA (dissolved in 10µl water) were added to 0.5ml microtubes 
containing the following master mix solution (8μl per sample):  
4μl of 5x First strand buffer (Invitrogen) 
2μl DTT 0.1M (Invitrogen)  
1μl dNTP (10mM)  
1μl RNAse-free DNase I (10U) (Roche).  
The reactions were incubated in a thermal cycler for 30 min at 37°C to digest genomic DNA 
contaminants, cooled on ice for 1 min, and subsequently heated for 15 min at 70°C to inactivate the 
DNAse I and denature the secondary structure of the RNA. Next, 1μl of the oligo dT (50µM) and 1μl of 
random hexamers N6 (500ng/μl) were added and the reactions incubated for 5 min at 70°C, thereafter 
cooled on ice for 1 min. After addition of 1μl of Superscript III reverse transcriptase (200U/μl) (Invitrogen) 
the samples were incubated for 5 min at 25°C, 60 min at 50°C and finally 15 min at 70°C. As a negative 
control, reaction where the reverse transcriptase was omitted has been included. Water was added to all 
samples to achieve the final concentration of 50ng/μl and the samples stored at -20°C until further 
processed. 
qRT-PCR 
The primers for qRT-PCR were designed to be exon spanning excluding potential genomic 
contamination and to give the amplicons relatively short in size (<200bp) ensuring a maximal 
amplification efficiency. Intron-exon boundaries were viewed with Pearl Primer software. The sequence of 
the used primers can be found in section 5.1.3. qRT-PCR was performed in triplicates on a Rotor-Gene 
3000 (Corbett Research) using SensiMix SYBR kit (Bioline) and the data acquired using Rotor-Gen 6 
software (Corbett Research). 1µl of cDNA (1-10ng) was added to 0.1ml strip tubes (LabGene Scientific) 
containing the following master mix solution (11.5µl per sample): 
6.25μl 2x SensiMix  
0.25µl 50x Syber Green,  
0.375μl Forward primer (10μM)  
0.375μl Reverse primer (10μM)  
µl H20 up to 12.5μL  
The cDNA was amplified using following PCR conditions: 
95°C 10 min  
40 cycles: 95°C 10 sec; 60°C 15 sec; 72° 20 sec 
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Expression levels of specific mRNA were normalized to GAPDH expression (2
-ΔCt
; ΔCt= Ct (gene of 
interest) - Ct (housekeeping gene)), averaged and mean values were compared between mutant and wild 
type cells using student T-test. Data were presented relative to the corresponding control value (i.e 
[Sox9
f/f
] mice or cells transduced with the empty vector) which was arbitrary set to 1 for comparison. In 
case of the whole thymic tissue, amounts of specific mRNA were normalized to the expression of TEC-
specific gene EpCam. PCR specificity was controlled by analyzing both the melting curves and the size of 
amplified products on a 1% agarose/ethidium bromide gel. Gel images were acquired on a Molecular 
Imager Gel Doc XR system using Quantity One 4.6.2 software (Bio-Rad). 
 
7.2.3. Histology 
Tissue embedding  
Freshly isolated thymic lobes or whole embryos (E10.5-13.5) were embedded in OCT compound 
(Medite) in Tissue-Tek Cryomolds (Miles). Tissues were frozen by submerging in a mixture of dry ice and 
methyl-butane isopentyl (Fluka) and then stored at –80°C. Frozen samples were cut at 6-8μm thickness 
using a cryostat (Roche) and mounted either on normal glass slides for HE staining or on SuperFrost plus 
slides (Menzel-Gläser) for IHC. Tissues sections were air dried for at least 1 h at RT, then either frozen at 
-80°C wrapped in aluminum foil or processed directly. 
Hematoxylin and eosin (HE) staining 
For HE staining, tissue sections were fixed in Delaunay`s fixation solution for 1min, then rehydrated 
in a series of ethanol dilutions for 1min each (100%, 96%, 70%,  50%) and finally in water for 1min. 
Tissues were stained with Mayer`s Hämalaun for 2 min, thereafter washed with warm water 3x1 min and 
stained with 1% Erythrosin. After washing with water for 1 min, sections were dehydrated in increasing 
ethanol concentrations (50%, 70%, 96%) for 1 min each, then in 100% ethanol for 2 min. Slides were 
then air dried before mounting the cover slips with Pertex. Imaging was done on a Nikon Eclipse E600 
microscope (4x/0.13 NA Plan Fluor objective), captured with a Nikon DXM 1200F camera, and processed 
with Nikon ACT-1 software (Nikon Instruments Europe).  
Immunohistochemistry (IHC) 
For immunohistochemical detection, tissue sections (6-8 µm) were circled by a PAN pen and fixed in 
a Kopplin Jar with cold acetone (-20°C) for 5 min at RT, washed in PBS and incubated with 5% goat 
serum/PBS for 10 min to block nonspecific binding prior incubation with primary antibodies. For nuclear 
stainings, the dissected tissues were fixed in 4% PFA/PBS overnight at 4°C, washed in PBS and sucrose 
gradient (5%, 10%, 20% sucrose/PBS) was run prior to cryopreservation in OCT compound containing 
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20% sucrose. For the detection of Sox9, tissue sections were fixed again (i.e. post cryopreservation) with 
acetone as described above whereas to detect Foxn1 protein antigen retrieval by heating was performed. 
Briefly, slides with dried sections were placed into a Kopplin jar containing 10mM Na citrate, pH6 and 
boiled twice in the microwave, allowing to cool down for 20 min in between. Subsequently, blocking was 
performed as describe above. Following primary antibodies diluted at the appropriated final concentration 
with 5% NGS/PBS were used: rabbit anti-cytokeratin (CK)5 polyclonal antibody (pAb), mouse anti-CK8 
monoclonal antibody (mAb), rabbit anti-Foxn1 pAb (Itoi et al. 2007a), rat anti-MTS10 mAb (Godfrey et al. 
1988), rabbit anti-Sox9 pAb  (Stolt et al. 2003), rat anti-ERTR7 mAb, rat anti-CD25 as well as biotinylated 
Ulex europaeus agglutinin-1 (UEA-1) lectin. After 2 h incubation with primary antibodies, slides were 
washed 2x10 min and sections incubated with appropriate Alexa-Fluor Goat IgG conjugated secondary 
antibody for 30 min at RT. As a negative control, primary antibody was either replaced with corresponding  
isotype control or omitted on purpose. Care was taken to remove the liquid remaining after the washing 
and prior adding of the antibody solution and slides were always incubated in a closed humid chamber 
box with a paper soaked with water to avoid drying of tissue sections. Sections were mounted with 
fluorescent mounting medium (Hydromount, National Diagnostics) and images acquired on a Zeiss LSM 
510 confocal microscope (10x/0.5 NA, 20x/0.5 NA, and 40x/0.5 NA objectives) using Zeiss LSM 510 
acquisition software, version 3.2 (Carl Zeiss). Quantitative image analysis of protein expression was 
performed using the NIH Image-J analysis software. The relative area of specific protein expression was 
determined as a percentage of stained pixels in the defined area of the thymus. The mean relative area 
was calculated using 3-4 sections from a minimum of 3 mutant and wild type mice analysed. Statistical 
analyses were performed using student t-test. 
IHC on coverslips 
For the detection of exogenous Sox9 expression in stably transduced TEC lines, IHC was performed 
on coverslip according to the Sigma protocol for the detection of monoclonal ANTI-FLAG M2 antibody. 
Briefly, cTEC1.2 transduced either with HA-tagged wild type and mutant Sox9 or with empty retroviral 
vector (control) were seeded (5x10
4
 cells/1ml medium) and grown on coverslips in a 12 well plate. Cells 
were fixed by incubation with 4% PFA/4% sucrose/PBS for 15 min at RT. Fixed cells were then washed 
2x5 min with PBS, permeabilized by incubation with 0.25% TritonX-100/PBS for 5 min, washed again and 
blocked with 10% BSA/PBS for 30 min at 37°C. Next, mouse anti-HA mAb or rabbit anti-Sox9 pAb (Stolt 
et al. 2003) diluted in 3% BSA/PBS were added for 2 h at 37°C. After washing, cells were incubated with 
Goat anti-Mouse A647 and Goat anti-Rabbit A555, respectively and DAPI for 45 min at 37°C. Cells were 
washed and coverslips mounted on glass slides with the cell side down using fluorescent mounting 
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medium (Hydromount; National Diagnostics). Samples were examined by confocal microscopy as 
described above. 
 
7.2.4. Laser capture microscopy (LCM) 
Tissue sections (10µm) of C57BL/6 embryos at day E10.5 of gestation were mounted on glass slides 
covered with a 1.35µm thin polyethylene foil (PALM Microlaser Technologies) which were pre-treated first 
with RNaseZap (Ambion) and then UV-irradiated in a cell culture hood for 30-60 min to improve the 
adherence of frozen sections. The sections were air dried for 2 min, fixed in 70% ethanol (Fluka) (1 min), 
stained with 1% Cresyl violet acetate (1 min), dehydrated (1 min 75% EtOH and 1 min 100% EtOH), air 
dried and stored at -80°C until used for LCM. DEPC-treated water was used to dilute the ethanol and 
working space was cleaned with RNaseZap to avoid contamination with RNases.  
The PALM Microlaser dissecting microscope (Carl Zeiss) was used to excise the specific cells from 
the ventral and dorsal aspect of the third pharyngeal pouch. All microdissected tissues were catapulted 
into the PALM Adhesive Caps (PALM Microlaser Technologies) by slightly increasing the energy (Δ5-
10U) of the laser. At the end of each LCM session which lasted at maximum one hour, 350μL of cell lysis 
buffer RLT (Qiagen) was added to the laser captured cell,  the cap was closed and tissue homogenized 
by vortexing for 20 sec. Total RNA was then extracted using the RNAeasy Micro Kit (Qiagen) and the 
manufacturer`s recommendation. The yield and integrity of isolated RNA was routinely assessed by RNA 
6000 Pico assay and Agilent 2100 bioanalyzer. Subsequently, cDNA was synthesized and analysed for 
Sox9 expression. 
 
7.2.5. Cell isolation and flow cytometry  
To obtain thymic stromal cells, thymi were cleaned of fat and connective tissue and either single (for 
TEC enumeration and analysis of Ki67 expression) or maximal three pooled thymi (for enrichment and 
cell sorting) were sequentially digested 3x15 min at 37°C with HBSS containing Collagenase D (1mg/ml) 
and DNase I (50µg/ml) (both Roche Diagnostic) (2ml per thymus) until a single-cell thymic suspension 
was achieved. After each step, the thymic fragments were gently resuspended, allowed to settle, the 
supernatant was transferred into a tube containing 5ml cold HBSS/5% FBS/10mM EDTA and digestion 
repeated using remaining thymic fragments. Supernatants from all digestions were centrifuged at 1500 
rpm for 5 min, resuspended in HBSS/5% FBS/10mM EDTA (2ml per thymus) and filtered through a 40μm 
mesh to remove clumps. Viable cells gated according to size were counted (total thymus cellularity) using 
a Z2 Coulter Counter (Beckman Coulter).  
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For phenotypic and numerical analysis of TEC, 20×10
6
 cells from non-enriched single-cell 
suspension were stained to avoid selective loss of any TEC subset consequent to the enrichment 
procedure. Following combination of directly conjugated antibodies was used: CD45 PECy7, EpCam Cy5, 
pan MHCII (I-A/I-E) Fluos and Ly51 PE. Cells were incubated with 1ml of antibody mixture (i.e 100µl per 
2x10
6
 cells) for 1 h on ice, thereafter washed with ice cold HBSS/ 2%FBS and harvested for flow 
cytometry. The labelled cells were acquired with a FACS Calibur flow cytometer (BD Bioscience) and 
data analysed using Cell Quest Pro Software (Becton Dickinson) or FlowJo 7.2.5 (Tree Star). For TEC 
quantification, forward/side scatter gates were set to include both T-cells and TEC and to exclude non-
viable cells. TEC defined as CD45
-
EpCam
+
 were subdivided based on Ly51 and MHCII expression into 
three subsets: cTEC (Ly51
+
MHCII
+
); mTEClo (Ly51
-
MHCII
lo
) and mTEC
hi
 (Ly51
-
MHCII
hi
). Absolute TEC 
numbers (i.e TEC cellularity) were derived from the percentage of TEC obtained in whole thymus (total 
thymic cellularity). The absolute numbers of different TEC subsets were then calculated as the percent of 
TEC cellularity which was set to 100%. 
To obtain lymphocytes, thymi and spleens were placed between a 40µm nylon mesh in 1mL of 
IMDM/2% FCS and gently squeezed with a plunger until all cells were in suspension. After washing, cells 
were resuspended in 2ml PBS/2% FBS per thymus, filtered and counted. 
For analysis of T-cell development, 1.5x10
6
 cells from the single cell suspuspension was stained with 
directly conjugated antibodies specific for CD3 Cy5, CD4 PE, CD8 PECy7 in combination with either 
CD24 FITC, or CD69 FITC. Development of lineage negative, double negative (DN) thymocytes was 
assessed by staining with directly conjugated antibodies specific for CD44 PE, CD25 FITC and c-kit APC 
combined with bio-conjugated lineage markers specific for CD3, CD4, CD8, TCRβ, TCRγδ, NK1, CD11b, 
CD11c, CD19 followed by Streptavidin (ST) PECy7. The frequency of splenic T and B cells was 
determined by staining cells with antibodies specific for B220 FITC, CD3 Cy5, CD4 PE and CD8 PECy7. 
For the staining, cells were distributed into a 96-well round bottom plate, spun down, resuspended in 
100μL of antibody solution per 1x106 cells and incubated for 30-45 min on ice in the dark. Cells were 
then washed and either harvested for flow cytometry or incubated with appropriate secondary reagent, 
washed and then analysed by flow cytometry. 
 
7.2.6. Thymic stromal cell (TSC) enrichment and sorting 
Enrichment of TEC by autoMACS 
TEC for sorting were enriched by EpCam-mediated magnetic separation on autoMACS (Miltenyi 
Biotec) according to the manufacturer's protocol. Briefly, thymic single-cell suspensions, each containing 
maximal three digested 4 week old thymi, were centrifuged at 1`500 rpm for 5 min and cells resuspended 
in HBSS/5% FBS at 100×10
6
 cells per ml (approximately 600-800×10
6
/6-8ml). Cells were stained with 
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biotinylated EpCam (G8.8) mAb for 15 min on ice, washed and again adjusted to 100x10
6
 cells per ml. 
35µl Anti-Biotin Microbeads (Miltenyi Biotec) was added and the mixture incubated for 15 min in the 
fridge, washed, filtered and resuspended once more at 100×10
6
 cells per ml. Labelled cells were 
positively selected on an AutoMACS machine (Miltenyi Biotec) using the "Possel/QRinse program. 
EpCam-enriched cells were collected in tubes pre-coated and filled with 2ml IMDM/10% FBS/2.5mM 
EDTA, recovered by centrifugation (1`800 rpm, 5 min), washed, resuspended in 1ml HBSS/5% FBS, and 
counted (app. 6-12×10
6
 per three 4 week old thymi). 
Cells were stained with the following combination of primary antibodies diluted in HBSS/5% FBS: 
CD45 PECy7, EpCam bio, Ly51 PE, MHC class II (I-A/I-E) Fluos, UEA-1 Cy5. Briefly, 100µL antibody 
mixture was added per 1×10
6
 enriched TEC and incubated for 1 h on ice. After washing, cells were 
incubated with ST APC-Cy7 for 15 min, thereafter washed, resuspended in 200µl HBSS/2% FBS and 2x 
concentrated DAPI solution (200µl) was added to final concentration of 0.1ng/µl. Different TEC 
populations (Figure 3.5 and Appendix 8.1) were sorted using a FACSAria (BD Biosciences) and 
subsequently proceeded for RNA isolation (RNAeasy Micro kit, Quigen) and qRT-PCR analysis. TEC 
purity was routinely assessed by re-analyzing sorted cell fractions and was always above 95%. DAPI and 
doublet discrimination by SSC-H/SSC-W were used to exclude the death cells. Thymi from mice of both 
sexes at 4 weeks of age were pooled to obtain sufficient TEC numbers for RNA isolation. Between 6-12 
Sox9-deficient and -proficient thymi were used per sort. 
Enrichment of TSC by Percol 
For analysis of Sox9 expression in different thymic stromal subsets, thymi from 15 adult 6 weeks old 
C57BL/6 mice were enzymatically digested as described before. TSC were enriched by depleting most 
thymocytes with gradient density centrifugation in Percoll PLUS silica-based colloidal medium (GE 
Healthcare). Thymic single-cell suspension each containing maximal three digested 4 week old thymi 
were centrifuged for 5 min at 1500 rpm, resuspended in 3ml Percoll dense (1.115kg/m3) and carefully 
overlaid with 3ml Percoll light (1.065 kg/m3) followed by 2ml 1xPBS. Samples were centrifuged at 2500 
rpm for 30 min, rotor radius 17.3, brake/acceleration off. Cells were collected from the interface Percoll 
light/PBS, into a fresh tube with 5ml PBS/2% FCS, washed, resuspended in 1mL PBS/2% FCS, filtered 
and counted. Usually, about 15-30x10
6
 Percoll-enriched stromal cells from three thymi were recovered. 
Cells were stained with the following combination of primary antibodies using 100μl Ab mixture per 1-
2x10
6
 cells: CD45 PECy7, EpCam bio with ST-PE, Ly51 FITC and MTS15 Cy5. Different TEC (CD45
-
EpCam
+
) and non-TEC (CD45
-
EpCam
-
Ly51
+
) subsets (Figure 3.3) were sorted using a FACSAria (BD 
Biosciences). 
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7.2.7. Ki67 staining 
To measure TEC proliferation, EpCam-enriched cells prepared as described above were stained for 
surface antigens for 30 min on ice using the combination of following primary antibody: CD45 PECy7, 
Ly51 A647 and MHC class II (I-A/I-E)-Fluos. After washing, TEC were fixed and permeabilized in 
Fixation/Permaebilization Buffer (Diluent and Concentrate mixed 3:1; eBioscience) for 30 min on ice, 
thereafter washed in 1x Permeabilization Buffer and stained with an anti-Ki67 PE mAb for 30 min on ice. 
After washing with 1x Permeabilization Buffer (eBioscience) cells were harvested for flow cytometry. Ki67 
expression was assessed in distinct TEC subsets (Appendix 8.2). Non-viable cells and hematopoietic 
cells were excluded from the analysis based on their FSC/SSC scatter properties. As a negative control 
for Ki67, Mouse IgG-PE antibody (isotype control) was used. An FcR block was employed before 
applying the antibody stain. Ki67 expression in cTEC isolated from 4 and 12 weeks old mice could not be 
accurately assessed, as the frequency of Ly51
+
 cTEC obtained per individual thymus was too low. The 
same protocol for Ki67 staining was used to analyse the proliferation of TEC lines retrovirally transduced 
with either wild type and mutant Sox9 or empty vector control. 
 
7.2.8. Generation of Sox9 retroviral constructs 
Full-length, wild type Sox9 (Sox9 WT) encodes amino acids 27-508 (76-1524bp, amplicon 1449bp) 
and contains the N-terminal (HMG) DNA binding domain and C-terminal transactivation (TA) domain. C-
terminal truncated, mutant Sox9 (Sox9 M) encodes amino acids 27-304 (76-912bp, amplicon 837bp) and 
lacks the TA domain but retains the DNA binding domain (Lefebvre et al. 1997). The forth ATG (26. 
codon) of the Sox9 coding sequence (362-1885bp) was used as a start codon. Two sets of Sox9-specific 
PCR primers containing BamHI/NotI restriction sites were designed by hand. For the generation of mutant 
Sox9, reverse primer introducing an additional stop codon (TGA) and containing NotI site was designed 
to terminate the translation. 
5`HA pPRIG_c (plasmid Polylinker Retroviral IRES GFP) (Albagli-Curiel et al. 2007) used in this 
study (Appendix 8.3) is an IRES-containing retroviral vector allowing expression of both the protein of 
interest (i.e Sox9 WT and Sox9 M) and a marker protein (eGFP) from a single bicistronic mRNA 
facilitating the selection of transduced cells based on eGFP detection. The hemagglutinin (HA) tag 
sequence is inserted in one (i.e c) of three reading frames 5' of the multiple cloning site (MCS) flanked by 
T7 and SP6 sequences and allows the detection of exogenous protein in target cells and pull down 
experiments. In contrast to many other retroviral vectors which harbour two complete LTR sequence, in 
this vector the 5`LTR in the U3 region has been replaced by CMV enhancer/promoter allowing more 
potent CMV-driven expression. Also the use of wild type IRES sequence enhances the translation of 
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eGFP about 10 fold without affecting any other important parameters (i.e viral titer or the cDNA 
expression).  
 
7.2.8.1. Cloning of wild type and mutant Sox9  
PCR amplification of Sox9  
cDNAs for wild type and mutant mouse Sox9 were PCR amplified from the OP9 DL1 cell line with the 
high fidelity KOD Hot Start DNA Polymerase (Novagen) and Sox9-specific primers introducing BamHI 
and NotI restriction sites. Following PCR reaction was set up:  
50ng cDNA (OP9 DL1) 
1µl Forward primer (10µM) 
1µl Reverse primer (10µM) 
5μl dNTPs (2mM) 
5µl KOD buffer  
2μl MgSO4 (25mM) 
1.2µl KOD Polymerase 
Add H2O up to 50µl 
PCR conditions  
94°C 4 min 
30 cycles: 94°C 30 sec; 58°C 30 sec; 68°C 2 min 
68°C 10 min 
The wild type (1449bp) and mutant (837bp) Sox9 fragments were precisely excised from a 1% agarose 
gel in order to avoid contamination with unspecific products that might be amplified by PCR. The 
subsequent purification of the amplicons from the piece of gel was done using the MinElute Gel 
Extraction kit (Qiagen) according to the manufacturer's instructions. The DNA fragments were eluted in 
15µl of TE buffer. Since KOD Hot Start DNA Polymerase generates blunt ends, purified PCR products 
were next digested for BamHI/NotI to obtain sticky ends. As the enzyme`s buffers were not compatible, 
the sequential digestions were performed with intermediate purification of fragments using MinElute PCR 
purifications kit (Qiagen). 
 
Restriction endonuclease digest of PCR products 
Sequential BamHI/NotI digestion of PCR-amplified Sox9 WT and Sox9 M 
(i) 15µl DNA 
 2µl BamHI Buffer (x10) 
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 1µl BamHI (10U/µl) 
 2µl H2O 
 Vtotal = 20µl; incubation for 1 h @ 37°C 
(ii) PCR Purification 
(iii) Velution = 15µl  
 2µl Orange Buffer (x10) 
 1µl NotI (10u/µl)  
 2µl H2O 
 Vtotal = 20µl; incubation for 2 h @ 37°C 
The digested DNA fragments were purified from the gel and eluted in 15µl of TE buffer. Wild type and 
mutant Sox9 were originally cloned into the retroviral vector LZRSpBMN-linker-IRES-eGFP (p166) 
(Heemskerk et al. 1997) (generously provided by H. Spits), but since for biochemical analysis we needed 
tagged-Sox9 they were cut out by BamHI/NotI digestion and re-cloned into 5`HA pPRIG  (Albagli-Curiel et 
al. 2007) retroviral vector. For this purpose, 5`HA pPRIG was cut with the same restriction enzyme as 
following. 
 
Sequential BamHI/NotI digestion of 5`HA pPRIG vector 
(i) 2µl cDNA (3.9µg/µl) 
 1µl BamHI Buffer (x10) 
 1µl BamHI (10U/µl) 
 6µl H2O 
 Vtotal = 10µl; incubation 1 h @ 37°C  
(ii) PCR Purification:  
(iii) Velution = 30µl 
 3.5 µl Orange Buffer (x10) 
 1µl NotI (10U/µl) 
 0.5µl H2O 
 Vtotal = 35µl; incubation 2 h @ 37°C  
(iv) Heat inactivation of NotI (20 min @ 80°C)  
 
Dephosphorylation of DNA 
The linearized vector backbone was dephosphorylated with calf intestine phosphatase (CIP) (Roche) 
to avoid self-ligation. Briefly, 1µl CIP was added to the vector and incubated for 30 min at 37°C followed 
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by another round of CIP addition and incubation. After dephosphorylation the retroviral backbone was gel-
purified using the gel extraction kit (Macherey Nagel) and eluted in 15µl of TE buffer. 
Ligations  
The amount of vector and insert was estimated on a 1% agarose gel and ligation reactions were carried 
out in a final volume of 10-20µl using a molar ratio of 1:3 vector:insert. “Sticky ends” were ligated for 1 h 
at RT with 1μl T4 ligase (Invitrogen). 
Ligation reaction:  
xy µl Vector backbone  
xy µl Insert  
2µl 5x DNA Ligase Reaction Buffer 
1µl T4 DNA Ligase (Invitrogen) (1U/µl) 
µl H2O up to 10-20µl 
 
Generation of competent bateria 
Competent bacteria for plasmid transformation were made in-house according to the TOP10 
competent cells protocol (OpenWetWare). For the preparation of competent bacteria 10µL of DH5α E. 
coli bacteria were mixed with 100µl LB medium, streaked on an agar plate and grown overnight for single 
colonies at 37°C. A single colony was inoculated in 5ml SOB medium and grown overnight at RT on a 
shaker at 220 rpm (Vaudaux-Eppendorf). The 5ml starting culture were added to 200ml SOB medium and 
grown at RT with shaking at 220 rpm to an optical density (OD600) of 0.5. The bacteria culture was then 
centrifuged at 3`000 g for 10 min at 4°C. The supernatant was removed and the pellet resuspended in 
80ml of ice-cold CCMB80 buffer (see 5.1.2), incubated on ice for 20 min, thereafter centrifuged again and 
resuspended in 20ml of ice-cold CCMB80 buffer. After another 20 min of incubation on ice, 200µl of the 
suspension were aliquoted into chilled PCR strip tubes and frozen at -80°C. 
 
Bacterial transformation 
To transform bacteria, 5µl of the ligation mix were incubated with 100μl of DH5α competent cells in 
chilled 15ml polypropylene tubes for 30 min on ice. The mixture was then transferred into a waterbath at 
42°C for 2 min and immediately placed back on ice for 2 min for the heat shock transformation. To 
recover bacteria, 500μl SOC medium was added and tubes were incubated at 37°C for 1 h shaking at 
220 rpm. 100μl bacteria were streaked onto prewarmed and dried agar plates supplemented with 
Ampicilin (100mg/ml) (Sigma) and grown overnight at 37°C. The plates were stored at 4°C until further 
use. 
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DNA extraction  
Single colonies were picked from plates and used to inoculate 2ml of LB medium containing 
Ampicillin (100mg/ml). Bacteria were grown overnight at 37°C in an incubator shaking at 220 rpm. 
Samples were then centrifuged at 4`000 rpm for 10 min at 4°C, the supernatant was discarded and the 
remaining pellet further processed for DNA extraction. The plasmids containing either no insert oder wild 
type and mutant Sox9 were purified using Miniprep or Maxiprep plasmid extraction kits (Macherey Nagel) 
according to the manufacturer’s guidelines. Each of the purified plasmids was eluted in 40µl elution 
buffer. The concentration of the purified plasmids was measured by optical density (OD) using the 
following formula: concentration (µg/ml) = 50 x OD260 x dilution. 
 
Restriction endonuclease digestions of plasmids 
Plasmids were screened for the presence of Sox9 inserts by performing either single digestions with 
enzymes that cut exclusively within the Sox9 sequence (SmaI, Sfi, BglI, AvaI) or by double digestions 
where one enzyme cut within the Sox9 and other one within the retroviral backbone (SfiI/BamHI, 
SfiI/SnaBI, Sfi/NotI). Restriction endonucleases were bought either from MBI Fermentas or NEB and in 
general, digestion reactions were carried out in a total volume of 10µl according to the manafacture`s 
instructions. The size of the digested plasmid fragments was checked on a 1% agarose gel. Positive 
clones were further confirmed by sequencing. 
 
DNA Sequencing 
Sox9 sequencing primers were designed using Vector NTI (Invitrogen) to generate 400-600bp 
products (max. 700bp allowed for sequencing) and to cover the full length of wild type and mutant Sox9, 
including the N`HA-tag and part of the vector backbone. For the sequencing of the Sox9 plasmids, the 
following PCR reaction was prepared in a 0.2ml microtube: 
500ng plasmid 
2µl Ready Reaction Mix v1.1 (Applied Biosystems) 
2µl Big Dye Terminator Sequencing Buffer (x5) 
0.5µl DMSO 
0.5µl Primer x (10µM) (see section 5.1.3 for its sequence) 
µl H2O up to 10µl.  
The DNA was amplified using the following PCR conditions: 
96°C 1min  
25 cycles: 96°C 15s; 50°C 5s; 60°C 4min  
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The PCR products were purified using nucleoSEQ columns (Macherey-Nagel) and the manufacturer's 
instructions. For the sequencing, 4µl of the purified products were mixed with 16µl of fresh Formamide 
(Sigma) in a new 0.2ml microtube and the mixture was store at 4°C. Sequencing was performed in-house 
on an ABI 310 sequencing machine (Applied Biosystems). Trace files were first checked for quality and 
reliability by inspecting the obtained profiles of fluorescence peaks. Analysis was carried out using Vector 
NTI software for sequence alignments and reassembly of single sequencing reactions. 
 
7.2.8.2. Production of Sox9 recombinant retroviruses and transduction of target cells  
Cell lines  
The retrovirus packaging cell line Platinum-E (Plat-E) (Morita et al. 2000) was a gift from T.Kitamura, 
(Tokyo, Japan). This cell line contains a packaging construct that utilizes the EF1α promoter which is 100 
fold more potent than the conventionally used MuLV-LTR promoter, and in combination with the Kozak 
sequence upstream of the initiation codon results in high expression of virus structural proteins (gag-pol 
and env). The cortical thymic epithelial cell line cTEC1.2 was derived from young animals (Kasai et al. 
1996) and was a gift from Dr. M. Kasai (Tokyo, Japan).  
PlatE cells were cultured in IMDM containing L-glutamine, 25mM HEPES and 3,024mg/L sodium 
bicarbonate supplemented with 10% FCS, 2-mercaptoethanol (50µM) and Penicillin (100U/ml)/ 
Streptomycin (100μg/ml) solution. cTEC1.2 were cultured in the same medium but in the absence of 
antibiotics. Cells were grown at 37°C with 5% CO2 in an incubator. To detach the cells, Trypsin 0.25% 
/EDTA was added for 5-10min at 37°C, thereafter cells were washed with the culture medium to inactivate 
Trypsin and recovered by centrifugation (1`500 rpm for 5 min at 4°C).  
 
Transfection of PlatE  
PlatE cells were grown in 2ml culture medium in a 6-well plate to reach 1/3 confluency. Plasmids 
containing only eGFP (control) and either the HA-tagged wild type or mutant Sox9-ires-eGFP sequence 
were transfected into PlatE cells using FuGene6 (Roche diagnostics) transfection formulation according 
to the manufacturer. Briefly, 3µl of Fugene6 reagent were mixed with 97µl of serum free IMDM media and 
incubated for 5 min at RT. 1µg of plasmid DNA was added, tubes flicked and incubated for 15 min at RT. 
PlatE medium was replaced with 2ml fresh media and 100µl of the DNA/transfection mixture added 
dropwise to the cells of each well. The plate was then gently stirred in a circular and horizontal fashion to 
get a homogenous distribution. The transfection efficiency was evaluated by FACS and IHC analysis of 
eGFP expression (Appendix 8.3). The supernatants containing virus particles were collected 48-72 h 
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later, filtered through a 0.45µm filter using a syringe and polybrene was added to a final concentration of 
10µg/ml.  
 
Transduction of TEC  
cTEC1.2 were grown in a 6-well plate to an approximate density of 30%. For the transduction, the 
medium was aspirated and 1ml of viral supernatant added. After 5 h incubation at 37°C 2ml fresh cell 
culture media were added to the cells. 72 h post-transduction eGFP
+
 cells were sorted using a FACSAria 
to deplete the cultures of untransduced cells. Sorted cells were then expanded for subsequent qRT-PCR, 
WB and IP analysis. Transduction efficiency of wild type Sox9 was always lower when compared to 
mutant Sox9 as evaluated by qRT-PCR, FACS and WB analysis of Sox9, HA and eGFP expression. 
 
7.2.9. Western blotting (WB) 
Cell lysate preparations  
For total lysate preparations, stably transduced cTEC1.2 with either HA-tagged Sox9 WT and Sox9 
M or an empty retroviral vector (control) were lysed in RIPA buffer (200µl per well of a 6-well plate) 
containing Complete protease inhibitor cocktail (Roche). Nuclear and cytoplasimic fractions were 
prepared using the CelLytic NuCLEAR Extraction kit (Sigma-Aldrich) according to the manufacturer`s 
instructions. Protein concentration was measured using the Bradford assay (Biorad) in comparison to a 
previously established standard curve and equal protein amounts were subjected to SDS-PAGE or stored 
at -20° until further use. 
SDS-Page Gel 
Glass plates were assembled according to the Mini-Protean 3 Electrophoresis system (Biorad). The 
separating gel (see 5.1.2) was poured, overlayed with H2O and left for 30 min at RT to polymerize. The 
water was removed, the stacking gel (see 5.1.2) poured onto the top of the separating gel and the comb 
inserted. Once the stacking gel has polymerized, the comb was removed and the glass plates with gels 
mounted in the electrophoresis apparatus. 1x Running buffer (see 5.1.2) was added to the system and 
the wells briefly washed using a syringe. Samples were prepared by heating them to 95°C for 5 minutes 
in 1x Loading buffer (see 5.1.2). Proteins (20-40μg per well) were loaded into the wells, one well was 
loaded with 2μl of a colored marker (Caleidoscope, Biorad) and the empty wells with 1x Loading buffer. 
The gel was run at 150V for appropriate time. The glass plates and stacking gel were removed and the 
separating gel rinsed with transfer buffer. 
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Transfer 
The nitrocellulose membrane cut to the appropriate size was pre-wet in 1x Transfer buffer (see 
5.1.2). The gel-membrane sandwich was assembled preventing air bubbles between the layers as 
following: Cathode (-): fiber pad - 2 Whatman papers - gel – membrane - 2 Whatman papers - fiber pad: 
Anode (+). The sandwich was inserted into a transfer plate and then put in the electrophoresis apparatus 
(BioRad) filled with 1xTransfer buffer. The electrophoris was run at 100V for 1h. 
 
Western Blot 
Once the proteins were transferred, the membrane was rinsed with TPBS (0.1% Tween 20 in PBS) 
and unspecific binding blocked with Blotto solution (5% skim milk in TPBS) for 1 h at RT. The membrane 
was then incubated overnight at 4°C on a shaking platform with following primary antibodies diluted in 
Blotto solution: mouse anti β-Catenin mAb, rabbit anti-Foxn1 pAb (Itoi et al. 2007a), mouse anti-HA mAb, 
and rabbit-anti Sox9 polyclonal Ab (Stolt et al. 2003). Rabbit anti-GAPDH polyclonal Ab, mouse anti-
Histon H1 mAb and mouse anti-α-Tubulin mAb served as loading or purity controls. The membrane was 
then washed 2x10 min with TPBS and incubated with the appropriate HRP-conjugated secondary 
antibodies diluted in Blotto for 45 min at RT (on a shaking platform, followed by washing 2x10 min with 
TPBS. Finally, the membrane was incubated for 5 min with SuperSignal West Pico Chemiluminescent 
Substrate working solution (Pierce) (Luminol/Enhancer and Stable Peroxide solution mixed 1:1). The wet 
membrane was then wrapped in a plastic foil, an appropriately sized piece of Kodax BioMax Light film 
(Sigma) was put on the membrane in a dark room and exposed for 5 sec to 60 min. 
 
7.2.10. Protein immunoprecipitation (IP) 
For IP experiments, HA-tagged Sox9 WT and Sox9 M or alternatively β-catenin were 
immunopercipitated from total cell lysates using anti-HA or β-catenin antibodies, respectively and Protein-
G GammaBind Plus Sepharose beads (GE Healthcare) according to the manufacturer`s instructions. 
Briefly, equal amounts of cleared lysates (1mg) of cTEC1.2 stably transduced to express HA-tagged Sox9 
WT or Sox9 M were incubated overnight at 4°C with antibodies specific for HA, β-catenin or mouse IgG 
as a control (5µg per sample). Protein-G beads were then added and the mixture incubated for 1 h at 
4°C. Immunoprecipitates were washed 3x with Ripa buffer, resolved by SDS-PAGE and analysed by WB 
analysis (as described above) using anti-β-catenin or Sox9 antibodies, respectively. The secondary 
reagents used were HPR-conjugated Goat-anti Mouse Ab and Goat-anti Rabbit Ab. Signals were 
detected with SuperSignal West Pico chemiluminiscent substrates (Pierce). The amounts of β-catenin 
and Sox9 protein were quantified using NIH Image-J software.  
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7.2.11. In vitro BrdU labelling of TEC 
To measure proliferation of TEC stably transduced to express either Sox9 WT and Sox9 M or empty 
vector (control), cells were seeded one day before the BrdU (Sigma-Aldrich) addition in a 6-well plate at 
density of 1x10
5 
cells per well. Next day, cells were pulsed with BrdU at final concentration of 1.25µg/ml 
and BrdU incorporation assessed 16 h and 24 h later. The total cell numbers were determined at the end 
of the experiment using a Neubauer chamber. For the BrdU staining, cells were trypsinized, washed with 
medium and resuspended in 0.5ml ice cold 0.15M NaCl. The suspensions were then added dropweise to 
1.2ml ice cold 95% ethanol in 5ml FACS tube while vortexing. Samples were incubated for 30 min on ice, 
spun down (2`000 rpm for 5 min at 4°C) and cells fixed with 0.5-1ml 1% PFA/0.01% Tween/PBS for 30 
min at RT. After centrifugation, cells were incubated in 1x DNAse incubation buffer containing RNAse-free 
DNAse I (Roche Diagnostics) at 5U/ml for 10 min at RT, thereafter spun down and stained with anti-BrdU 
PE mAb diluted 1:1 with 1x PBS for 30 min at RT. The cells were then washed with 1xPBS, resuspended 
in 100µl PBS/2% FBS and BrdU incorporation analysed by flow cytometry. Experiments were always 
performed in triplicates for both a 16 h and 24 h BrdU pulse. As a negative control, cells not exposed but 
stained for BrdU were used. Also, an isotype control, i.e cells treated with BrdU and stained with Mouse 
IgG1-PE isotype antibody was included. 
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10. APPENDIX 
10.1. Figures 
 
Appendix Figure 8.1. Cellular and molecular analysis of adult thymic epithelia. 
(A) Gating strategy used to sort distinct TEC subsets from adult 4 week old Sox9 deficient and proficient mice. 
Alive (DAPI
-
) TEC (CD45
-
EpCam
+
) were separated into cTEC (UEA1
-
Ly51
+
) and mTEC (UEA-1
+
Ly51
-
). The mTEC were further 
differentiated into immature (MHCII
lo
; mTEC
lo
) and mature (MHCII
hi
; mTEC
hi
) subsets. (B) Assessment of TEC purity by (i) re-
analysing of sorted cell fractions and (ii) qRT-PCR analysis using ß5t as cTEC, Aire as mTEC
hi
 and CCL21 as mTEC
lo
 marker. The 
expression of each TEC subset-specific marker was set to an arbitrary value of 1 and compared with the signal detected in two 
other subsets, respectively. For assessment of possible contamination with the cells of hematopoietic origin, CD45 expression 
detected in distinct TEC subsets was normalized to GAPDH and compared to EpCam expression in the same subset which was 
arbitrary set to a value of 1. (C) RNA integrity of sorted TEC was assessed using RNA 6000 Pico assay and Agilent 2100 
bioanalyzer. Electropherograms and corresponding gel picture are shown. (D) Sorted TEC subsets were plotted according to their 
size (FSC) and granularity (SSC). 
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Appendix Figure 8.2. Composition and proliferation of thymus with Sox9 proficient and deficient TEC. 
(A) Representative dot plots show gates used to define and quantify three major TEC subsets present in whole 
thymic preparation of [Sox9
f/f
] and [Sox9
f/f
::Foxn1Cre] mice at the indicated ages. TEC defined as CD45
-
EpCam
+
 
cells were subdivided based on Ly51 and MHCII expression into: cTEC (MHCII
+
Ly51
+
), mTEC
lo
 (MHCII
lo
Ly51
-
) and 
mTEC
hi 
(MHCII
hi
Ly51
-
). Different gates were applied because levels of MHCII expression changed with age and the 
compensation needed to be accordingly adjusted. (B) Assessment of TEC proliferation in Sox9 deficient and 
proficient mice. Representative histograms of Ki67 expression in above defined TEC subsets with markers set 
according to isotype control are shown. 
  
Appendix 
132 
 
Appendix Figure 8.3. Retroviral transduction of cTEC1.2 line with mutant Sox9 (Sox9 M) and wild type Sox9 
(Sox9 WT). 
(A) Design of retroviral vector pPRIG 5'HA. CMV: cytomegalovirus promoter; LTR: long terminal repeat; HMG: high 
mobility group; TA: transactivation domain; IRES: internal ribosomal entry site; eGFP: enhanced green fluorescent 
protein; HA: hemagglutinin tag; Sox9 M: mutant Sox9; Sox9 WT: wild type Sox9. (B) Generation of retroviruses and 
transduction of target cells. (i) Transfection of Plat-E packaging cell line with an empty retroviral vector encoding 
eGFP (control) or a vector recombinant for either a HA-tagged Sox9 M- or a Sox9 WT- ires – eGFP (upper panels) 
and transduction of cTEC1.2 (lower panels). (ii) eGFP translated from IRES as a reporter gene served to assess 
transduction efficiency (upper panels) and to sort eGFP
+
 cell populations which have stably integrated the viral 
construct into the genome (lower panels). (C) Assessment of Sox9 expression in stably transduced cTEC1.2. (i) Up 
regulation of Sox9 mRNA expression levels in cTEC1.2 transduced to express HA-tagged mutant (M) or wild type 
(WT) form of Sox9. The Sox9 data represents the mean ± SD of triplicate qRT-PCR analyses where Sox9 expression 
in cells transduced with an empty retroviral vector (control) was set arbitrary to a value of 1. The data is 
representative of four independent experiments. Statistical significance was calculated using the paired t-test; *p < 
.05, **p < .01. (ii) Detection of HA-tagged mutant and wild type Sox9 in transduced cells by WB analysis using anti-
HA antibody. (D) Exogenous Sox9 protein expression in cTEC1.2 transduced with mutant or wild type Sox9 was 
assessed by immunofluorescence analysis using (i) anti-Sox9 and (ii) anti-HA antibodies. 
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10.2. Abbreviations 
 
Aire  murine autoimmune regulator protein 
APECED  autoimmune polyendocrinopathy candidiasis ectodermal dystrophy 
bp   base pair 
CD   cluster of differentiation 
cDNA complementary DNA 
CDS   coding sequence 
CK cytokeratin 
CMV   cytomegalovirus 
cTEC cortical thymic epithelial cell 
DC   dendritic cell 
DN double negative T cells 
DNA   deoxyribonucleic acid 
DP double positive T cells 
E embryonic day of gestation 
ECM  extracellular matrix 
eGFP = enhanced green fluorescent protein 
FACS   fluorescence activated cell sorting 
H-2   mouse MHC (see also HLA and MHC) 
HA tag hemagglutinin tag 
HLA   human leukocyte antigen (see also MHC and H-2) 
HMG high mobility group 
HSC   hematopoietic stem cell 
Ig immunoglobulin 
IRES   internal ribosomal entry site 
ISP   immature single positive 
LCM laser capture microdissection 
LTR long terminal repeat 
M mutant 
MHC major histocompatibility complex (See also HLA and H-2) 
mAb   monoclonal antibody 
mRNA messenger RNA 
mTEC medullary thymic epithelial cell 
NCC   neural crest cells 
ORF open reading frame 
NK natural killer cell 
NLS   nuclear localization signal 
pAb   polyclonal antibody 
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PCR  polymerase chain reaction 
PGA promiscuous gene expression 
pp  pharyngeal pouch 
qRT-PCR  quantitative real time polymerase chain reaction 
Rag   recombination activation gene 
RNA ribonucleic acid 
RT room temperature 
RTE recent thymic emigrant 
SCID severe combined immunodeficient 
SOX9  human Sry-box containing protein 9 
Sox9  murine Sry-box containing protein 9 
sox9 murine Sry-box containing gene 9  
SP   single positive T cells 
TA transactivation domain 
TCR  T cell receptor 
TEC  thymic epithelial cell 
TSA  tissue specific antigen 
WT wild type 
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